data_2lm3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lm3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.77 29.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -108.1 48.07 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 40.0 110.638 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.78 0.32 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.444 -0.344 . . . . 40.0 110.74 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.94 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -92.35 7.55 42.39 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.058 0.456 . . . . 40.0 110.059 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.94 158.84 21.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.02 -0.536 . . . . 40.0 111.082 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.33 107.65 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.018 -0.537 . . . . 40.0 110.141 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.11 135.02 27.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.598 ' O ' HG21 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.95 7.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.682 ' CB ' ' O ' ' A' ' 324' ' ' SER . 21.1 ttm180 . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 112.651 0.612 . . . . 40.0 112.651 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.117 0.484 . . . . 40.0 111.012 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 311' ' ' SER . 29.1 p -133.81 85.7 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.738 -0.665 . . . . 40.0 110.274 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.442 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.706 ' HZ2' ' HB3' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . 0.411 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.639 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.25 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -66.62 -40.01 88.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.529 -0.305 . . . . 40.0 111.466 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.86 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.55 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . 0.43 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.643 HE21 ' HH ' ' A' ' 466' ' ' TYR . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.55 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.42 HG21 HD12 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' ASP . . . . . 0.738 ' H ' ' HG1' ' A' ' 459' ' ' THR . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' THR . . . . . 0.738 ' HG1' ' H ' ' A' ' 440' ' ' ASP . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . 0.406 HD11 HG23 ' A' ' 465' ' ' ILE . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.643 ' HH ' HE21 ' A' ' 418' ' ' GLN . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . 0.411 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . 0.681 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.16 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 16.4 tttp 61.76 -22.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.545 . . . . 40.0 111.269 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' CYS . . . . . 0.706 ' HB3' ' HZ2' ' A' ' 372' ' ' LYS . 38.2 t -62.24 124.96 22.27 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.556 -0.457 . . . . 40.0 110.062 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 1.5 m -72.71 -20.95 61.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 40.0 111.326 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.604 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.68 116.63 45.27 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' THR . . . . . 0.607 ' CG2' ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' SER . . . . . 0.888 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.67 30.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.58 47.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.578 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.66 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.807 -0.357 . . . . 40.0 110.74 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.01 47.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.2 5.78 47.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 40.0 110.304 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.81 158.91 20.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 40.0 111.082 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.6 107.9 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.102 -0.499 . . . . 40.0 110.04 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.21 135.02 27.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.618 ' O ' HG22 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 173.1 7.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 51.2 ttm-85 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 40.0 111.034 178.64 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 121.202 0.525 . . . . 40.0 111.707 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' THR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 311' ' ' SER . 29.1 p -154.75 85.7 1.11 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.281 -0.872 . . . . 40.0 110.274 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.724 ' HZ2' ' CB ' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.37 53.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.09 -39.31 86.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.87 -0.332 . . . . 40.0 111.463 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.88 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.55 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.558 HE21 ' HH ' ' A' ' 466' ' ' TYR . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.55 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG23 HD11 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.415 HG23 HD13 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 458' ' ' ILE . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . 0.405 HD13 HG23 ' A' ' 465' ' ' ILE . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.558 ' HH ' HE21 ' A' ' 418' ' ' GLN . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . 0.68 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.02 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 22.6 mttp 61.55 -21.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.786 -0.643 . . . . 40.0 111.375 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' CYS . . . . . 0.724 ' CB ' ' HZ2' ' A' ' 372' ' ' LYS . 38.2 t -62.24 124.9 22.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.71 -0.396 . . . . 40.0 110.062 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 9.4 t -73.4 -19.8 60.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.407 -0.36 . . . . 40.0 111.458 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.604 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.05 116.63 46.18 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' THR . . . . . 0.618 HG22 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.74 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -107.9 47.7 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 40.0 110.658 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.57 0.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.868 -0.333 . . . . 40.0 110.74 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.85 47.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -91.83 5.96 47.91 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.652 -0.419 . . . . 40.0 110.154 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.41 158.99 16.31 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.062 -0.517 . . . . 40.0 111.082 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . 0.515 ' CG1' ' OG ' ' A' ' 323' ' ' SER . 11.9 p -121.66 108.27 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.906 -0.405 . . . . 40.0 109.906 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.71 135.02 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 40.0 111.142 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.599 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' SER . . . . . 0.515 ' OG ' ' CG1' ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 171.11 8.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 . . . . . 0 N--CA 1.467 0.404 0 CA-C-O 120.866 0.365 . . . . 40.0 110.664 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 C--O 1.232 0.137 0 N-CA-C 108.971 -0.752 . . . . 40.0 108.971 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 311' ' ' SER . 29.1 p -150.85 85.7 1.36 Allowed 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 119.418 -0.913 . . . . 40.0 110.274 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' THR . . . . . 0.626 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.626 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.442 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.709 ' HZ1' ' HB3' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . 0.411 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.32 53.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' GLN . . . . . 0.548 ' H ' HE21 ' A' ' 393' ' ' GLN . 0.8 OUTLIER -67.45 -39.44 85.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.649 -0.42 . . . . 40.0 111.404 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.27 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.832 -0.347 . . . . 40.0 111.17 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.55 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . 0.43 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.55 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . 0.411 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . 0.681 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 63.74 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 34.7 tttp 61.29 -21.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.664 -0.698 . . . . 40.0 111.303 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' CYS . . . . . 0.709 ' HB3' ' HZ1' ' A' ' 372' ' ' LYS . 38.2 t -61.45 124.94 22.04 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.585 -0.446 . . . . 40.0 110.062 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 16.2 m -73.27 -19.7 61.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 40.0 111.526 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.605 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.52 116.63 47.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' THR . . . . . 0.606 ' CG2' ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.403 HD11 ' HH ' ' A' ' 364' ' ' TYR . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -107.79 47.79 0.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 40.0 110.636 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 310' ' ' ILE . 1.5 tt -140.7 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.774 0.321 . . . . 40.0 110.74 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.06 47.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -91.51 5.59 48.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.915 0.388 . . . . 40.0 110.23 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.77 158.97 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.985 -0.552 . . . . 40.0 111.082 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 70.4 t -120.73 108.24 22.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 40.0 109.976 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.38 135.02 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.608 ' O ' HG21 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.76 7.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.679 ' O ' ' O ' ' A' ' 324' ' ' SER . 19.8 mtt180 . . . . . 0 N--CA 1.464 0.242 0 CA-C-N 115.784 -0.644 . . . . 40.0 112.041 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 350' ' ' THR . 21.6 t . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.819 0.342 . . . . 40.0 110.504 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' THR . . . . . 0.419 ' N ' ' SG ' ' A' ' 349' ' ' CYS . 29.1 p -138.92 85.7 2.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 40.0 110.274 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.442 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.731 ' HZ3' ' CB ' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . 0.411 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.24 53.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -66.41 -40.6 89.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.498 -0.319 . . . . 40.0 111.299 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.43 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.551 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . 0.432 ' C ' HG13 ' A' ' 405' ' ' VAL . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.432 HG13 ' C ' ' A' ' 404' ' ' TRP . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.551 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . 0.411 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . 0.68 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 -21.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 40.0 111.236 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' CYS . . . . . 0.731 ' CB ' ' HZ3' ' A' ' 372' ' ' LYS . 38.2 t -62.23 124.96 22.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.567 -0.453 . . . . 40.0 110.062 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 3.1 t -73.5 -19.11 61.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 40.0 111.565 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -71.02 116.63 48.49 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' THR . . . . . 0.608 HG21 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.69 29.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 5.9 p-10 -107.87 47.81 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.697 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.64 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.457 -0.338 . . . . 40.0 110.74 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.88 47.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 312' ' ' HIS . 3.2 t-80 -92.09 7.82 40.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.99 -0.55 . . . . 40.0 110.253 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -65.64 158.94 25.96 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.915 -0.584 . . . . 40.0 111.082 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.75 108.03 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.757 -0.656 . . . . 40.0 110.117 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.93 135.02 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.31 9.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 324' ' ' SER . 11.3 ttp85 . . . . . 0 C--N 1.328 -0.339 0 N-CA-C 109.399 -0.593 . . . . 40.0 109.399 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 350' ' ' THR . 1.6 p . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.048 0.451 . . . . 40.0 110.677 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 349' ' ' CYS . 29.1 p 53.32 85.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.592 -0.731 . . . . 40.0 110.274 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.442 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.745 ' HZ3' ' CB ' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . 0.662 ' HG ' ' H ' ' A' ' 382' ' ' GLY . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.662 ' H ' ' HG ' ' A' ' 380' ' ' CYS . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.22 53.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.78 -41.14 88.17 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.547 -0.461 . . . . 40.0 111.263 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.16 34.09 5.33 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.885 -0.326 . . . . 40.0 111.17 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . 0.53 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.549 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . 0.43 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . 0.53 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.549 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . 0.63 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.401 HG21 HD12 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' TYR . . . . . 0.698 ' HH ' HD21 ' A' ' 482' ' ' ASN . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.698 HD21 ' HH ' ' A' ' 480' ' ' TYR . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . 0.681 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 63.81 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? 61.68 -22.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.651 -0.704 . . . . 40.0 111.214 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' CYS . . . . . 0.745 ' CB ' ' HZ3' ' A' ' 372' ' ' LYS . 38.2 t -61.43 124.97 22.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.636 -0.426 . . . . 40.0 110.062 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 2.5 t -73.11 -20.45 60.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 40.0 111.449 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.7 116.63 45.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -108.03 47.52 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.371 -0.377 . . . . 40.0 110.638 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.08 0.32 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.426 -0.352 . . . . 40.0 110.74 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.07 47.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.37 6.06 46.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 40.0 110.233 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -64.07 158.91 21.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 40.0 111.082 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.43 108.25 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.04 -0.527 . . . . 40.0 110.014 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.49 135.02 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.614 ' O ' HG21 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.5 9.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.637 ' CB ' ' O ' ' A' ' 324' ' ' SER . 2.2 mtp85 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 121.433 0.635 . . . . 40.0 110.642 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . 0.462 ' O ' ' ND2' ' A' ' 482' ' ' ASN . 49.6 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.631 0.253 . . . . 40.0 111.001 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 311' ' ' SER . 29.1 p 47.76 85.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.616 -0.433 . . . . 40.0 110.274 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.706 ' HZ1' ' HB3' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.639 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.23 53.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -67.01 -40.28 87.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.779 -0.368 . . . . 40.0 111.32 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.97 34.09 5.37 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.883 -0.327 . . . . 40.0 111.17 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.551 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.551 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . 0.41 HD12 HG23 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' ASP . . . . . 0.726 ' H ' ' HG1' ' A' ' 459' ' ' THR . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 458' ' ' ILE . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' THR . . . . . 0.726 ' HG1' ' H ' ' A' ' 440' ' ' ASP . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.511 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . 0.68 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.1 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 31.6 mttm 61.43 -21.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.949 -0.569 . . . . 40.0 111.357 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' CYS . . . . . 0.706 ' HB3' ' HZ1' ' A' ' 372' ' ' LYS . 38.2 t -62.48 125.02 22.49 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.6 -0.44 . . . . 40.0 110.062 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 14.8 p -73.12 -19.73 61.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.127 -0.488 . . . . 40.0 111.563 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.606 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.84 116.63 48.09 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' SER . . . . . 0.889 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.72 29.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.03 47.95 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.397 . . . . 40.0 110.527 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.63 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.431 -0.35 . . . . 40.0 110.74 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.95 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -91.9 6.38 46.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.941 0.401 . . . . 40.0 110.183 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.0 158.87 18.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.01 -0.541 . . . . 40.0 111.082 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.76 107.79 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.218 -0.446 . . . . 40.0 109.947 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.94 135.02 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.614 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.52 9.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.173 0 CA-C-O 121.197 0.523 . . . . 40.0 111.646 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . 0.416 ' HG ' ' C ' ' A' ' 392' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.837 0.351 . . . . 40.0 110.203 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 311' ' ' SER . 29.1 p -145.22 85.7 1.74 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 40.0 110.274 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.719 ' HZ1' ' HB3' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.35 53.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -67.65 -39.0 84.61 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.628 -0.429 . . . . 40.0 111.473 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.48 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.848 -0.341 . . . . 40.0 111.17 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.549 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . 0.432 ' C ' HG13 ' A' ' 405' ' ' VAL . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.432 HG13 ' C ' ' A' ' 404' ' ' TRP . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.574 HE21 ' HH ' ' A' ' 466' ' ' TYR . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.549 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 458' ' ' ILE . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . 0.574 ' HH ' HE21 ' A' ' 418' ' ' GLN . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . 0.679 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.12 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 28.6 tttp 61.8 -21.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.019 -0.537 . . . . 40.0 111.434 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' CYS . . . . . 0.719 ' HB3' ' HZ1' ' A' ' 372' ' ' LYS . 38.2 t -62.69 124.93 22.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.612 -0.435 . . . . 40.0 110.062 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 10.2 p -73.09 -20.39 60.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 40.0 111.431 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.604 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.74 116.63 45.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.62 30.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.41 47.04 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 40.0 110.709 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.37 0.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.841 -0.344 . . . . 40.0 110.74 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.95 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.06 4.14 52.91 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.141 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -61.21 159.05 12.76 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.068 -0.514 . . . . 40.0 111.082 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.65 108.27 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 40.0 110.068 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.52 135.02 27.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.61 7.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.939 0.4 . . . . 40.0 110.233 178.734 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.23 0.062 0 N-CA-C 109.003 -0.74 . . . . 40.0 109.003 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 311' ' ' SER . 29.1 p -145.18 85.7 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.791 -0.763 . . . . 40.0 110.274 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.712 ' HZ3' ' HB3' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.39 53.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' GLN . . . . . 0.42 ' OE1' ' OD1' ' A' ' 394' ' ' ASN . 0.0 OUTLIER -67.02 -40.4 87.23 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.593 -0.443 . . . . 40.0 111.175 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.55 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.773 -0.371 . . . . 40.0 111.17 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.552 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . 0.43 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . 0.451 ' C ' HG13 ' A' ' 405' ' ' VAL . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . 0.451 HG13 ' C ' ' A' ' 404' ' ' TRP . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' GLN . . . . . 0.84 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . 0.84 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.552 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . 0.63 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG21 HD12 ' A' ' 458' ' ' ILE . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . 0.678 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.44 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.39 -21.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.186 -0.461 . . . . 40.0 111.113 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' CYS . . . . . 0.712 ' HB3' ' HZ3' ' A' ' 372' ' ' LYS . 38.2 t -63.33 124.84 22.28 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.688 -0.405 . . . . 40.0 110.062 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 3.3 t -73.37 -20.39 60.77 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.879 -0.328 . . . . 40.0 111.368 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.605 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.14 116.63 43.98 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -107.83 47.85 0.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 40.0 110.677 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.74 0.32 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.472 -0.331 . . . . 40.0 110.74 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.06 47.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.99 4.49 51.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 40.0 110.207 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.25 159.03 15.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 40.0 111.082 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.27 108.73 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.585 . . . . 40.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -91.06 135.02 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.608 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 174.58 6.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 324' ' ' SER . 17.2 mtt-85 . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 113.49 0.922 . . . . 40.0 113.49 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.23 0.064 0 N-CA-C 110.131 -0.322 . . . . 40.0 110.131 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 311' ' ' SER . 29.1 p -145.9 85.7 1.7 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.405 . . . . 40.0 110.274 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.713 ' HZ3' ' HB3' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.639 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.27 53.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' GLN . . . . . 0.485 ' NE2' ' OD1' ' A' ' 390' ' ' ASN . 3.7 mt-30 -66.76 -40.34 88.23 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.743 -0.383 . . . . 40.0 111.354 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.11 34.09 5.37 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.967 -0.293 . . . . 40.0 111.17 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.55 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.55 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.44 HG21 HD11 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' ILE . . . . . 0.436 HD13 HG22 ' A' ' 458' ' ' ILE . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . 0.678 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.21 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . 0.405 ' O ' ' CZ ' ' A' ' 325' ' ' ARG . 0.9 OUTLIER 61.28 -20.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.558 . . . . 40.0 111.393 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' CYS . . . . . 0.713 ' HB3' ' HZ3' ' A' ' 372' ' ' LYS . 38.2 t -63.12 124.84 22.19 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.677 -0.409 . . . . 40.0 110.062 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.2 -19.85 61.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 40.0 111.493 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.606 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.19 116.63 46.52 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.654 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.654 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.68 30.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.607 ' N ' HD21 ' A' ' 309' ' ' ASN . 0.8 OUTLIER -107.77 47.88 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 40.0 110.643 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.9 0.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.883 -0.327 . . . . 40.0 110.74 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.09 47.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' A' ' 312' ' ' HIS . 0.0 OUTLIER -90.92 4.98 50.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 40.0 110.254 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 159.01 18.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 40.0 111.082 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . 0.509 ' CG1' ' OG ' ' A' ' 323' ' ' SER . 14.9 p -121.73 108.29 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 40.0 109.91 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.74 135.02 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 40.0 111.142 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.619 ' O ' HG21 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' SER . . . . . 0.509 ' OG ' ' CG1' ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' SER . . . . . 0.767 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 173.79 7.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.547 ' CA ' ' HE ' ' A' ' 325' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.922 -0.581 . . . . 40.0 111.52 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . 0.678 ' SG ' ' O ' ' A' ' 392' ' ' GLU . 1.1 t . . . . . 0 CA--C 1.522 -0.131 0 N-CA-C 109.429 -0.582 . . . . 40.0 109.429 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' THR . . . . . 0.628 ' OG1' ' O ' ' A' ' 349' ' ' CYS . 29.1 p 57.46 85.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.92 -0.582 . . . . 40.0 110.274 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.442 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' TRP . . . . . 0.455 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.75 ' HZ1' ' CB ' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' VAL . . . . . 0.411 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . 0.552 ' HG ' ' H ' ' A' ' 382' ' ' GLY . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.552 ' H ' ' HG ' ' A' ' 380' ' ' CYS . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.637 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . 0.678 ' O ' ' SG ' ' A' ' 349' ' ' CYS . 61.0 mm-40 -52.09 -37.05 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -66.42 -40.57 89.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.527 -0.306 . . . . 40.0 111.347 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.67 34.09 5.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.637 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . 0.561 ' OH ' ' SG ' ' A' ' 349' ' ' CYS . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . 0.53 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.549 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . 0.53 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.549 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' SER . . . . . 0.847 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . 0.847 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . 0.63 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' VAL . . . . . 0.455 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . 0.411 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' TYR . . . . . 0.597 ' HH ' HD21 ' A' ' 482' ' ' ASN . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.597 HD21 ' HH ' ' A' ' 480' ' ' TYR . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.767 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . 0.675 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.49 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt 61.04 -20.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.988 -0.551 . . . . 40.0 111.41 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' CYS . . . . . 0.75 ' CB ' ' HZ1' ' A' ' 372' ' ' LYS . 38.2 t -63.89 125.03 23.06 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.062 -0.347 . . . . 40.0 110.062 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 3.5 t -73.14 -20.21 60.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 40.0 111.516 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.09 116.63 46.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' THR . . . . . 0.619 HG21 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.77 29.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -108.1 48.07 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 40.0 110.638 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.78 0.32 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.444 -0.344 . . . . 40.0 110.74 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.94 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' HIS . . . . . 0.614 ' O ' ' ND2' ' A' ' 326' ' ' ASN . 7.4 m-70 -92.35 7.55 42.39 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.058 0.456 . . . . 40.0 110.059 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.94 158.84 21.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.02 -0.536 . . . . 40.0 111.082 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.33 107.65 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.018 -0.537 . . . . 40.0 110.141 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.11 135.02 27.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.598 ' O ' HG21 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.95 7.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.682 ' CB ' ' O ' ' A' ' 324' ' ' SER . 21.1 ttm180 122.83 -35.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.651 0.612 . . . . 40.0 112.651 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 312' ' ' HIS . 0.1 OUTLIER 64.0 166.46 0.11 Allowed Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 109.017 -0.735 . . . . 40.0 109.017 -179.011 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.613 ' O ' ' C ' ' A' ' 328' ' ' GLN . 2.9 Cg_endo -41.71 179.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.702 2.268 . . . . 40.0 112.004 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.613 ' C ' ' O ' ' A' ' 327' ' ' PRO . 28.0 mt-30 -17.11 -66.72 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.265 -0.425 . . . . 40.0 110.489 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.564 ' CD1' ' HA ' ' A' ' 331' ' ' TYR . 0.4 OUTLIER -166.43 49.04 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.34 0 CA-C-N 115.825 -0.625 . . . . 40.0 110.603 179.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.489 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 7.1 tpp 61.52 15.83 7.07 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 118.289 -1.364 . . . . 40.0 107.486 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.564 ' HA ' ' CD1' ' A' ' 329' ' ' ILE . 1.5 p90 36.51 34.23 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.201 -1.363 . . . . 40.0 109.225 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' A' ' 333' ' ' ALA . 2.4 pt20 -114.62 -36.56 4.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.193 -0.912 . . . . 40.0 111.223 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . 0.64 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 30.98 97.64 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.533 -0.758 . . . . 40.0 111.471 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.441 ' HD2' ' CG2' ' A' ' 339' ' ' THR . 4.8 Cg_exo -67.64 12.67 0.19 Allowed 'Trans proline' 0 C--N 1.297 -2.138 0 C-N-CA 121.739 1.626 . . . . 40.0 109.469 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.64 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 135.58 -50.74 0.84 Allowed Glycine 0 C--N 1.333 0.38 0 CA-C-N 114.633 -1.167 . . . . 40.0 110.73 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.604 ' C ' HD23 ' A' ' 337' ' ' LEU . 27.4 m -106.9 35.97 2.82 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 120.728 -0.389 . . . . 40.0 111.055 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' LEU . . . . . 0.821 ' N ' HD21 ' A' ' 337' ' ' LEU . 0.5 OUTLIER 63.3 -101.46 0.1 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.371 0.605 . . . . 40.0 111.358 177.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . 0.686 ' O ' ' OG1' ' A' ' 339' ' ' THR . 0.1 OUTLIER -60.58 -42.74 97.29 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 107.163 -1.421 . . . . 40.0 107.163 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.686 ' OG1' ' O ' ' A' ' 338' ' ' PHE . 2.5 p 57.12 -104.59 0.23 Allowed 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 112.003 -2.362 . . . . 40.0 112.056 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.773 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 15.0 p90 174.06 66.93 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 110.753 -2.931 . . . . 40.0 105.625 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . 0.63 ' O ' ' N ' ' A' ' 345' ' ' ASN . 3.4 Cg_exo -39.43 87.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.234 1.29 . . . . 40.0 112.634 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 340' ' ' PHE . 4.6 p -74.52 -14.55 60.83 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.948 -0.76 . . . . 40.0 108.948 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 344' ' ' THR . 0.3 OUTLIER -53.73 -15.42 1.23 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.599 -0.889 . . . . 40.0 108.599 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.678 ' O ' ' O ' ' A' ' 345' ' ' ASN . 4.5 t -179.93 27.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.334 -1.303 . . . . 40.0 109.721 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . 0.678 ' O ' ' O ' ' A' ' 344' ' ' THR . 15.6 m-20 -41.78 -172.91 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.494 0.664 . . . . 40.0 110.5 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . . . . . . . . . 55.5 t80 53.9 18.83 1.74 Allowed 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 119.473 -0.891 . . . . 40.0 110.535 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.468 ' ND2' ' SG ' ' A' ' 349' ' ' CYS . 3.6 t30 -173.24 129.0 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.6 -0.727 . . . . 40.0 109.896 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.18 -34.87 6.25 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.686 0.279 . . . . 40.0 110.819 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . 0.468 ' SG ' ' ND2' ' A' ' 347' ' ' ASN . 3.2 m 72.58 76.38 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 40.0 111.012 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 311' ' ' SER . 29.1 p -133.81 85.7 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.738 -0.665 . . . . 40.0 110.274 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.442 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.706 ' HZ2' ' HB3' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . 0.411 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.639 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.25 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -66.62 -40.01 88.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.529 -0.305 . . . . 40.0 111.466 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.86 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.55 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . 0.43 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.643 HE21 ' HH ' ' A' ' 466' ' ' TYR . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.55 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.42 HG21 HD12 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' ASP . . . . . 0.738 ' H ' ' HG1' ' A' ' 459' ' ' THR . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' THR . . . . . 0.738 ' HG1' ' H ' ' A' ' 440' ' ' ASP . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . 0.406 HD11 HG23 ' A' ' 465' ' ' ILE . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.643 ' HH ' HE21 ' A' ' 418' ' ' GLN . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . 0.411 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . 0.681 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.16 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 16.4 tttp 61.76 -22.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.545 . . . . 40.0 111.269 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' CYS . . . . . 0.706 ' HB3' ' HZ2' ' A' ' 372' ' ' LYS . 38.2 t -62.24 124.96 22.27 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.556 -0.457 . . . . 40.0 110.062 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 1.5 m -72.71 -20.95 61.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 40.0 111.326 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.604 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.68 116.63 45.27 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.607 ' CG2' ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' SER . . . . . 0.888 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.67 30.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.58 47.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.578 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.66 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.807 -0.357 . . . . 40.0 110.74 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.01 47.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.2 5.78 47.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 40.0 110.304 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.81 158.91 20.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 40.0 111.082 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.6 107.9 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.102 -0.499 . . . . 40.0 110.04 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.21 135.02 27.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.618 ' O ' HG22 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 173.1 7.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 51.2 ttm-85 69.73 109.96 0.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 40.0 111.034 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.53 ' ND2' ' H ' ' A' ' 330' ' ' MET . 0.0 OUTLIER -100.17 151.89 37.66 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 40.0 109.739 179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.556 ' O ' ' C ' ' A' ' 328' ' ' GLN . 2.8 Cg_endo -45.77 178.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.449 2.099 . . . . 40.0 111.921 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.635 ' H ' ' CD ' ' A' ' 328' ' ' GLN . 0.5 OUTLIER -23.89 -58.51 0.05 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.254 -0.43 . . . . 40.0 110.314 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.54 HD11 ' H ' ' A' ' 331' ' ' TYR . 0.6 OUTLIER -163.69 44.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 CA-C-N 115.827 -0.624 . . . . 40.0 110.894 178.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.53 ' H ' ' ND2' ' A' ' 326' ' ' ASN . 8.2 tpt 60.9 14.29 5.13 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 118.17 -1.412 . . . . 40.0 108.378 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.54 ' H ' HD11 ' A' ' 329' ' ' ILE . 23.6 m-85 41.12 28.33 0.06 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.993 -1.003 . . . . 40.0 109.068 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . 0.529 ' O ' ' O ' ' A' ' 333' ' ' ALA . 3.4 pt20 -106.12 -39.9 5.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.211 -0.904 . . . . 40.0 112.27 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . 0.724 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 30.4 99.14 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.086 -0.507 . . . . 40.0 110.659 -177.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 337' ' ' LEU . 4.7 Cg_exo -69.74 17.48 0.2 Allowed 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.022 1.815 . . . . 40.0 108.682 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.724 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 130.0 -54.3 0.79 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 113.768 -1.56 . . . . 40.0 110.037 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.542 ' HB ' HG22 ' A' ' 339' ' ' THR . 6.5 m -106.2 45.81 0.96 Allowed 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 120.692 -0.403 . . . . 40.0 110.898 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' LEU . . . . . 0.793 ' CD2' ' N ' ' A' ' 337' ' ' LEU . 0.7 OUTLIER 60.6 -104.16 0.17 Allowed 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.677 0.751 . . . . 40.0 112.182 176.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . 0.916 ' O ' ' OG1' ' A' ' 339' ' ' THR . 0.0 OUTLIER -73.88 -39.11 64.16 Favored 'General case' 0 CA--C 1.48 -1.719 0 N-CA-C 107.183 -1.414 . . . . 40.0 107.183 178.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.916 ' OG1' ' O ' ' A' ' 338' ' ' PHE . 28.6 p 65.1 -106.41 0.13 Allowed 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 112.539 -2.119 . . . . 40.0 111.95 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.789 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 20.0 p90 171.82 67.33 0.03 OUTLIER Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 110.479 -3.055 . . . . 40.0 105.867 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 345' ' ' ASN . 4.1 Cg_exo -34.81 95.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 121.105 1.203 . . . . 40.0 111.978 -175.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.649 ' C ' ' H ' ' A' ' 344' ' ' THR . 1.2 p -67.49 -15.51 63.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.2 -0.909 . . . . 40.0 111.063 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.32 -8.91 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.548 0.69 . . . . 40.0 109.495 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.692 ' O ' ' O ' ' A' ' 345' ' ' ASN . 1.4 t -176.69 -33.6 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.484 -1.235 . . . . 40.0 108.546 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . 0.692 ' O ' ' O ' ' A' ' 344' ' ' THR . 0.0 OUTLIER 36.87 -172.58 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.067 0 CA-C-O 122.143 0.973 . . . . 40.0 111.383 178.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 346' ' ' PHE . 90.3 t80 43.94 68.69 0.49 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 113.829 -1.532 . . . . 40.0 111.639 173.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -162.85 -175.26 4.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.196 -0.456 . . . . 40.0 110.405 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 349' ' ' CYS . 0.2 OUTLIER -177.17 179.85 0.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.041 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 348' ' ' TYR . 2.3 t 88.8 -173.73 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.202 0.525 . . . . 40.0 111.707 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' THR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 311' ' ' SER . 29.1 p -154.75 85.7 1.11 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.281 -0.872 . . . . 40.0 110.274 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.724 ' HZ2' ' CB ' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.37 53.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.09 -39.31 86.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.87 -0.332 . . . . 40.0 111.463 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.88 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.55 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.558 HE21 ' HH ' ' A' ' 466' ' ' TYR . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.55 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG23 HD11 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.415 HG23 HD13 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 458' ' ' ILE . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . 0.405 HD13 HG23 ' A' ' 465' ' ' ILE . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.558 ' HH ' HE21 ' A' ' 418' ' ' GLN . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . 0.68 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.02 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 22.6 mttp 61.55 -21.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.786 -0.643 . . . . 40.0 111.375 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' CYS . . . . . 0.724 ' CB ' ' HZ2' ' A' ' 372' ' ' LYS . 38.2 t -62.24 124.9 22.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.71 -0.396 . . . . 40.0 110.062 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 9.4 t -73.4 -19.8 60.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.407 -0.36 . . . . 40.0 111.458 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.604 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.05 116.63 46.18 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.618 HG22 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.74 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -107.9 47.7 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 40.0 110.658 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.57 0.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.868 -0.333 . . . . 40.0 110.74 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.85 47.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -91.83 5.96 47.91 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.652 -0.419 . . . . 40.0 110.154 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.41 158.99 16.31 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.062 -0.517 . . . . 40.0 111.082 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . 0.515 ' CG1' ' OG ' ' A' ' 323' ' ' SER . 11.9 p -121.66 108.27 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.906 -0.405 . . . . 40.0 109.906 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.71 135.02 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 40.0 111.142 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.599 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' SER . . . . . 0.515 ' OG ' ' CG1' ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 171.11 8.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -132.7 134.68 45.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.866 0.365 . . . . 40.0 110.664 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.648 ' N ' ' CD ' ' A' ' 327' ' ' PRO . 1.4 m-80 -156.05 41.47 0.14 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.087 -0.506 . . . . 40.0 110.619 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 326' ' ' ASN . 2.6 Cg_endo -46.78 -177.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.996 2.464 . . . . 40.0 112.577 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.535 ' C ' ' O ' ' A' ' 327' ' ' PRO . 2.0 mt-30 -28.12 -73.28 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.498 -0.774 . . . . 40.0 109.675 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.533 ' CD1' ' HA ' ' A' ' 331' ' ' TYR . 0.6 OUTLIER -150.78 45.54 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 CA-C-N 115.836 -0.62 . . . . 40.0 110.664 178.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 0.8 OUTLIER 60.18 14.53 4.59 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 118.356 -1.338 . . . . 40.0 108.627 178.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.714 ' CG ' ' O ' ' A' ' 331' ' ' TYR . 13.0 t80 42.5 30.41 0.21 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.524 -1.216 . . . . 40.0 109.505 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . 0.547 ' CG ' ' N ' ' A' ' 333' ' ' ALA . 11.9 pt20 -113.73 -43.24 3.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.382 -0.826 . . . . 40.0 111.195 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . 0.547 ' N ' ' CG ' ' A' ' 332' ' ' GLN . . . 35.87 94.21 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.191 -0.913 . . . . 40.0 111.23 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -72.91 45.08 0.85 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.269 1.98 . . . . 40.0 110.693 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 115.29 -72.87 0.25 Allowed Glycine 0 N--CA 1.454 -0.156 0 N-CA-C 110.221 -1.152 . . . . 40.0 110.221 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 337' ' ' LEU . 0.2 OUTLIER -70.16 -72.42 0.2 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.861 -0.792 . . . . 40.0 108.861 178.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' LEU . . . . . 0.924 ' CG ' ' H ' ' A' ' 338' ' ' PHE . 0.0 OUTLIER 165.49 -83.6 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.277 -1.328 . . . . 40.0 111.368 179.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . 0.924 ' H ' ' CG ' ' A' ' 337' ' ' LEU . 28.8 m-85 -64.19 -52.98 56.29 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 106.394 -1.706 . . . . 40.0 106.394 177.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.715 ' HG1' ' H ' ' A' ' 340' ' ' PHE . 13.3 p 55.78 -106.24 0.31 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 112.046 -2.343 . . . . 40.0 112.94 177.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.763 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 15.1 p90 171.49 71.46 0.03 OUTLIER Pre-proline 0 C--N 1.292 -1.909 0 CA-C-N 110.315 -3.13 . . . . 40.0 104.774 -175.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . 0.51 ' O ' ' CG ' ' A' ' 345' ' ' ASN . 4.5 Cg_exo -36.11 84.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.297 -2.156 0 C-N-CA 121.842 1.694 . . . . 40.0 113.41 -175.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.618 ' N ' ' O ' ' A' ' 340' ' ' PHE . 0.1 OUTLIER -77.61 -10.08 59.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.913 -0.773 . . . . 40.0 108.913 178.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 344' ' ' THR . 2.2 pt? -52.3 -18.5 1.59 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.288 -1.004 . . . . 40.0 108.288 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.656 ' O ' ' O ' ' A' ' 345' ' ' ASN . 6.2 t -178.29 26.39 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.815 -1.539 . . . . 40.0 109.933 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . 0.656 ' O ' ' O ' ' A' ' 344' ' ' THR . 1.3 m120 -43.51 -176.74 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.821 -0.807 . . . . 40.0 108.821 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.609 ' CG ' ' O ' ' A' ' 346' ' ' PHE . 11.3 t80 52.4 35.87 18.51 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.124 -1.03 . . . . 40.0 110.665 175.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.497 ' O ' ' OD1' ' A' ' 347' ' ' ASN . 13.9 t-20 -156.73 12.79 0.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.724 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -83.99 111.02 18.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.159 0.504 . . . . 40.0 110.925 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 28.3 p -167.01 171.07 11.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.439 -0.8 . . . . 40.0 108.971 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 311' ' ' SER . 29.1 p -150.85 85.7 1.36 Allowed 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 119.418 -0.913 . . . . 40.0 110.274 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' THR . . . . . 0.626 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.626 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.442 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.709 ' HZ1' ' HB3' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . 0.411 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.32 53.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' GLN . . . . . 0.548 ' H ' HE21 ' A' ' 393' ' ' GLN . 0.8 OUTLIER -67.45 -39.44 85.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.649 -0.42 . . . . 40.0 111.404 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.27 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.832 -0.347 . . . . 40.0 111.17 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.55 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . 0.43 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.55 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . 0.411 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . 0.681 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 63.74 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 34.7 tttp 61.29 -21.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.664 -0.698 . . . . 40.0 111.303 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' CYS . . . . . 0.709 ' HB3' ' HZ1' ' A' ' 372' ' ' LYS . 38.2 t -61.45 124.94 22.04 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.585 -0.446 . . . . 40.0 110.062 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 16.2 m -73.27 -19.7 61.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 40.0 111.526 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.605 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.52 116.63 47.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.606 ' CG2' ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.403 HD11 ' HH ' ' A' ' 364' ' ' TYR . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -107.79 47.79 0.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 40.0 110.636 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 310' ' ' ILE . 1.5 tt -140.7 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.774 0.321 . . . . 40.0 110.74 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.06 47.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -91.51 5.59 48.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.915 0.388 . . . . 40.0 110.23 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.77 158.97 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.985 -0.552 . . . . 40.0 111.082 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 70.4 t -120.73 108.24 22.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 40.0 109.976 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.38 135.02 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.608 ' O ' HG21 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.76 7.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.679 ' O ' ' O ' ' A' ' 324' ' ' SER . 19.8 mtt180 42.81 126.17 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.784 -0.644 . . . . 40.0 112.041 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.697 ' N ' ' CD ' ' A' ' 327' ' ' PRO . 16.9 t30 -96.88 -37.28 0.27 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.061 -0.518 . . . . 40.0 111.829 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 326' ' ' ASN . 3.7 Cg_exo -72.27 -176.79 2.34 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 C-N-CA 123.193 2.596 . . . . 40.0 113.919 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -104.38 -37.05 7.37 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.91 -1.95 . . . . 40.0 107.204 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.612 ' O ' ' HB3' ' A' ' 330' ' ' MET . 0.0 OUTLIER -168.35 1.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 113.735 -1.575 . . . . 40.0 111.565 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.612 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 12.6 tpt 71.35 15.87 6.2 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.594 -0.842 . . . . 40.0 111.465 176.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.773 ' CG ' ' O ' ' A' ' 331' ' ' TYR . 6.3 t80 38.65 23.27 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.052 0.453 . . . . 40.0 110.729 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 330' ' ' MET . 11.5 pt20 -118.57 -26.97 6.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 40.0 111.069 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . 0.641 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 16.91 94.92 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 115.419 -0.81 . . . . 40.0 113.147 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.507 ' CG ' ' CZ ' ' A' ' 340' ' ' PHE . 4.6 Cg_exo -72.63 17.68 0.36 Allowed 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 123.233 2.622 . . . . 40.0 108.686 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.641 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 97.53 18.65 27.51 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 114.286 -1.325 . . . . 40.0 109.951 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.748 ' O ' ' N ' ' A' ' 338' ' ' PHE . 66.6 m -138.21 4.02 2.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.851 -0.674 . . . . 40.0 109.754 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' LEU . . . . . 0.752 ' CD2' ' N ' ' A' ' 337' ' ' LEU . 0.0 OUTLIER 47.26 -72.12 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.275 -0.875 . . . . 40.0 110.289 -178.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . 0.847 ' O ' ' OG1' ' A' ' 339' ' ' THR . 10.4 m-85 -50.53 -17.11 0.44 Allowed 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 105.912 -1.884 . . . . 40.0 105.912 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.847 ' OG1' ' O ' ' A' ' 338' ' ' PHE . 73.7 p 63.53 -109.52 0.27 Allowed 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 112.911 -1.95 . . . . 40.0 110.89 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.682 ' O ' ' N ' ' A' ' 342' ' ' SER . 0.0 OUTLIER 171.92 66.01 0.03 OUTLIER Pre-proline 0 C--N 1.286 -2.169 0 CA-C-N 110.193 -3.185 . . . . 40.0 106.29 -177.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 345' ' ' ASN . 5.4 Cg_exo -30.43 84.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.313 1.342 . . . . 40.0 112.513 -174.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 340' ' ' PHE . 1.7 p -73.18 -6.17 44.04 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.834 -1.076 . . . . 40.0 109.135 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -4.71 3.94 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.272 -0.876 . . . . 40.0 108.886 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.67 ' O ' ' N ' ' A' ' 346' ' ' PHE . 2.9 t -178.66 -32.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.358 -1.292 . . . . 40.0 108.969 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' A' ' 341' ' ' PRO . 6.8 m-20 27.06 -82.61 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 122.674 1.226 . . . . 40.0 111.443 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 344' ' ' THR . 17.7 t80 -87.97 -52.22 5.39 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 112.338 -2.21 . . . . 40.0 111.319 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.562 ' N ' ' O ' ' A' ' 344' ' ' THR . 17.8 t-20 -58.12 145.46 36.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.955 -0.566 . . . . 40.0 110.947 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' TYR . . . . . 0.503 ' CZ ' ' OD1' ' A' ' 347' ' ' ASN . 2.4 m-85 24.52 99.11 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.818 -0.628 . . . . 40.0 111.783 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 350' ' ' THR . 21.6 t -70.63 -124.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.444 -0.343 . . . . 40.0 110.504 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' THR . . . . . 0.419 ' N ' ' SG ' ' A' ' 349' ' ' CYS . 29.1 p -138.92 85.7 2.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 40.0 110.274 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.442 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.731 ' HZ3' ' CB ' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . 0.411 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.24 53.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -66.41 -40.6 89.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.498 -0.319 . . . . 40.0 111.299 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ASN . . . . . 0.528 ' OD1' ' CZ ' ' A' ' 346' ' ' PHE . 43.5 m-20 -119.43 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.551 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . 0.432 ' C ' HG13 ' A' ' 405' ' ' VAL . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.432 HG13 ' C ' ' A' ' 404' ' ' TRP . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.551 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . 0.411 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . 0.68 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 -21.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 40.0 111.236 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' CYS . . . . . 0.731 ' CB ' ' HZ3' ' A' ' 372' ' ' LYS . 38.2 t -62.23 124.96 22.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.567 -0.453 . . . . 40.0 110.062 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 3.1 t -73.5 -19.11 61.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 40.0 111.565 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -71.02 116.63 48.49 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.608 HG21 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.69 29.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 5.9 p-10 -107.87 47.81 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.697 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.64 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.457 -0.338 . . . . 40.0 110.74 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.88 47.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 312' ' ' HIS . 3.2 t-80 -92.09 7.82 40.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.99 -0.55 . . . . 40.0 110.253 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -65.64 158.94 25.96 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.915 -0.584 . . . . 40.0 111.082 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.75 108.03 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.757 -0.656 . . . . 40.0 110.117 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.93 135.02 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.31 9.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 324' ' ' SER . 11.3 ttp85 77.89 93.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.399 -0.593 . . . . 40.0 109.399 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.537 ' OD1' ' NE2' ' A' ' 312' ' ' HIS . 0.5 OUTLIER -63.43 156.32 70.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 40.0 112.044 -178.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.499 ' HB2' ' H ' ' A' ' 328' ' ' GLN . 2.6 Cg_endo -80.3 -100.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 123.157 2.571 . . . . 40.0 112.087 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.509 ' HG2' ' H ' ' A' ' 329' ' ' ILE . 1.0 OUTLIER -65.69 -49.6 67.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.639 -0.504 . . . . 40.0 109.639 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.626 HD13 ' H ' ' A' ' 331' ' ' TYR . 1.0 OUTLIER -175.75 38.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 CA-C-N 115.905 -0.589 . . . . 40.0 110.582 178.246 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.529 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 9.9 tpt 63.0 8.06 3.0 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 118.45 -1.3 . . . . 40.0 108.92 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.701 ' CG ' ' O ' ' A' ' 331' ' ' TYR . 13.8 t80 50.06 20.48 0.61 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.702 -1.136 . . . . 40.0 108.925 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . 0.526 ' O ' ' C ' ' A' ' 333' ' ' ALA . 16.2 pt20 -95.98 -40.36 9.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.012 -0.994 . . . . 40.0 110.849 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 332' ' ' GLN . . . 18.07 94.82 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.19 -0.914 . . . . 40.0 112.151 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.48 38.59 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.158 1.906 . . . . 40.0 110.834 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 119.48 -69.23 0.35 Allowed Glycine 0 CA--C 1.511 -0.196 0 N-CA-C 110.411 -1.075 . . . . 40.0 110.411 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.67 ' O ' ' HB3' ' A' ' 337' ' ' LEU . 0.2 OUTLIER -69.42 -72.7 0.18 Allowed 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 109.073 -0.714 . . . . 40.0 109.073 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' LEU . . . . . 0.9 ' CG ' ' H ' ' A' ' 338' ' ' PHE . 0.0 OUTLIER 165.95 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.376 -1.284 . . . . 40.0 111.846 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . 0.9 ' H ' ' CG ' ' A' ' 337' ' ' LEU . 13.0 m-85 -60.95 -54.07 49.52 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.702 -1.592 . . . . 40.0 106.702 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.725 HG23 ' H ' ' A' ' 337' ' ' LEU . 22.0 p 53.88 -108.31 0.42 Allowed 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 112.025 -2.352 . . . . 40.0 111.864 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.734 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 13.0 p90 176.19 66.07 0.07 OUTLIER Pre-proline 0 C--N 1.287 -2.11 0 CA-C-N 110.456 -3.065 . . . . 40.0 105.424 -176.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . 0.819 ' O ' ' N ' ' A' ' 345' ' ' ASN . 2.7 Cg_endo -36.6 80.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 121.862 1.708 . . . . 40.0 112.157 -175.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.683 ' N ' ' O ' ' A' ' 340' ' ' PHE . 3.0 p -59.28 -21.73 60.09 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.404 -0.518 . . . . 40.0 110.194 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.12 -18.54 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 122.036 0.922 . . . . 40.0 109.132 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.538 ' H ' ' C ' ' A' ' 342' ' ' SER . 6.6 t -167.69 -38.78 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.632 -1.622 . . . . 40.0 107.937 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . 0.819 ' N ' ' O ' ' A' ' 341' ' ' PRO . 0.0 OUTLIER 43.44 -168.55 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 114.644 -1.162 . . . . 40.0 110.575 178.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 347' ' ' ASN . 46.6 t80 49.0 85.63 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.529 -1.214 . . . . 40.0 110.515 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 346' ' ' PHE . 1.0 OUTLIER -47.2 -175.1 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.505 -0.77 . . . . 40.0 111.728 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' TYR . . . . . 0.429 ' CB ' ' O ' ' A' ' 347' ' ' ASN . 4.6 t80 79.26 81.75 0.06 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.537 -0.756 . . . . 40.0 110.599 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 350' ' ' THR . 1.6 p 173.65 -90.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.677 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 349' ' ' CYS . 29.1 p 53.32 85.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.592 -0.731 . . . . 40.0 110.274 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.442 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.745 ' HZ3' ' CB ' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . 0.662 ' HG ' ' H ' ' A' ' 382' ' ' GLY . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.662 ' H ' ' HG ' ' A' ' 380' ' ' CYS . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.22 53.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.78 -41.14 88.17 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.547 -0.461 . . . . 40.0 111.263 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.16 34.09 5.33 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.885 -0.326 . . . . 40.0 111.17 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . 0.53 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.549 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . 0.43 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . 0.53 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.549 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . 0.63 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.401 HG21 HD12 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . 0.698 ' HH ' HD21 ' A' ' 482' ' ' ASN . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.698 HD21 ' HH ' ' A' ' 480' ' ' TYR . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . 0.681 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 63.81 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? 61.68 -22.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.651 -0.704 . . . . 40.0 111.214 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' CYS . . . . . 0.745 ' CB ' ' HZ3' ' A' ' 372' ' ' LYS . 38.2 t -61.43 124.97 22.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.636 -0.426 . . . . 40.0 110.062 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 2.5 t -73.11 -20.45 60.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 40.0 111.449 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.7 116.63 45.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -108.03 47.52 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.371 -0.377 . . . . 40.0 110.638 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.08 0.32 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.426 -0.352 . . . . 40.0 110.74 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.07 47.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.37 6.06 46.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 40.0 110.233 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -64.07 158.91 21.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 40.0 111.082 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.43 108.25 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.04 -0.527 . . . . 40.0 110.014 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.49 135.02 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.614 ' O ' HG21 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.5 9.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.637 ' CB ' ' O ' ' A' ' 324' ' ' SER . 2.2 mtp85 142.0 -172.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.433 0.635 . . . . 40.0 110.642 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.798 ' O ' ' O ' ' A' ' 327' ' ' PRO . 0.0 OUTLIER -128.76 163.17 46.98 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.051 -0.977 . . . . 40.0 108.943 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.798 ' O ' ' O ' ' A' ' 326' ' ' ASN . 3.2 Cg_exo -39.9 -145.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 123.071 2.514 . . . . 40.0 112.463 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.453 ' C ' ' CG2' ' A' ' 329' ' ' ILE . 16.6 mm-40 -71.91 -38.63 69.88 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 106.457 -1.682 . . . . 40.0 106.457 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.658 HD12 ' H ' ' A' ' 331' ' ' TYR . 0.0 OUTLIER -175.02 6.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 113.41 -1.723 . . . . 40.0 110.14 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.502 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 1.5 tpt 71.81 8.5 6.08 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.033 -0.667 . . . . 40.0 111.326 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.658 ' H ' HD12 ' A' ' 329' ' ' ILE . 0.1 OUTLIER 43.63 27.51 0.16 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.833 -0.802 . . . . 40.0 108.833 -179.622 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . 0.601 ' O ' ' C ' ' A' ' 333' ' ' ALA . 0.0 OUTLIER -131.87 -22.0 2.39 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.408 -0.815 . . . . 40.0 112.091 -178.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . 0.696 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 9.07 97.74 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 116.418 -0.355 . . . . 40.0 111.54 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.569 ' HG2' ' HG1' ' A' ' 339' ' ' THR . 4.7 Cg_exo -65.17 20.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 121.809 1.673 . . . . 40.0 110.433 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.696 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 125.65 -55.53 0.73 Allowed Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.256 -0.884 . . . . 40.0 111.362 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.56 ' C ' HD23 ' A' ' 337' ' ' LEU . 28.0 m -103.04 29.56 5.4 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 120.779 0.323 . . . . 40.0 111.377 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' LEU . . . . . 0.854 ' CD2' ' N ' ' A' ' 337' ' ' LEU . 0.5 OUTLIER 60.58 -102.82 0.14 Allowed 'General case' 0 N--CA 1.425 -1.69 0 C-N-CA 120.384 -0.527 . . . . 40.0 111.205 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . 0.547 ' O ' ' OG1' ' A' ' 339' ' ' THR . 0.7 OUTLIER -46.58 -45.33 18.77 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 106.643 -1.614 . . . . 40.0 106.643 178.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.569 ' HG1' ' HG2' ' A' ' 334' ' ' PRO . 3.9 p 50.85 -103.27 0.13 Allowed 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 111.372 -2.649 . . . . 40.0 111.852 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.719 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 16.1 p90 171.7 68.96 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.771 0 CA-C-N 110.292 -3.14 . . . . 40.0 105.381 -176.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 345' ' ' ASN . 3.0 Cg_exo -37.47 84.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.65 1.566 . . . . 40.0 112.168 -175.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.647 ' N ' ' O ' ' A' ' 340' ' ' PHE . 2.6 p -70.22 -14.14 62.49 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.679 -0.691 . . . . 40.0 109.419 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.41 -14.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.846 0.831 . . . . 40.0 108.969 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.589 ' H ' ' C ' ' A' ' 342' ' ' SER . 4.7 t -174.65 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.083 -1.417 . . . . 40.0 108.739 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . 0.804 ' O ' ' N ' ' A' ' 347' ' ' ASN . 0.9 OUTLIER 35.69 -152.36 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.59 -0.732 . . . . 40.0 109.996 178.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.521 ' O ' ' O ' ' A' ' 347' ' ' ASN . 29.7 t80 18.86 -68.9 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 113.653 -1.612 . . . . 40.0 112.744 174.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.804 ' N ' ' O ' ' A' ' 345' ' ' ASN . 22.2 m120 -35.39 163.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.015 -0.539 . . . . 40.0 111.5 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 350' ' ' THR . 46.9 m-85 58.72 74.54 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.886 -0.597 . . . . 40.0 110.15 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . 0.462 ' O ' ' ND2' ' A' ' 482' ' ' ASN . 49.6 t -72.0 19.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.879 -0.6 . . . . 40.0 111.001 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 348' ' ' TYR . 29.1 p 47.76 85.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.616 -0.433 . . . . 40.0 110.274 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.706 ' HZ1' ' HB3' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.639 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.23 53.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -67.01 -40.28 87.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.779 -0.368 . . . . 40.0 111.32 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.97 34.09 5.37 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.883 -0.327 . . . . 40.0 111.17 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.551 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.551 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . 0.41 HD12 HG23 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' ASP . . . . . 0.726 ' H ' ' HG1' ' A' ' 459' ' ' THR . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 458' ' ' ILE . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' THR . . . . . 0.726 ' HG1' ' H ' ' A' ' 440' ' ' ASP . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.511 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . 0.68 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.1 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 31.6 mttm 61.43 -21.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.949 -0.569 . . . . 40.0 111.357 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' CYS . . . . . 0.706 ' HB3' ' HZ1' ' A' ' 372' ' ' LYS . 38.2 t -62.48 125.02 22.49 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.6 -0.44 . . . . 40.0 110.062 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 14.8 p -73.12 -19.73 61.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.127 -0.488 . . . . 40.0 111.563 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.606 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.84 116.63 48.09 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' SER . . . . . 0.889 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.72 29.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.03 47.95 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.397 . . . . 40.0 110.527 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.63 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.431 -0.35 . . . . 40.0 110.74 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.95 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -91.9 6.38 46.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.941 0.401 . . . . 40.0 110.183 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.0 158.87 18.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.01 -0.541 . . . . 40.0 111.082 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.76 107.79 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.218 -0.446 . . . . 40.0 109.947 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.94 135.02 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.614 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.52 9.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.471 ' C ' HD21 ' A' ' 326' ' ' ASN . 0.1 OUTLIER -153.09 133.2 13.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.197 0.523 . . . . 40.0 111.646 -179.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.556 ' N ' HD21 ' A' ' 326' ' ' ASN . 0.0 OUTLIER -169.75 62.78 0.45 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.385 -0.825 . . . . 40.0 109.842 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 326' ' ' ASN . 3.7 Cg_exo -75.64 -150.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.955 2.437 . . . . 40.0 112.784 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.457 ' C ' ' CG2' ' A' ' 329' ' ' ILE . 1.9 mm100 -72.47 -32.36 66.17 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.466 -1.309 . . . . 40.0 107.466 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.687 ' O ' ' CB ' ' A' ' 330' ' ' MET . 0.0 OUTLIER -177.27 -6.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.165 -1.38 . . . . 40.0 111.927 179.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.687 ' CB ' ' O ' ' A' ' 329' ' ' ILE . 22.9 tpp 88.83 12.3 0.08 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.072 -0.651 . . . . 40.0 111.215 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.651 ' CG ' ' O ' ' A' ' 331' ' ' TYR . 9.3 t80 48.78 10.99 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.201 -0.666 . . . . 40.0 109.201 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . 0.585 ' H ' ' C ' ' A' ' 330' ' ' MET . 4.7 pt20 -100.7 -40.94 7.11 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.55 -0.75 . . . . 40.0 111.443 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . 0.618 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 31.66 92.73 0.05 OUTLIER Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.854 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -67.19 28.72 0.12 Allowed 'Trans proline' 0 C--N 1.3 -2.007 0 C-N-CA 121.618 1.545 . . . . 40.0 111.203 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.618 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 123.65 -61.5 0.58 Allowed Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.765 -0.652 . . . . 40.0 111.825 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.72 ' C ' HD22 ' A' ' 337' ' ' LEU . 2.7 m -76.3 -47.24 24.33 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 121.211 -0.196 . . . . 40.0 110.828 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' LEU . . . . . 0.774 ' H ' HG22 ' A' ' 339' ' ' THR . 0.1 OUTLIER 140.09 -82.53 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 125.247 1.592 . . . . 40.0 107.494 -177.316 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . 0.538 ' O ' ' OG1' ' A' ' 339' ' ' THR . 86.7 m-85 -79.31 -29.8 42.55 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 105.071 -2.196 . . . . 40.0 105.071 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.774 HG22 ' H ' ' A' ' 337' ' ' LEU . 11.9 p 50.76 -105.71 0.21 Allowed 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 111.402 -2.635 . . . . 40.0 111.83 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.725 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 20.0 p90 174.51 66.81 0.05 OUTLIER Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 110.303 -3.135 . . . . 40.0 105.664 -177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . 0.769 ' O ' ' N ' ' A' ' 345' ' ' ASN . 2.8 Cg_endo -36.07 85.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.87 1.713 . . . . 40.0 111.796 -175.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.631 ' N ' ' O ' ' A' ' 340' ' ' PHE . 13.0 p -55.25 -21.76 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.857 -0.611 . . . . 40.0 111.121 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 343' ' ' LEU . 0.1 OUTLIER -49.35 -19.11 0.46 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.878 0.847 . . . . 40.0 109.714 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.634 ' C ' ' OD1' ' A' ' 345' ' ' ASN . 13.6 t -163.82 -37.29 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.004 -1.453 . . . . 40.0 108.138 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . 0.769 ' N ' ' O ' ' A' ' 341' ' ' PRO . 0.2 OUTLIER 40.7 -171.67 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 114.536 -1.211 . . . . 40.0 111.34 177.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' A' ' 347' ' ' ASN . 86.4 t80 46.67 -86.9 0.01 OUTLIER 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 113.711 -1.586 . . . . 40.0 112.362 173.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.554 ' N ' ' O ' ' A' ' 345' ' ' ASN . 22.4 t-20 -39.22 150.84 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.708 0.289 . . . . 40.0 110.571 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' TYR . . . . . 0.523 ' N ' ' OD1' ' A' ' 347' ' ' ASN . 0.3 OUTLIER -137.61 -27.4 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.343 -0.389 . . . . 40.0 110.594 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . 0.416 ' HG ' ' C ' ' A' ' 392' ' ' GLU . 0.0 OUTLIER -60.78 175.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 40.0 110.203 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 311' ' ' SER . 29.1 p -145.22 85.7 1.74 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 40.0 110.274 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.719 ' HZ1' ' HB3' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.35 53.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -67.65 -39.0 84.61 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.628 -0.429 . . . . 40.0 111.473 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.48 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.848 -0.341 . . . . 40.0 111.17 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.549 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . 0.432 ' C ' HG13 ' A' ' 405' ' ' VAL . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.432 HG13 ' C ' ' A' ' 404' ' ' TRP . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.574 HE21 ' HH ' ' A' ' 466' ' ' TYR . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.549 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 458' ' ' ILE . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . 0.574 ' HH ' HE21 ' A' ' 418' ' ' GLN . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . 0.679 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.12 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 28.6 tttp 61.8 -21.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.019 -0.537 . . . . 40.0 111.434 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' CYS . . . . . 0.719 ' HB3' ' HZ1' ' A' ' 372' ' ' LYS . 38.2 t -62.69 124.93 22.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.612 -0.435 . . . . 40.0 110.062 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 10.2 p -73.09 -20.39 60.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 40.0 111.431 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.604 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.74 116.63 45.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.62 30.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.41 47.04 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 40.0 110.709 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.37 0.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.841 -0.344 . . . . 40.0 110.74 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.95 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.06 4.14 52.91 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.141 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -61.21 159.05 12.76 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.068 -0.514 . . . . 40.0 111.082 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.65 108.27 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 40.0 110.068 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.52 135.02 27.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.61 7.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -150.56 74.75 1.19 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.939 0.4 . . . . 40.0 110.233 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.508 ' OD1' ' NZ ' ' A' ' 485' ' ' LYS . 1.3 t-20 -128.11 86.29 58.4 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.05 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -61.67 -155.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.348 2.032 . . . . 40.0 112.951 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.442 ' C ' ' CG2' ' A' ' 329' ' ' ILE . 44.0 mt-30 -40.12 -54.92 2.21 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.003 -0.544 . . . . 40.0 109.701 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.602 ' O ' ' CB ' ' A' ' 330' ' ' MET . 0.0 OUTLIER -154.48 14.91 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 CA-C-N 115.476 -0.784 . . . . 40.0 110.585 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.602 ' CB ' ' O ' ' A' ' 329' ' ' ILE . 3.1 tpt 78.53 16.37 1.17 Allowed 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.685 -0.806 . . . . 40.0 111.854 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.651 ' CG ' ' O ' ' A' ' 331' ' ' TYR . 52.0 t80 43.38 19.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.865 -0.734 . . . . 40.0 109.043 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . 0.578 ' O ' ' C ' ' A' ' 333' ' ' ALA . 4.5 pt20 -108.54 -40.48 5.09 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.464 -0.789 . . . . 40.0 111.518 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . 0.609 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 2.12 100.53 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.672 0 CA-C-N 115.784 -0.643 . . . . 40.0 112.488 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.36 29.94 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.563 1.509 . . . . 40.0 110.62 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.609 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 124.64 -65.94 0.54 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 110.451 -1.06 . . . . 40.0 110.451 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.629 ' O ' ' HB3' ' A' ' 337' ' ' LEU . 0.2 OUTLIER -71.54 -72.27 0.23 Allowed 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 108.679 -0.859 . . . . 40.0 108.679 178.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' LEU . . . . . 0.938 ' CG ' ' H ' ' A' ' 338' ' ' PHE . 0.0 OUTLIER 166.25 -88.76 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.268 -1.333 . . . . 40.0 111.718 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . 0.938 ' H ' ' CG ' ' A' ' 337' ' ' LEU . 6.0 m-85 -65.51 -48.22 73.3 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.015 -1.476 . . . . 40.0 107.015 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.711 HG23 ' H ' ' A' ' 337' ' ' LEU . 19.1 p 51.28 -104.22 0.16 Allowed 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 112.985 -1.916 . . . . 40.0 112.827 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.746 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 16.9 p90 174.04 67.01 0.04 OUTLIER Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 109.945 -3.298 . . . . 40.0 104.971 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . 0.762 ' O ' ' N ' ' A' ' 345' ' ' ASN . 3.5 Cg_exo -35.59 86.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.602 1.535 . . . . 40.0 112.396 -175.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 340' ' ' PHE . 0.0 OUTLIER -67.54 -21.48 65.46 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.042 -0.725 . . . . 40.0 109.042 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -42.9 -23.95 0.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.91 0.862 . . . . 40.0 109.32 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.49 ' N ' ' C ' ' A' ' 342' ' ' SER . 12.9 t -160.02 -38.4 0.05 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.048 -1.433 . . . . 40.0 108.342 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . 0.762 ' N ' ' O ' ' A' ' 341' ' ' PRO . 1.5 m-20 38.28 -156.43 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 114.979 -1.01 . . . . 40.0 110.525 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.449 ' CE1' ' ND2' ' A' ' 347' ' ' ASN . 29.3 t80 52.65 92.91 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.454 -1.248 . . . . 40.0 111.263 175.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 347' ' ' ASN . 0.6 OUTLIER 63.83 109.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.506 -0.77 . . . . 40.0 110.222 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 349' ' ' CYS . 1.1 t80 -142.43 -6.53 0.91 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.396 -0.366 . . . . 40.0 110.886 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . 0.446 ' O ' ' O ' ' A' ' 348' ' ' TYR . 1.7 t -60.01 -151.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.003 -0.74 . . . . 40.0 109.003 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 311' ' ' SER . 29.1 p -145.18 85.7 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.791 -0.763 . . . . 40.0 110.274 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.712 ' HZ3' ' HB3' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.39 53.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' GLN . . . . . 0.42 ' OE1' ' OD1' ' A' ' 394' ' ' ASN . 0.0 OUTLIER -67.02 -40.4 87.23 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.593 -0.443 . . . . 40.0 111.175 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.55 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.773 -0.371 . . . . 40.0 111.17 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.552 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . 0.43 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . 0.451 ' C ' HG13 ' A' ' 405' ' ' VAL . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.451 HG13 ' C ' ' A' ' 404' ' ' TRP . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLN . . . . . 0.84 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . 0.84 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.552 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . 0.63 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG21 HD12 ' A' ' 458' ' ' ILE . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . 0.678 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.44 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.508 ' NZ ' ' OD1' ' A' ' 326' ' ' ASN . 0.4 OUTLIER 61.39 -21.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.186 -0.461 . . . . 40.0 111.113 179.153 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' CYS . . . . . 0.712 ' HB3' ' HZ3' ' A' ' 372' ' ' LYS . 38.2 t -63.33 124.84 22.28 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.688 -0.405 . . . . 40.0 110.062 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 3.3 t -73.37 -20.39 60.77 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.879 -0.328 . . . . 40.0 111.368 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.605 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.14 116.63 43.98 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.655 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.655 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -107.83 47.85 0.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 40.0 110.677 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.74 0.32 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.472 -0.331 . . . . 40.0 110.74 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.06 47.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.99 4.49 51.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 40.0 110.207 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -62.25 159.03 15.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 40.0 111.082 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.27 108.73 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.585 . . . . 40.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -91.06 135.02 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.608 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' SER . . . . . 0.768 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 174.58 6.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.511 ' O ' ' O ' ' A' ' 326' ' ' ASN . 17.2 mtt-85 81.86 3.99 1.3 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.49 0.922 . . . . 40.0 113.49 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.577 ' O ' ' O ' ' A' ' 327' ' ' PRO . 0.0 OUTLIER 50.75 174.25 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 119.775 -0.77 . . . . 40.0 109.533 179.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' A' ' 326' ' ' ASN . 3.4 Cg_exo -46.15 -164.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.034 1.823 . . . . 40.0 113.264 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.544 ' C ' ' O ' ' A' ' 327' ' ' PRO . 0.0 OUTLIER -25.23 -73.16 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.357 -0.838 . . . . 40.0 110.375 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.554 HD11 ' O ' ' A' ' 329' ' ' ILE . 0.1 OUTLIER -159.05 51.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 CA-C-N 115.998 -0.547 . . . . 40.0 111.491 179.095 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.525 ' O ' ' CD1' ' A' ' 331' ' ' TYR . 6.4 tpt 60.05 16.6 6.02 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 118.122 -1.431 . . . . 40.0 107.884 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 330' ' ' MET . 8.5 p90 37.41 32.65 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.538 -1.21 . . . . 40.0 109.425 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 330' ' ' MET . 10.6 pt20 -115.66 -33.66 5.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.414 -0.812 . . . . 40.0 110.695 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . 0.566 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 32.55 87.17 0.11 Allowed Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.568 -0.742 . . . . 40.0 111.6 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.419 ' HD2' ' CG2' ' A' ' 339' ' ' THR . 3.4 Cg_exo -68.01 33.29 0.15 Allowed 'Trans proline' 0 C--N 1.302 -1.92 0 C-N-CA 122.351 2.034 . . . . 40.0 111.429 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 120.79 -66.31 0.44 Allowed Glycine 0 CA--C 1.52 0.357 0 N-CA-C 111.114 -0.795 . . . . 40.0 111.114 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.71 ' C ' HD21 ' A' ' 337' ' ' LEU . 2.2 m -69.1 -51.46 38.39 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 120.776 0.322 . . . . 40.0 110.814 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' LEU . . . . . 0.87 ' H ' HG21 ' A' ' 339' ' ' THR . 0.1 OUTLIER 139.62 -82.21 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 125.437 1.71 . . . . 40.0 106.778 -176.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . 0.652 ' O ' ' OG1' ' A' ' 339' ' ' THR . 59.0 t80 -72.45 -36.18 68.46 Favored 'General case' 0 CA--C 1.472 -2.045 0 N-CA-C 104.328 -2.471 . . . . 40.0 104.328 175.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.87 HG21 ' H ' ' A' ' 337' ' ' LEU . 1.4 p 55.43 -96.94 0.06 Allowed 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 110.821 -2.899 . . . . 40.0 111.843 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.78 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 29.1 p90 167.04 70.31 0.0 OUTLIER Pre-proline 0 C--N 1.288 -2.09 0 CA-C-N 109.708 -3.405 . . . . 40.0 105.668 -176.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . 0.679 ' O ' ' N ' ' A' ' 345' ' ' ASN . 2.5 Cg_endo -39.04 87.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.562 1.508 . . . . 40.0 112.136 -175.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 340' ' ' PHE . 0.0 OUTLIER -68.56 -19.27 64.47 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.54 -0.464 . . . . 40.0 110.063 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -44.89 -19.6 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.919 0.866 . . . . 40.0 109.648 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 346' ' ' PHE . 6.5 t -167.6 -37.5 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.908 -1.496 . . . . 40.0 108.366 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . 0.679 ' N ' ' O ' ' A' ' 341' ' ' PRO . 2.7 m-20 38.17 -86.36 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 122.735 1.255 . . . . 40.0 110.981 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.625 ' N ' ' O ' ' A' ' 344' ' ' THR . 5.4 t80 -66.02 74.46 0.08 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 112.36 -2.2 . . . . 40.0 111.791 -178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.454 ' CG ' ' O ' ' A' ' 346' ' ' PHE . 33.5 m-20 -176.87 46.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.924 -0.58 . . . . 40.0 109.771 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.26 85.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 40.0 110.609 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . 0.416 ' N ' ' O ' ' A' ' 347' ' ' ASN . 3.8 t -113.97 108.84 17.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.905 -0.589 . . . . 40.0 110.131 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 311' ' ' SER . 29.1 p -145.9 85.7 1.7 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.405 . . . . 40.0 110.274 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' TRP . . . . . 0.456 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.713 ' HZ3' ' HB3' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.639 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.27 53.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' GLN . . . . . 0.485 ' NE2' ' OD1' ' A' ' 390' ' ' ASN . 3.7 mt-30 -66.76 -40.34 88.23 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.743 -0.383 . . . . 40.0 111.354 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.11 34.09 5.37 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.967 -0.293 . . . . 40.0 111.17 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.55 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.55 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' SER . . . . . 0.848 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . 0.848 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.44 HG21 HD11 ' A' ' 437' ' ' ILE . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' ILE . . . . . 0.436 HD13 HG22 ' A' ' 458' ' ' ILE . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.768 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . 0.678 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.21 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.405 ' O ' ' CZ ' ' A' ' 325' ' ' ARG . 0.9 OUTLIER 61.28 -20.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.558 . . . . 40.0 111.393 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' CYS . . . . . 0.713 ' HB3' ' HZ3' ' A' ' 372' ' ' LYS . 38.2 t -63.12 124.84 22.19 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.677 -0.409 . . . . 40.0 110.062 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.2 -19.85 61.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 40.0 111.493 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.606 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.19 116.63 46.52 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.654 ' CG2' ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.654 ' H ' ' CG2' ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ALA . . . . . . . . . . . . . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.68 30.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.607 ' N ' HD21 ' A' ' 309' ' ' ASN . 0.8 OUTLIER -107.77 47.88 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 40.0 110.643 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 tt -140.9 0.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.883 -0.327 . . . . 40.0 110.74 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.09 47.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' A' ' 312' ' ' HIS . 0.0 OUTLIER -90.92 4.98 50.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 40.0 110.254 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -63.22 159.01 18.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 40.0 111.082 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . 0.509 ' CG1' ' OG ' ' A' ' 323' ' ' SER . 14.9 p -121.73 108.29 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 40.0 109.91 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.74 135.02 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 40.0 111.142 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.619 ' O ' HG21 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' SER . . . . . 0.509 ' OG ' ' CG1' ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' SER . . . . . 0.767 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 173.79 7.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.547 ' CA ' ' HE ' ' A' ' 325' ' ' ARG . 0.0 OUTLIER 81.12 -160.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.922 -0.581 . . . . 40.0 111.52 177.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.744 ' O ' ' O ' ' A' ' 327' ' ' PRO . 0.0 OUTLIER -152.65 165.47 17.49 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.256 -0.884 . . . . 40.0 109.719 -179.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.744 ' O ' ' O ' ' A' ' 326' ' ' ASN . 3.0 Cg_exo -41.63 -148.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 123.167 2.578 . . . . 40.0 112.671 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.485 ' C ' ' O ' ' A' ' 327' ' ' PRO . 4.7 mt-30 -34.87 -67.42 0.14 Allowed 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.575 -0.528 . . . . 40.0 109.575 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.637 HD11 ' N ' ' A' ' 331' ' ' TYR . 0.0 OUTLIER -153.67 22.36 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.495 -1.137 0 CA-C-N 115.478 -0.783 . . . . 40.0 108.924 178.108 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.567 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 2.0 ttt 76.6 16.15 2.02 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.776 -1.102 . . . . 40.0 111.082 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.637 ' N ' HD11 ' A' ' 329' ' ' ILE . 7.7 m-85 38.8 34.29 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.85 -1.167 . . . . 40.0 107.85 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' GLN . . . . . 0.693 ' O ' ' O ' ' A' ' 333' ' ' ALA . 5.5 pt20 -120.15 -50.54 2.25 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.116 -0.947 . . . . 40.0 111.477 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . 0.712 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 18.75 118.48 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 123.89 0.744 . . . . 40.0 112.368 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.53 ' C ' ' H ' ' A' ' 336' ' ' THR . 3.6 Cg_exo -74.57 36.42 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 N-CA-C 106.425 -2.183 . . . . 40.0 106.425 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.712 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 82.4 -10.54 54.57 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 106.35 -2.7 . . . . 40.0 106.35 -175.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' THR . . . . . 0.751 ' O ' ' N ' ' A' ' 338' ' ' PHE . 0.2 OUTLIER -119.39 69.63 0.83 Allowed 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 113.611 -1.295 . . . . 40.0 109.702 178.137 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' LEU . . . . . 0.75 ' CD2' ' N ' ' A' ' 337' ' ' LEU . 0.8 OUTLIER 39.35 -76.28 0.0 OUTLIER 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.368 -1.287 . . . . 40.0 112.837 178.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . 0.751 ' N ' ' O ' ' A' ' 336' ' ' THR . 0.0 OUTLIER -145.78 -58.76 0.32 Allowed 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 114.378 -1.283 . . . . 40.0 107.735 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.686 ' OG1' ' O ' ' A' ' 338' ' ' PHE . 1.0 OUTLIER 59.25 -99.9 0.1 Allowed 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 111.818 -2.446 . . . . 40.0 112.153 179.207 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.743 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 25.1 p90 173.21 68.67 0.04 OUTLIER Pre-proline 0 C--N 1.293 -1.865 0 CA-C-N 110.42 -3.082 . . . . 40.0 105.296 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 338' ' ' PHE . 3.1 Cg_exo -37.2 118.43 0.23 Allowed 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 121.704 1.603 . . . . 40.0 111.882 -175.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.577 ' O ' ' N ' ' A' ' 344' ' ' THR . 82.9 p -72.13 -24.08 61.41 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.504 -0.478 . . . . 40.0 111.502 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 344' ' ' THR . 0.7 OUTLIER -44.13 -17.43 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.541 0.686 . . . . 40.0 109.408 178.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.61 ' O ' ' O ' ' A' ' 345' ' ' ASN . 2.0 t -179.18 28.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.603 -1.18 . . . . 40.0 109.836 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . 0.61 ' O ' ' O ' ' A' ' 344' ' ' THR . 0.1 OUTLIER -41.72 -176.52 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.636 0.731 . . . . 40.0 110.944 -179.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 345' ' ' ASN . 43.5 t80 56.4 94.42 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.454 -1.248 . . . . 40.0 112.578 174.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.458 ' O ' ' NE2' ' A' ' 312' ' ' HIS . 15.9 t-20 179.45 56.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.494 -0.776 . . . . 40.0 109.611 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.48 139.2 51.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.26 0.553 . . . . 40.0 111.998 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . 0.678 ' SG ' ' O ' ' A' ' 392' ' ' GLU . 1.1 t -175.53 -52.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.362 -0.836 . . . . 40.0 109.429 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' THR . . . . . 0.628 ' OG1' ' O ' ' A' ' 349' ' ' CYS . 29.1 p 57.46 85.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.92 -0.582 . . . . 40.0 110.274 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' SER . . . . . 0.968 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.442 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' TRP . . . . . 0.455 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.75 ' HZ1' ' CB ' ' A' ' 486' ' ' CYS . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' CE3' ' O ' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' VAL . . . . . 0.411 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . 0.552 ' HG ' ' H ' ' A' ' 382' ' ' GLY . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.552 ' H ' ' HG ' ' A' ' 380' ' ' CYS . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.637 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.678 ' O ' ' SG ' ' A' ' 349' ' ' CYS . 61.0 mm-40 -52.09 -37.05 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -66.42 -40.57 89.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.527 -0.306 . . . . 40.0 111.347 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.67 34.09 5.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.637 ' HB3' ' HA ' ' A' ' 391' ' ' ILE . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . 0.561 ' OH ' ' SG ' ' A' ' 349' ' ' CYS . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . 0.53 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.549 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . 0.53 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLN . . . . . 0.841 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . 0.841 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.549 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' SER . . . . . 0.847 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.416 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . 0.847 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . 0.63 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' VAL . . . . . 0.455 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.657 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 460' ' ' ASN . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 457' ' ' ASN . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . 0.411 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' PHE . . . . . 0.968 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . 0.597 ' HH ' HD21 ' A' ' 482' ' ' ASN . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.597 HD21 ' HH ' ' A' ' 480' ' ' TYR . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.767 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . 0.675 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.49 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt 61.04 -20.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.988 -0.551 . . . . 40.0 111.41 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' CYS . . . . . 0.75 ' CB ' ' HZ1' ' A' ' 372' ' ' LYS . 38.2 t -63.89 125.03 23.06 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.062 -0.347 . . . . 40.0 110.062 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 3.5 t -73.14 -20.21 60.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 40.0 111.516 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.09 116.63 46.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' THR . . . . . 0.619 HG21 ' O ' ' A' ' 320' ' ' ARG . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' LEU . . . . . 0.873 ' O ' ' O ' ' A' ' 493' ' ' CYS . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' SER . . . . . 0.887 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.77 29.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -108.1 48.07 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 40.0 110.638 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.78 0.32 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.444 -0.344 . . . . 40.0 110.74 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.94 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' HIS . . . . . 0.485 ' C ' HG22 ' A' ' 350' ' ' THR . 7.4 m-70 -92.35 7.55 42.39 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.058 0.456 . . . . 40.0 110.059 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.94 158.84 21.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.02 -0.536 . . . . 40.0 111.082 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.33 107.65 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.018 -0.537 . . . . 40.0 110.141 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.11 135.02 27.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.95 7.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.682 ' CB ' ' O ' ' A' ' 324' ' ' SER . 21.1 ttm180 . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 112.651 0.612 . . . . 40.0 112.651 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.117 0.484 . . . . 40.0 111.012 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -133.81 85.7 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.738 -0.665 . . . . 40.0 110.274 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.25 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -66.62 -40.01 88.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.529 -0.305 . . . . 40.0 111.466 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.86 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 484' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.16 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 16.4 tttp 61.76 -22.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.545 . . . . 40.0 111.269 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 486' ' ' CYS . . . . . 0.643 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.24 124.96 22.27 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.556 -0.457 . . . . 40.0 110.062 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 1.5 m -72.71 -20.95 61.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 40.0 111.326 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.68 116.63 45.27 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.67 30.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.58 47.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.578 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.66 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.807 -0.357 . . . . 40.0 110.74 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.01 47.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' HIS . . . . . 0.485 ' C ' HG22 ' A' ' 350' ' ' THR . 0.0 OUTLIER -91.2 5.78 47.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 40.0 110.304 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.81 158.91 20.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 40.0 111.082 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.6 107.9 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.102 -0.499 . . . . 40.0 110.04 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.21 135.02 27.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 173.1 7.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 51.2 ttm-85 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 40.0 111.034 178.64 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 121.202 0.525 . . . . 40.0 111.707 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -154.75 85.7 1.11 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.281 -0.872 . . . . 40.0 110.274 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.37 53.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.09 -39.31 86.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.87 -0.332 . . . . 40.0 111.463 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.88 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 484' ' ' ARG . . . . . 0.642 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.02 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 22.6 mttp 61.55 -21.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.786 -0.643 . . . . 40.0 111.375 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 486' ' ' CYS . . . . . 0.642 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.24 124.9 22.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.71 -0.396 . . . . 40.0 110.062 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 9.4 t -73.4 -19.8 60.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.407 -0.36 . . . . 40.0 111.458 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.05 116.63 46.18 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.74 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -107.9 47.7 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 40.0 110.658 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.57 0.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.868 -0.333 . . . . 40.0 110.74 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.85 47.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' HIS . . . . . 0.458 ' C ' HG22 ' A' ' 350' ' ' THR . 27.7 m-70 -91.83 5.96 47.91 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.652 -0.419 . . . . 40.0 110.154 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -62.41 158.99 16.31 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.062 -0.517 . . . . 40.0 111.082 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 314' ' ' VAL . 11.9 p -121.66 108.27 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.906 -0.405 . . . . 40.0 109.906 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.71 135.02 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 40.0 111.142 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' SER . . . . . 0.515 ' OG ' ' CG1' ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 171.11 8.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 . . . . . 0 N--CA 1.467 0.404 0 CA-C-O 120.866 0.365 . . . . 40.0 110.664 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 C--O 1.232 0.137 0 N-CA-C 108.971 -0.752 . . . . 40.0 108.971 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -150.85 85.7 1.36 Allowed 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 119.418 -0.913 . . . . 40.0 110.274 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.32 53.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -67.45 -39.44 85.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.649 -0.42 . . . . 40.0 111.404 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.27 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.832 -0.347 . . . . 40.0 111.17 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 484' ' ' ARG . . . . . 0.644 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 63.74 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 34.7 tttp 61.29 -21.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.664 -0.698 . . . . 40.0 111.303 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 486' ' ' CYS . . . . . 0.644 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -61.45 124.94 22.04 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.585 -0.446 . . . . 40.0 110.062 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 16.2 m -73.27 -19.7 61.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 40.0 111.526 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.52 116.63 47.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -107.79 47.79 0.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 40.0 110.636 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.7 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.774 0.321 . . . . 40.0 110.74 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.06 47.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' HIS . . . . . 0.465 ' C ' HG22 ' A' ' 350' ' ' THR . 0.9 OUTLIER -91.51 5.59 48.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.915 0.388 . . . . 40.0 110.23 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -62.77 158.97 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.985 -0.552 . . . . 40.0 111.082 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 70.4 t -120.73 108.24 22.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 40.0 109.976 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.38 135.02 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.76 7.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.679 ' O ' ' O ' ' A' ' 324' ' ' SER . 19.8 mtt180 . . . . . 0 N--CA 1.464 0.242 0 CA-C-N 115.784 -0.644 . . . . 40.0 112.041 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 350' ' ' THR . 21.6 t . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.819 0.342 . . . . 40.0 110.504 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -138.92 85.7 2.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 40.0 110.274 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 25.6 m120 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.24 53.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 393' ' ' GLN . 0.2 OUTLIER -66.41 -40.6 89.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.498 -0.319 . . . . 40.0 111.299 -179.096 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.43 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 484' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 -21.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 40.0 111.236 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 486' ' ' CYS . . . . . 0.643 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.23 124.96 22.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.567 -0.453 . . . . 40.0 110.062 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 3.1 t -73.5 -19.11 61.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 40.0 111.565 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -71.02 116.63 48.49 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.69 29.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 5.9 p-10 -107.87 47.81 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.697 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.64 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.457 -0.338 . . . . 40.0 110.74 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.88 47.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 312' ' ' HIS . 5.6 t60 -92.09 7.82 40.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.99 -0.55 . . . . 40.0 110.253 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -65.64 158.94 25.96 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.915 -0.584 . . . . 40.0 111.082 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.75 108.03 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.757 -0.656 . . . . 40.0 110.117 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.93 135.02 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.31 9.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 324' ' ' SER . 11.3 ttp85 . . . . . 0 C--N 1.328 -0.339 0 N-CA-C 109.399 -0.593 . . . . 40.0 109.399 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' CYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 350' ' ' THR . 1.6 p . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.048 0.451 . . . . 40.0 110.677 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p 53.32 85.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.592 -0.731 . . . . 40.0 110.274 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.22 53.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.78 -41.14 88.17 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.547 -0.461 . . . . 40.0 111.263 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.16 34.09 5.33 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.885 -0.326 . . . . 40.0 111.17 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 484' ' ' ARG . . . . . 0.644 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 63.81 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? 61.68 -22.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.651 -0.704 . . . . 40.0 111.214 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 486' ' ' CYS . . . . . 0.644 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -61.43 124.97 22.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.636 -0.426 . . . . 40.0 110.062 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 487' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 487' ' ' THR . 2.5 t -73.11 -20.45 60.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 40.0 111.449 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.7 116.63 45.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -108.03 47.52 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.371 -0.377 . . . . 40.0 110.638 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.08 0.32 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.426 -0.352 . . . . 40.0 110.74 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.07 47.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' HIS . . . . . 0.489 ' C ' HG22 ' A' ' 350' ' ' THR . 0.0 OUTLIER -91.37 6.06 46.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 40.0 110.233 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -64.07 158.91 21.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 40.0 111.082 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.43 108.25 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.04 -0.527 . . . . 40.0 110.014 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.49 135.02 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.5 9.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.637 ' CB ' ' O ' ' A' ' 324' ' ' SER . 2.2 mtp85 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 121.433 0.635 . . . . 40.0 110.642 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' CYS . . . . . 0.462 ' O ' ' ND2' ' A' ' 482' ' ' ASN . 49.6 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.631 0.253 . . . . 40.0 111.001 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p 47.76 85.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.616 -0.433 . . . . 40.0 110.274 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.23 53.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -67.01 -40.28 87.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.779 -0.368 . . . . 40.0 111.32 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.97 34.09 5.37 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.883 -0.327 . . . . 40.0 111.17 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 484' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.1 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 31.6 mttm 61.43 -21.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.949 -0.569 . . . . 40.0 111.357 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 486' ' ' CYS . . . . . 0.643 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.48 125.02 22.49 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.6 -0.44 . . . . 40.0 110.062 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 14.8 p -73.12 -19.73 61.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.127 -0.488 . . . . 40.0 111.563 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.84 116.63 48.09 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.72 29.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.03 47.95 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.397 . . . . 40.0 110.527 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.63 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.431 -0.35 . . . . 40.0 110.74 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.95 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' HIS . . . . . 0.469 ' C ' HG22 ' A' ' 350' ' ' THR . 1.5 t60 -91.9 6.38 46.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.941 0.401 . . . . 40.0 110.183 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.0 158.87 18.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.01 -0.541 . . . . 40.0 111.082 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' VAL . . . . . 0.439 HG23 ' OG ' ' A' ' 323' ' ' SER . 0.4 OUTLIER -120.76 107.79 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.218 -0.446 . . . . 40.0 109.947 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.94 135.02 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' SER . . . . . 0.439 ' OG ' HG23 ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.52 9.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.173 0 CA-C-O 121.197 0.523 . . . . 40.0 111.646 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.837 0.351 . . . . 40.0 110.203 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -145.22 85.7 1.74 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 40.0 110.274 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.35 53.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -67.65 -39.0 84.61 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.628 -0.429 . . . . 40.0 111.473 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.48 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.848 -0.341 . . . . 40.0 111.17 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 484' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.12 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 28.6 tttp 61.8 -21.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.019 -0.537 . . . . 40.0 111.434 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 486' ' ' CYS . . . . . 0.641 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.69 124.93 22.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.612 -0.435 . . . . 40.0 110.062 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 10.2 p -73.09 -20.39 60.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 40.0 111.431 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.74 116.63 45.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.62 30.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.41 47.04 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 40.0 110.709 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.37 0.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.841 -0.344 . . . . 40.0 110.74 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.95 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' HIS . . . . . 0.437 ' C ' HG22 ' A' ' 350' ' ' THR . 0.5 OUTLIER -91.06 4.14 52.91 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.141 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -61.21 159.05 12.76 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.068 -0.514 . . . . 40.0 111.082 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.65 108.27 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 40.0 110.068 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.52 135.02 27.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.61 7.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.939 0.4 . . . . 40.0 110.233 178.734 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.23 0.062 0 N-CA-C 109.003 -0.74 . . . . 40.0 109.003 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -145.18 85.7 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.791 -0.763 . . . . 40.0 110.274 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.39 53.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' GLN . . . . . 0.42 ' OE1' ' OD1' ' A' ' 394' ' ' ASN . 0.0 OUTLIER -67.02 -40.4 87.23 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.593 -0.443 . . . . 40.0 111.175 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.55 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.773 -0.371 . . . . 40.0 111.17 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 484' ' ' ARG . . . . . 0.64 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.44 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.39 -21.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.186 -0.461 . . . . 40.0 111.113 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 486' ' ' CYS . . . . . 0.64 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -63.33 124.84 22.28 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.688 -0.405 . . . . 40.0 110.062 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 3.3 t -73.37 -20.39 60.77 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.879 -0.328 . . . . 40.0 111.368 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.14 116.63 43.98 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -107.83 47.85 0.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 40.0 110.677 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.74 0.32 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.472 -0.331 . . . . 40.0 110.74 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.06 47.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' HIS . . . . . 0.457 ' C ' HG22 ' A' ' 350' ' ' THR . 0.1 OUTLIER -90.99 4.49 51.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 40.0 110.207 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -62.25 159.03 15.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 40.0 111.082 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.27 108.73 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.585 . . . . 40.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -91.06 135.02 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 174.58 6.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 324' ' ' SER . 17.2 mtt-85 . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 113.49 0.922 . . . . 40.0 113.49 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.23 0.064 0 N-CA-C 110.131 -0.322 . . . . 40.0 110.131 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -145.9 85.7 1.7 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.405 . . . . 40.0 110.274 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 25.6 m120 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.27 53.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' GLN . . . . . 0.473 ' OE1' ' ND2' ' A' ' 390' ' ' ASN . 1.1 mt-30 -66.76 -40.34 88.23 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.743 -0.383 . . . . 40.0 111.354 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.11 34.09 5.37 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.967 -0.293 . . . . 40.0 111.17 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 484' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.21 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.405 ' O ' ' CZ ' ' A' ' 325' ' ' ARG . 0.9 OUTLIER 61.28 -20.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.558 . . . . 40.0 111.393 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 486' ' ' CYS . . . . . 0.641 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -63.12 124.84 22.19 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.677 -0.409 . . . . 40.0 110.062 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 487' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 487' ' ' THR . 0.1 OUTLIER -73.2 -19.85 61.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 40.0 111.493 -179.435 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.19 116.63 46.52 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.68 30.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -107.77 47.88 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 40.0 110.643 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.9 0.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.883 -0.327 . . . . 40.0 110.74 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.09 47.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 312' ' ' HIS . 0.0 OUTLIER -90.92 4.98 50.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 40.0 110.254 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.22 159.01 18.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 40.0 111.082 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 314' ' ' VAL . 14.9 p -121.73 108.29 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 40.0 109.91 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.74 135.02 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 40.0 111.142 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' SER . . . . . 0.509 ' OG ' ' CG1' ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 173.79 7.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.574 ' HE ' ' CA ' ' A' ' 325' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.922 -0.581 . . . . 40.0 111.52 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' CYS . . . . . 0.678 ' SG ' ' O ' ' A' ' 392' ' ' GLU . 1.1 t . . . . . 0 CA--C 1.522 -0.131 0 N-CA-C 109.429 -0.582 . . . . 40.0 109.429 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' THR . . . . . 0.628 ' OG1' ' O ' ' A' ' 349' ' ' CYS . 29.1 p 57.46 85.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.92 -0.582 . . . . 40.0 110.274 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.678 ' O ' ' SG ' ' A' ' 349' ' ' CYS . 61.0 mm-40 -52.09 -37.05 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -66.42 -40.57 89.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.527 -0.306 . . . . 40.0 111.347 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.67 34.09 5.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' TYR . . . . . 0.561 ' OH ' ' SG ' ' A' ' 349' ' ' CYS . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 484' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.49 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt 61.04 -20.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.988 -0.551 . . . . 40.0 111.41 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 486' ' ' CYS . . . . . 0.637 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -63.89 125.03 23.06 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.062 -0.347 . . . . 40.0 110.062 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 487' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 487' ' ' THR . 3.5 t -73.14 -20.21 60.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 40.0 111.516 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.09 116.63 46.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.77 29.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -108.1 48.07 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 40.0 110.638 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.78 0.32 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.444 -0.344 . . . . 40.0 110.74 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.94 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' HIS . . . . . 0.485 ' C ' HG22 ' A' ' 350' ' ' THR . 7.4 m-70 -92.35 7.55 42.39 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.058 0.456 . . . . 40.0 110.059 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.94 158.84 21.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.02 -0.536 . . . . 40.0 111.082 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.33 107.65 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.018 -0.537 . . . . 40.0 110.141 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.11 135.02 27.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.95 7.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.682 ' CB ' ' O ' ' A' ' 324' ' ' SER . 21.1 ttm180 122.83 -35.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.651 0.612 . . . . 40.0 112.651 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.567 ' O ' ' O ' ' A' ' 327' ' ' PRO . 1.2 m-20 64.0 166.46 0.11 Allowed Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 109.017 -0.735 . . . . 40.0 109.017 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.613 ' O ' ' C ' ' A' ' 328' ' ' GLN . 2.9 Cg_endo -41.71 179.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.702 2.268 . . . . 40.0 112.004 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.813 ' O ' HG23 ' A' ' 329' ' ' ILE . 28.0 mt-30 -17.11 -66.72 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.265 -0.425 . . . . 40.0 110.489 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.813 HG23 ' O ' ' A' ' 328' ' ' GLN . 0.4 OUTLIER -166.43 49.04 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.34 0 CA-C-N 115.825 -0.625 . . . . 40.0 110.603 179.137 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.492 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 7.1 tpp 61.52 15.83 7.07 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 118.289 -1.364 . . . . 40.0 107.486 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.57 ' H ' HD12 ' A' ' 329' ' ' ILE . 1.5 p90 36.51 34.23 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.201 -1.363 . . . . 40.0 109.225 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' A' ' 333' ' ' ALA . 2.4 pt20 -114.62 -36.56 4.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.193 -0.912 . . . . 40.0 111.223 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ALA . . . . . 0.629 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 30.98 97.64 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.533 -0.758 . . . . 40.0 111.471 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.448 ' HG2' ' OG1' ' A' ' 339' ' ' THR . 4.8 Cg_exo -67.64 12.67 0.19 Allowed 'Trans proline' 0 C--N 1.297 -2.138 0 C-N-CA 121.739 1.626 . . . . 40.0 109.469 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.629 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 135.58 -50.74 0.84 Allowed Glycine 0 C--N 1.333 0.38 0 CA-C-N 114.633 -1.167 . . . . 40.0 110.73 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 336' ' ' THR . 27.4 m -106.9 35.97 2.82 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 120.728 -0.389 . . . . 40.0 111.055 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' LEU . . . . . 0.901 HD22 ' N ' ' A' ' 337' ' ' LEU . 0.5 OUTLIER 63.3 -101.46 0.1 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.371 0.605 . . . . 40.0 111.358 177.579 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.716 ' C ' ' HG1' ' A' ' 339' ' ' THR . 0.1 OUTLIER -60.58 -42.74 97.29 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 107.163 -1.421 . . . . 40.0 107.163 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.716 ' HG1' ' C ' ' A' ' 338' ' ' PHE . 2.5 p 57.12 -104.59 0.23 Allowed 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 112.003 -2.362 . . . . 40.0 112.056 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.773 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 15.0 p90 174.06 66.93 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 110.753 -2.931 . . . . 40.0 105.625 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' PRO . . . . . 0.63 ' O ' ' N ' ' A' ' 345' ' ' ASN . 3.4 Cg_exo -39.43 87.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.234 1.29 . . . . 40.0 112.634 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 340' ' ' PHE . 4.6 p -74.52 -14.55 60.83 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.948 -0.76 . . . . 40.0 108.948 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 344' ' ' THR . 0.3 OUTLIER -53.73 -15.42 1.23 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.599 -0.889 . . . . 40.0 108.599 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.828 ' N ' HD12 ' A' ' 343' ' ' LEU . 4.5 t -179.93 27.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.334 -1.303 . . . . 40.0 109.721 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.678 ' O ' ' O ' ' A' ' 344' ' ' THR . 15.6 m-20 -41.78 -172.91 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.494 0.664 . . . . 40.0 110.5 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' PHE . . . . . . . . . . . . . 55.5 t80 53.9 18.83 1.74 Allowed 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 119.473 -0.891 . . . . 40.0 110.535 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.419 HD22 ' HG3' ' A' ' 395' ' ' GLU . 2.1 t-20 -173.24 129.0 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.6 -0.727 . . . . 40.0 109.896 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.18 -34.87 6.25 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.686 0.279 . . . . 40.0 110.819 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 3.2 m 72.58 76.38 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 40.0 111.012 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -133.81 85.7 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.738 -0.665 . . . . 40.0 110.274 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.25 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -66.62 -40.01 88.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.529 -0.305 . . . . 40.0 111.466 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.86 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 484' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.16 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 16.4 tttp 61.76 -22.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.545 . . . . 40.0 111.269 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' CYS . . . . . 0.643 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.24 124.96 22.27 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.556 -0.457 . . . . 40.0 110.062 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 1.5 m -72.71 -20.95 61.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 40.0 111.326 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.68 116.63 45.27 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.67 30.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.58 47.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.578 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.66 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.807 -0.357 . . . . 40.0 110.74 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.01 47.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' HIS . . . . . 0.485 ' C ' HG22 ' A' ' 350' ' ' THR . 0.0 OUTLIER -91.2 5.78 47.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 40.0 110.304 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.81 158.91 20.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 40.0 111.082 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.6 107.9 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.102 -0.499 . . . . 40.0 110.04 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.21 135.02 27.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 173.1 7.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 51.2 ttm-85 69.73 109.96 0.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 40.0 111.034 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 327' ' ' PRO . 0.3 OUTLIER -100.17 151.89 37.66 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 40.0 109.739 179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.556 ' O ' ' C ' ' A' ' 328' ' ' GLN . 2.8 Cg_endo -45.77 178.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.449 2.099 . . . . 40.0 111.921 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.72 ' CD ' ' H ' ' A' ' 328' ' ' GLN . 1.8 mp0 -23.89 -58.51 0.05 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.254 -0.43 . . . . 40.0 110.314 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 328' ' ' GLN . 0.6 OUTLIER -163.69 44.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 CA-C-N 115.827 -0.624 . . . . 40.0 110.894 178.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.46 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 8.2 tpt 60.9 14.29 5.13 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 118.17 -1.412 . . . . 40.0 108.378 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.68 ' H ' HD12 ' A' ' 329' ' ' ILE . 23.6 m-85 41.12 28.33 0.06 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.993 -1.003 . . . . 40.0 109.068 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLN . . . . . 0.529 ' O ' ' O ' ' A' ' 333' ' ' ALA . 3.4 pt20 -106.12 -39.9 5.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.211 -0.904 . . . . 40.0 112.27 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ALA . . . . . 0.704 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 30.4 99.14 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.086 -0.507 . . . . 40.0 110.659 -177.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 337' ' ' LEU . 4.7 Cg_exo -69.74 17.48 0.2 Allowed 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.022 1.815 . . . . 40.0 108.682 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.704 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 130.0 -54.3 0.79 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 113.768 -1.56 . . . . 40.0 110.037 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.776 ' HB ' HG22 ' A' ' 339' ' ' THR . 6.5 m -106.2 45.81 0.96 Allowed 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 120.692 -0.403 . . . . 40.0 110.898 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' LEU . . . . . 0.887 HD22 ' N ' ' A' ' 337' ' ' LEU . 0.7 OUTLIER 60.6 -104.16 0.17 Allowed 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.677 0.751 . . . . 40.0 112.182 176.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.916 ' O ' ' OG1' ' A' ' 339' ' ' THR . 0.0 OUTLIER -73.88 -39.11 64.16 Favored 'General case' 0 CA--C 1.48 -1.719 0 N-CA-C 107.183 -1.414 . . . . 40.0 107.183 178.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.916 ' OG1' ' O ' ' A' ' 338' ' ' PHE . 28.6 p 65.1 -106.41 0.13 Allowed 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 112.539 -2.119 . . . . 40.0 111.95 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.789 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 20.0 p90 171.82 67.33 0.03 OUTLIER Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 110.479 -3.055 . . . . 40.0 105.867 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 345' ' ' ASN . 4.1 Cg_exo -34.81 95.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 121.105 1.203 . . . . 40.0 111.978 -175.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.607 ' C ' ' H ' ' A' ' 344' ' ' THR . 1.2 p -67.49 -15.51 63.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.2 -0.909 . . . . 40.0 111.063 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 344' ' ' THR . 0.4 OUTLIER -50.32 -8.91 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.548 0.69 . . . . 40.0 109.495 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.731 ' N ' HD12 ' A' ' 343' ' ' LEU . 1.4 t -176.69 -33.6 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.484 -1.235 . . . . 40.0 108.546 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.692 ' O ' ' O ' ' A' ' 344' ' ' THR . 1.0 OUTLIER 36.87 -172.58 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.067 0 CA-C-O 122.143 0.973 . . . . 40.0 111.383 178.62 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.465 ' O ' ' CD2' ' A' ' 346' ' ' PHE . 90.3 t80 43.94 68.69 0.49 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 113.829 -1.532 . . . . 40.0 111.639 173.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -162.85 -175.26 4.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.196 -0.456 . . . . 40.0 110.405 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 349' ' ' CYS . 0.2 OUTLIER -177.17 179.85 0.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.041 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 348' ' ' TYR . 2.3 t 88.8 -173.73 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.202 0.525 . . . . 40.0 111.707 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -154.75 85.7 1.11 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.281 -0.872 . . . . 40.0 110.274 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.37 53.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.09 -39.31 86.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.87 -0.332 . . . . 40.0 111.463 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.88 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 484' ' ' ARG . . . . . 0.642 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.02 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 22.6 mttp 61.55 -21.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.786 -0.643 . . . . 40.0 111.375 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' CYS . . . . . 0.642 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.24 124.9 22.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.71 -0.396 . . . . 40.0 110.062 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 9.4 t -73.4 -19.8 60.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.407 -0.36 . . . . 40.0 111.458 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.05 116.63 46.18 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.74 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -107.9 47.7 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 40.0 110.658 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.57 0.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.868 -0.333 . . . . 40.0 110.74 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.85 47.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' HIS . . . . . 0.458 ' C ' HG22 ' A' ' 350' ' ' THR . 27.7 m-70 -91.83 5.96 47.91 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.652 -0.419 . . . . 40.0 110.154 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -62.41 158.99 16.31 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.062 -0.517 . . . . 40.0 111.082 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 314' ' ' VAL . 11.9 p -121.66 108.27 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.906 -0.405 . . . . 40.0 109.906 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.71 135.02 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 40.0 111.142 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' SER . . . . . 0.515 ' OG ' ' CG1' ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 171.11 8.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -132.7 134.68 45.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.866 0.365 . . . . 40.0 110.664 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.648 ' N ' ' CD ' ' A' ' 327' ' ' PRO . 1.4 m-80 -156.05 41.47 0.14 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.087 -0.506 . . . . 40.0 110.619 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 326' ' ' ASN . 2.6 Cg_endo -46.78 -177.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.996 2.464 . . . . 40.0 112.577 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.535 ' C ' ' O ' ' A' ' 327' ' ' PRO . 2.0 mt-30 -28.12 -73.28 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.498 -0.774 . . . . 40.0 109.675 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.684 HD12 ' H ' ' A' ' 331' ' ' TYR . 0.6 OUTLIER -150.78 45.54 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 CA-C-N 115.836 -0.62 . . . . 40.0 110.664 178.221 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.49 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 0.8 OUTLIER 60.18 14.53 4.59 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 118.356 -1.338 . . . . 40.0 108.627 178.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.714 ' O ' ' CG ' ' A' ' 331' ' ' TYR . 13.0 t80 42.5 30.41 0.21 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.524 -1.216 . . . . 40.0 109.505 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' GLN . . . . . 0.547 ' CG ' ' N ' ' A' ' 333' ' ' ALA . 11.9 pt20 -113.73 -43.24 3.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.382 -0.826 . . . . 40.0 111.195 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ALA . . . . . 0.547 ' N ' ' CG ' ' A' ' 332' ' ' GLN . . . 35.87 94.21 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.191 -0.913 . . . . 40.0 111.23 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -72.91 45.08 0.85 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.269 1.98 . . . . 40.0 110.693 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 115.29 -72.87 0.25 Allowed Glycine 0 N--CA 1.454 -0.156 0 N-CA-C 110.221 -1.152 . . . . 40.0 110.221 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.648 ' C ' HD22 ' A' ' 337' ' ' LEU . 0.2 OUTLIER -70.16 -72.42 0.2 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.861 -0.792 . . . . 40.0 108.861 178.673 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 337' ' ' LEU . . . . . 0.912 ' CG ' ' H ' ' A' ' 338' ' ' PHE . 0.0 OUTLIER 165.49 -83.6 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.277 -1.328 . . . . 40.0 111.368 179.45 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.912 ' H ' ' CG ' ' A' ' 337' ' ' LEU . 28.8 m-85 -64.19 -52.98 56.29 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 106.394 -1.706 . . . . 40.0 106.394 177.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.845 HG23 ' H ' ' A' ' 337' ' ' LEU . 13.3 p 55.78 -106.24 0.31 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 112.046 -2.343 . . . . 40.0 112.94 177.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.763 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 15.1 p90 171.49 71.46 0.03 OUTLIER Pre-proline 0 C--N 1.292 -1.909 0 CA-C-N 110.315 -3.13 . . . . 40.0 104.774 -175.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' PRO . . . . . 0.51 ' O ' ' CG ' ' A' ' 345' ' ' ASN . 4.5 Cg_exo -36.11 84.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.297 -2.156 0 C-N-CA 121.842 1.694 . . . . 40.0 113.41 -175.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.618 ' N ' ' O ' ' A' ' 340' ' ' PHE . 0.1 OUTLIER -77.61 -10.08 59.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.913 -0.773 . . . . 40.0 108.913 178.656 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.511 ' N ' HD23 ' A' ' 343' ' ' LEU . 2.2 pt? -52.3 -18.5 1.59 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.288 -1.004 . . . . 40.0 108.288 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.656 ' O ' ' O ' ' A' ' 345' ' ' ASN . 6.2 t -178.29 26.39 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.815 -1.539 . . . . 40.0 109.933 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.73 ' ND2' ' O ' ' A' ' 340' ' ' PHE . 27.4 m-20 -43.51 -176.74 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.821 -0.807 . . . . 40.0 108.821 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.609 ' CG ' ' O ' ' A' ' 346' ' ' PHE . 11.3 t80 52.4 35.87 18.51 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.124 -1.03 . . . . 40.0 110.665 175.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.638 ' ND2' ' O ' ' A' ' 347' ' ' ASN . 0.4 OUTLIER -156.73 12.79 0.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.724 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 348' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -83.99 111.02 18.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.159 0.504 . . . . 40.0 110.925 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 28.3 p -167.01 171.07 11.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.439 -0.8 . . . . 40.0 108.971 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -150.85 85.7 1.36 Allowed 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 119.418 -0.913 . . . . 40.0 110.274 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.32 53.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -67.45 -39.44 85.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.649 -0.42 . . . . 40.0 111.404 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.27 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.832 -0.347 . . . . 40.0 111.17 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' ARG . . . . . 0.644 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 63.74 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 34.7 tttp 61.29 -21.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.664 -0.698 . . . . 40.0 111.303 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' CYS . . . . . 0.644 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -61.45 124.94 22.04 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.585 -0.446 . . . . 40.0 110.062 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 16.2 m -73.27 -19.7 61.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 40.0 111.526 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.52 116.63 47.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -107.79 47.79 0.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 40.0 110.636 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.7 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.774 0.321 . . . . 40.0 110.74 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.06 47.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' HIS . . . . . 0.465 ' C ' HG22 ' A' ' 350' ' ' THR . 0.9 OUTLIER -91.51 5.59 48.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.915 0.388 . . . . 40.0 110.23 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -62.77 158.97 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.985 -0.552 . . . . 40.0 111.082 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 70.4 t -120.73 108.24 22.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 40.0 109.976 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.38 135.02 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.76 7.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.679 ' O ' ' O ' ' A' ' 324' ' ' SER . 19.8 mtt180 42.81 126.17 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.784 -0.644 . . . . 40.0 112.041 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.697 ' N ' ' CD ' ' A' ' 327' ' ' PRO . 16.9 t30 -96.88 -37.28 0.27 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.061 -0.518 . . . . 40.0 111.829 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 326' ' ' ASN . 3.7 Cg_exo -72.27 -176.79 2.34 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 C-N-CA 123.193 2.596 . . . . 40.0 113.919 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.38 -37.05 7.37 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.91 -1.95 . . . . 40.0 107.204 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.78 HD13 ' N ' ' A' ' 331' ' ' TYR . 0.0 OUTLIER -168.35 1.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 113.735 -1.575 . . . . 40.0 111.565 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.619 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 12.6 tpt 71.35 15.87 6.2 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.594 -0.842 . . . . 40.0 111.465 176.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.78 ' N ' HD13 ' A' ' 329' ' ' ILE . 6.3 t80 38.65 23.27 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.052 0.453 . . . . 40.0 110.729 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 330' ' ' MET . 11.5 pt20 -118.57 -26.97 6.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 40.0 111.069 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ALA . . . . . 0.608 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 16.91 94.92 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 115.419 -0.81 . . . . 40.0 113.147 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 1.012 ' HD3' HG22 ' A' ' 339' ' ' THR . 4.6 Cg_exo -72.63 17.68 0.36 Allowed 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 123.233 2.622 . . . . 40.0 108.686 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.608 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 97.53 18.65 27.51 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 114.286 -1.325 . . . . 40.0 109.951 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.748 ' O ' ' N ' ' A' ' 338' ' ' PHE . 66.6 m -138.21 4.02 2.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.851 -0.674 . . . . 40.0 109.754 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' LEU . . . . . 1.111 ' O ' HG23 ' A' ' 339' ' ' THR . 0.0 OUTLIER 47.26 -72.12 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.275 -0.875 . . . . 40.0 110.289 -178.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.847 ' O ' ' OG1' ' A' ' 339' ' ' THR . 10.4 m-85 -50.53 -17.11 0.44 Allowed 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 105.912 -1.884 . . . . 40.0 105.912 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' THR . . . . . 1.111 HG23 ' O ' ' A' ' 337' ' ' LEU . 73.7 p 63.53 -109.52 0.27 Allowed 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 112.911 -1.95 . . . . 40.0 110.89 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.682 ' O ' ' N ' ' A' ' 342' ' ' SER . 0.0 OUTLIER 171.92 66.01 0.03 OUTLIER Pre-proline 0 C--N 1.286 -2.169 0 CA-C-N 110.193 -3.185 . . . . 40.0 106.29 -177.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 341' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 345' ' ' ASN . 5.4 Cg_exo -30.43 84.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.313 1.342 . . . . 40.0 112.513 -174.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 340' ' ' PHE . 1.7 p -73.18 -6.17 44.04 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.834 -1.076 . . . . 40.0 109.135 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 344' ' ' THR . 0.3 OUTLIER -64.24 -4.71 3.94 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.272 -0.876 . . . . 40.0 108.886 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.67 ' O ' ' N ' ' A' ' 346' ' ' PHE . 2.9 t -178.66 -32.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.358 -1.292 . . . . 40.0 108.969 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' A' ' 341' ' ' PRO . 6.8 m-20 27.06 -82.61 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 122.674 1.226 . . . . 40.0 111.443 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 344' ' ' THR . 17.7 t80 -87.97 -52.22 5.39 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 112.338 -2.21 . . . . 40.0 111.319 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.562 ' N ' ' O ' ' A' ' 344' ' ' THR . 17.8 t-20 -58.12 145.46 36.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.955 -0.566 . . . . 40.0 110.947 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' TYR . . . . . 0.503 ' CZ ' ' OD1' ' A' ' 347' ' ' ASN . 2.4 m-85 24.52 99.11 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.818 -0.628 . . . . 40.0 111.783 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 350' ' ' THR . 21.6 t -70.63 -124.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.444 -0.343 . . . . 40.0 110.504 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -138.92 85.7 2.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 40.0 110.274 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 25.6 m120 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.24 53.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 393' ' ' GLN . 0.2 OUTLIER -66.41 -40.6 89.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.498 -0.319 . . . . 40.0 111.299 -179.096 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ASN . . . . . 0.528 ' OD1' ' CZ ' ' A' ' 346' ' ' PHE . 43.5 m-20 -119.43 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 484' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 -21.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 40.0 111.236 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 486' ' ' CYS . . . . . 0.643 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.23 124.96 22.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.567 -0.453 . . . . 40.0 110.062 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 3.1 t -73.5 -19.11 61.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 40.0 111.565 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -71.02 116.63 48.49 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.69 29.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 5.9 p-10 -107.87 47.81 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.697 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.64 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.457 -0.338 . . . . 40.0 110.74 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.88 47.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 312' ' ' HIS . 3.2 t-80 -92.09 7.82 40.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.99 -0.55 . . . . 40.0 110.253 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -65.64 158.94 25.96 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.915 -0.584 . . . . 40.0 111.082 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.75 108.03 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.757 -0.656 . . . . 40.0 110.117 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.93 135.02 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.31 9.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 324' ' ' SER . 11.3 ttp85 77.89 93.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.399 -0.593 . . . . 40.0 109.399 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.537 ' OD1' ' NE2' ' A' ' 312' ' ' HIS . 0.5 OUTLIER -63.43 156.32 70.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 40.0 112.044 -178.325 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 328' ' ' GLN . 2.6 Cg_endo -80.3 -100.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 123.157 2.571 . . . . 40.0 112.087 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.897 ' O ' HG23 ' A' ' 329' ' ' ILE . 1.0 OUTLIER -65.69 -49.6 67.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.639 -0.504 . . . . 40.0 109.639 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.897 HG23 ' O ' ' A' ' 328' ' ' GLN . 1.0 OUTLIER -175.75 38.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 CA-C-N 115.905 -0.589 . . . . 40.0 110.582 178.246 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.537 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 9.9 tpt 63.0 8.06 3.0 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 118.45 -1.3 . . . . 40.0 108.92 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.868 ' H ' HD12 ' A' ' 329' ' ' ILE . 13.8 t80 50.06 20.48 0.61 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.702 -1.136 . . . . 40.0 108.925 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' GLN . . . . . 0.526 ' O ' ' C ' ' A' ' 333' ' ' ALA . 16.2 pt20 -95.98 -40.36 9.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.012 -0.994 . . . . 40.0 110.849 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 332' ' ' GLN . . . 18.07 94.82 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.19 -0.914 . . . . 40.0 112.151 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.48 38.59 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.158 1.906 . . . . 40.0 110.834 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 119.48 -69.23 0.35 Allowed Glycine 0 CA--C 1.511 -0.196 0 N-CA-C 110.411 -1.075 . . . . 40.0 110.411 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.661 ' O ' ' HB3' ' A' ' 337' ' ' LEU . 0.2 OUTLIER -69.42 -72.7 0.18 Allowed 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 109.073 -0.714 . . . . 40.0 109.073 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 337' ' ' LEU . . . . . 0.93 ' CG ' ' H ' ' A' ' 338' ' ' PHE . 0.0 OUTLIER 165.95 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.376 -1.284 . . . . 40.0 111.846 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.93 ' H ' ' CG ' ' A' ' 337' ' ' LEU . 13.0 m-85 -60.95 -54.07 49.52 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.702 -1.592 . . . . 40.0 106.702 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.833 HG23 ' H ' ' A' ' 337' ' ' LEU . 22.0 p 53.88 -108.31 0.42 Allowed 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 112.025 -2.352 . . . . 40.0 111.864 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.734 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 13.0 p90 176.19 66.07 0.07 OUTLIER Pre-proline 0 C--N 1.287 -2.11 0 CA-C-N 110.456 -3.065 . . . . 40.0 105.424 -176.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' PRO . . . . . 0.819 ' O ' ' N ' ' A' ' 345' ' ' ASN . 2.7 Cg_endo -36.6 80.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 121.862 1.708 . . . . 40.0 112.157 -175.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.683 ' N ' ' O ' ' A' ' 340' ' ' PHE . 3.0 p -59.28 -21.73 60.09 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.404 -0.518 . . . . 40.0 110.194 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.12 -18.54 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 122.036 0.922 . . . . 40.0 109.132 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.531 ' N ' ' C ' ' A' ' 342' ' ' SER . 6.6 t -167.69 -38.78 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.632 -1.622 . . . . 40.0 107.937 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.819 ' N ' ' O ' ' A' ' 341' ' ' PRO . 1.1 m-20 43.44 -168.55 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 114.644 -1.162 . . . . 40.0 110.575 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 347' ' ' ASN . 46.6 t80 49.0 85.63 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.529 -1.214 . . . . 40.0 110.515 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 346' ' ' PHE . 1.0 OUTLIER -47.2 -175.1 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.505 -0.77 . . . . 40.0 111.728 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 348' ' ' TYR . . . . . 0.429 ' CB ' ' O ' ' A' ' 347' ' ' ASN . 4.6 t80 79.26 81.75 0.06 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.537 -0.756 . . . . 40.0 110.599 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 350' ' ' THR . 1.6 p 173.65 -90.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.677 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p 53.32 85.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.592 -0.731 . . . . 40.0 110.274 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.22 53.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.78 -41.14 88.17 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.547 -0.461 . . . . 40.0 111.263 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.16 34.09 5.33 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.885 -0.326 . . . . 40.0 111.17 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 484' ' ' ARG . . . . . 0.644 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 63.81 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? 61.68 -22.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.651 -0.704 . . . . 40.0 111.214 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' CYS . . . . . 0.644 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -61.43 124.97 22.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.636 -0.426 . . . . 40.0 110.062 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 487' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 487' ' ' THR . 2.5 t -73.11 -20.45 60.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 40.0 111.449 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.7 116.63 45.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -108.03 47.52 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.371 -0.377 . . . . 40.0 110.638 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.08 0.32 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.426 -0.352 . . . . 40.0 110.74 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.07 47.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' HIS . . . . . 0.489 ' C ' HG22 ' A' ' 350' ' ' THR . 0.0 OUTLIER -91.37 6.06 46.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 40.0 110.233 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -64.07 158.91 21.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 40.0 111.082 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.43 108.25 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.04 -0.527 . . . . 40.0 110.014 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.49 135.02 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.5 9.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.637 ' CB ' ' O ' ' A' ' 324' ' ' SER . 2.2 mtp85 142.0 -172.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.433 0.635 . . . . 40.0 110.642 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.798 ' O ' ' O ' ' A' ' 327' ' ' PRO . 0.0 OUTLIER -128.76 163.17 46.98 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.051 -0.977 . . . . 40.0 108.943 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.798 ' O ' ' O ' ' A' ' 326' ' ' ASN . 3.2 Cg_exo -39.9 -145.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 123.071 2.514 . . . . 40.0 112.463 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.663 ' C ' HG22 ' A' ' 329' ' ' ILE . 16.6 mm-40 -71.91 -38.63 69.88 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 106.457 -1.682 . . . . 40.0 106.457 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.907 HD13 ' N ' ' A' ' 331' ' ' TYR . 0.0 OUTLIER -175.02 6.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 113.41 -1.723 . . . . 40.0 110.14 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.511 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 1.5 tpt 71.81 8.5 6.08 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.033 -0.667 . . . . 40.0 111.326 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.907 ' N ' HD13 ' A' ' 329' ' ' ILE . 0.1 OUTLIER 43.63 27.51 0.16 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.833 -0.802 . . . . 40.0 108.833 -179.622 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 332' ' ' GLN . . . . . 0.601 ' O ' ' C ' ' A' ' 333' ' ' ALA . 0.0 OUTLIER -131.87 -22.0 2.39 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.408 -0.815 . . . . 40.0 112.091 -178.462 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ALA . . . . . 0.669 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 9.07 97.74 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 116.418 -0.355 . . . . 40.0 111.54 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.424 ' CD ' HG21 ' A' ' 339' ' ' THR . 4.7 Cg_exo -65.17 20.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 121.809 1.673 . . . . 40.0 110.433 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.669 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 125.65 -55.53 0.73 Allowed Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.256 -0.884 . . . . 40.0 111.362 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 336' ' ' THR . 28.0 m -103.04 29.56 5.4 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 120.779 0.323 . . . . 40.0 111.377 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' LEU . . . . . 0.876 HD22 ' N ' ' A' ' 337' ' ' LEU . 0.5 OUTLIER 60.58 -102.82 0.14 Allowed 'General case' 0 N--CA 1.425 -1.69 0 C-N-CA 120.384 -0.527 . . . . 40.0 111.205 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.547 ' O ' ' OG1' ' A' ' 339' ' ' THR . 0.7 OUTLIER -46.58 -45.33 18.77 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 106.643 -1.614 . . . . 40.0 106.643 178.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.586 HG22 ' H ' ' A' ' 336' ' ' THR . 3.9 p 50.85 -103.27 0.13 Allowed 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 111.372 -2.649 . . . . 40.0 111.852 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.719 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 16.1 p90 171.7 68.96 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.771 0 CA-C-N 110.292 -3.14 . . . . 40.0 105.381 -176.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 345' ' ' ASN . 3.0 Cg_exo -37.47 84.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.65 1.566 . . . . 40.0 112.168 -175.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.647 ' N ' ' O ' ' A' ' 340' ' ' PHE . 2.6 p -70.22 -14.14 62.49 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.679 -0.691 . . . . 40.0 109.419 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.573 HD12 HG22 ' A' ' 344' ' ' THR . 0.6 OUTLIER -47.41 -14.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.846 0.831 . . . . 40.0 108.969 178.146 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.573 HG22 HD12 ' A' ' 343' ' ' LEU . 4.7 t -174.65 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.083 -1.417 . . . . 40.0 108.739 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.804 ' O ' ' N ' ' A' ' 347' ' ' ASN . 0.9 OUTLIER 35.69 -152.36 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.59 -0.732 . . . . 40.0 109.996 178.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.521 ' O ' ' O ' ' A' ' 347' ' ' ASN . 29.7 t80 18.86 -68.9 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 113.653 -1.612 . . . . 40.0 112.744 174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.804 ' N ' ' O ' ' A' ' 345' ' ' ASN . 84.8 m-20 -35.39 163.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.015 -0.539 . . . . 40.0 111.5 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' TYR . . . . . 0.49 ' C ' ' H ' ' A' ' 350' ' ' THR . 46.9 m-85 58.72 74.54 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.886 -0.597 . . . . 40.0 110.15 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.462 ' O ' ' ND2' ' A' ' 482' ' ' ASN . 49.6 t -72.0 19.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.879 -0.6 . . . . 40.0 111.001 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p 47.76 85.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.616 -0.433 . . . . 40.0 110.274 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.23 53.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -67.01 -40.28 87.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.779 -0.368 . . . . 40.0 111.32 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.97 34.09 5.37 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.883 -0.327 . . . . 40.0 111.17 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 484' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.1 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 31.6 mttm 61.43 -21.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.949 -0.569 . . . . 40.0 111.357 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' CYS . . . . . 0.643 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.48 125.02 22.49 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.6 -0.44 . . . . 40.0 110.062 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 14.8 p -73.12 -19.73 61.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.127 -0.488 . . . . 40.0 111.563 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.84 116.63 48.09 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.72 29.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.03 47.95 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.397 . . . . 40.0 110.527 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.63 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.431 -0.35 . . . . 40.0 110.74 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.95 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' HIS . . . . . 0.469 ' C ' HG22 ' A' ' 350' ' ' THR . 1.5 t60 -91.9 6.38 46.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.941 0.401 . . . . 40.0 110.183 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.0 158.87 18.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.01 -0.541 . . . . 40.0 111.082 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.439 HG23 ' OG ' ' A' ' 323' ' ' SER . 0.4 OUTLIER -120.76 107.79 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.218 -0.446 . . . . 40.0 109.947 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.94 135.02 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' SER . . . . . 0.439 ' OG ' HG23 ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.52 9.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.09 133.2 13.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.197 0.523 . . . . 40.0 111.646 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.503 ' N ' ' HD3' ' A' ' 327' ' ' PRO . 10.8 p-10 -169.75 62.78 0.45 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.385 -0.825 . . . . 40.0 109.842 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 326' ' ' ASN . 3.7 Cg_exo -75.64 -150.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.955 2.437 . . . . 40.0 112.784 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.686 ' C ' HG22 ' A' ' 329' ' ' ILE . 1.9 mm100 -72.47 -32.36 66.17 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.466 -1.309 . . . . 40.0 107.466 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.786 ' C ' HD13 ' A' ' 329' ' ' ILE . 0.0 OUTLIER -177.27 -6.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.165 -1.38 . . . . 40.0 111.927 179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.687 ' CB ' ' O ' ' A' ' 329' ' ' ILE . 22.9 tpp 88.83 12.3 0.08 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.072 -0.651 . . . . 40.0 111.215 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.725 ' N ' HD13 ' A' ' 329' ' ' ILE . 9.3 t80 48.78 10.99 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.201 -0.666 . . . . 40.0 109.201 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' GLN . . . . . 0.564 ' N ' ' C ' ' A' ' 330' ' ' MET . 4.7 pt20 -100.7 -40.94 7.11 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.55 -0.75 . . . . 40.0 111.443 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 31.66 92.73 0.05 OUTLIER Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.854 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -67.19 28.72 0.12 Allowed 'Trans proline' 0 C--N 1.3 -2.007 0 C-N-CA 121.618 1.545 . . . . 40.0 111.203 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 123.65 -61.5 0.58 Allowed Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.765 -0.652 . . . . 40.0 111.825 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.816 ' O ' HD23 ' A' ' 337' ' ' LEU . 2.7 m -76.3 -47.24 24.33 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 121.211 -0.196 . . . . 40.0 110.828 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' LEU . . . . . 0.816 HD23 ' O ' ' A' ' 336' ' ' THR . 0.1 OUTLIER 140.09 -82.53 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 125.247 1.592 . . . . 40.0 107.494 -177.316 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.538 ' O ' ' OG1' ' A' ' 339' ' ' THR . 86.7 m-85 -79.31 -29.8 42.55 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 105.071 -2.196 . . . . 40.0 105.071 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.811 HG23 ' H ' ' A' ' 337' ' ' LEU . 11.9 p 50.76 -105.71 0.21 Allowed 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 111.402 -2.635 . . . . 40.0 111.83 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.725 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 20.0 p90 174.51 66.81 0.05 OUTLIER Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 110.303 -3.135 . . . . 40.0 105.664 -177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' PRO . . . . . 0.769 ' O ' ' N ' ' A' ' 345' ' ' ASN . 2.8 Cg_endo -36.07 85.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.87 1.713 . . . . 40.0 111.796 -175.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.631 ' N ' ' O ' ' A' ' 340' ' ' PHE . 13.0 p -55.25 -21.76 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.857 -0.611 . . . . 40.0 111.121 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 343' ' ' LEU . 0.1 OUTLIER -49.35 -19.11 0.46 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.878 0.847 . . . . 40.0 109.714 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.634 ' C ' ' OD1' ' A' ' 345' ' ' ASN . 13.6 t -163.82 -37.29 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.004 -1.453 . . . . 40.0 108.138 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.769 ' N ' ' O ' ' A' ' 341' ' ' PRO . 0.2 OUTLIER 40.7 -171.67 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 114.536 -1.211 . . . . 40.0 111.34 177.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' A' ' 347' ' ' ASN . 86.4 t80 46.67 -86.9 0.01 OUTLIER 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 113.711 -1.586 . . . . 40.0 112.362 173.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.554 ' N ' ' O ' ' A' ' 345' ' ' ASN . 22.4 t-20 -39.22 150.84 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.708 0.289 . . . . 40.0 110.571 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' TYR . . . . . 0.523 ' N ' ' OD1' ' A' ' 347' ' ' ASN . 0.3 OUTLIER -137.61 -27.4 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.343 -0.389 . . . . 40.0 110.594 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.78 175.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 40.0 110.203 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -145.22 85.7 1.74 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 40.0 110.274 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.35 53.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -67.65 -39.0 84.61 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.628 -0.429 . . . . 40.0 111.473 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.48 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.848 -0.341 . . . . 40.0 111.17 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 484' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.12 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 28.6 tttp 61.8 -21.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.019 -0.537 . . . . 40.0 111.434 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' CYS . . . . . 0.641 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.69 124.93 22.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.612 -0.435 . . . . 40.0 110.062 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 10.2 p -73.09 -20.39 60.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 40.0 111.431 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.74 116.63 45.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.62 30.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.41 47.04 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 40.0 110.709 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.37 0.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.841 -0.344 . . . . 40.0 110.74 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.95 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' HIS . . . . . 0.437 ' C ' HG22 ' A' ' 350' ' ' THR . 0.5 OUTLIER -91.06 4.14 52.91 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.141 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -61.21 159.05 12.76 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.068 -0.514 . . . . 40.0 111.082 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.65 108.27 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 40.0 110.068 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.52 135.02 27.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.61 7.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -150.56 74.75 1.19 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.939 0.4 . . . . 40.0 110.233 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.508 ' OD1' ' NZ ' ' A' ' 485' ' ' LYS . 1.3 t-20 -128.11 86.29 58.4 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.05 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -61.67 -155.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.348 2.032 . . . . 40.0 112.951 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.494 ' C ' HG22 ' A' ' 329' ' ' ILE . 44.0 mt-30 -40.12 -54.92 2.21 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.003 -0.544 . . . . 40.0 109.701 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.828 HG13 ' HB2' ' A' ' 333' ' ' ALA . 0.0 OUTLIER -154.48 14.91 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 CA-C-N 115.476 -0.784 . . . . 40.0 110.585 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.602 ' CB ' ' O ' ' A' ' 329' ' ' ILE . 3.1 tpt 78.53 16.37 1.17 Allowed 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.685 -0.806 . . . . 40.0 111.854 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.727 ' H ' HD13 ' A' ' 329' ' ' ILE . 52.0 t80 43.38 19.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.865 -0.734 . . . . 40.0 109.043 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' GLN . . . . . 0.578 ' O ' ' C ' ' A' ' 333' ' ' ALA . 2.6 pt20 -108.54 -40.48 5.09 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.464 -0.789 . . . . 40.0 111.518 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ALA . . . . . 0.828 ' HB2' HG13 ' A' ' 329' ' ' ILE . . . 2.12 100.53 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.672 0 CA-C-N 115.784 -0.643 . . . . 40.0 112.488 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.36 29.94 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.563 1.509 . . . . 40.0 110.62 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 124.64 -65.94 0.54 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 110.451 -1.06 . . . . 40.0 110.451 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.624 ' C ' HD22 ' A' ' 337' ' ' LEU . 0.2 OUTLIER -71.54 -72.27 0.23 Allowed 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 108.679 -0.859 . . . . 40.0 108.679 178.719 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 337' ' ' LEU . . . . . 0.898 ' CG ' ' H ' ' A' ' 338' ' ' PHE . 0.0 OUTLIER 166.25 -88.76 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.268 -1.333 . . . . 40.0 111.718 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.898 ' H ' ' CG ' ' A' ' 337' ' ' LEU . 6.0 m-85 -65.51 -48.22 73.3 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.015 -1.476 . . . . 40.0 107.015 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.839 HG23 ' H ' ' A' ' 337' ' ' LEU . 19.1 p 51.28 -104.22 0.16 Allowed 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 112.985 -1.916 . . . . 40.0 112.827 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.746 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 16.9 p90 174.04 67.01 0.04 OUTLIER Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 109.945 -3.298 . . . . 40.0 104.971 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' PRO . . . . . 0.751 ' O ' ' N ' ' A' ' 345' ' ' ASN . 3.5 Cg_exo -35.59 86.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.602 1.535 . . . . 40.0 112.396 -175.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 340' ' ' PHE . 0.0 OUTLIER -67.54 -21.48 65.46 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.042 -0.725 . . . . 40.0 109.042 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.698 HD12 HG22 ' A' ' 344' ' ' THR . 0.2 OUTLIER -42.9 -23.95 0.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.91 0.862 . . . . 40.0 109.32 178.292 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.698 HG22 HD12 ' A' ' 343' ' ' LEU . 12.9 t -160.02 -38.4 0.05 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.048 -1.433 . . . . 40.0 108.342 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.751 ' N ' ' O ' ' A' ' 341' ' ' PRO . 1.5 m-20 38.28 -156.43 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 114.979 -1.01 . . . . 40.0 110.525 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.449 ' CE1' ' ND2' ' A' ' 347' ' ' ASN . 29.3 t80 52.65 92.91 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.454 -1.248 . . . . 40.0 111.263 175.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 347' ' ' ASN . 0.6 OUTLIER 63.83 109.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.506 -0.77 . . . . 40.0 110.222 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 348' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 349' ' ' CYS . 1.1 t80 -142.43 -6.53 0.91 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.396 -0.366 . . . . 40.0 110.886 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.446 ' O ' ' O ' ' A' ' 348' ' ' TYR . 1.7 t -60.01 -151.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.003 -0.74 . . . . 40.0 109.003 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -145.18 85.7 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.791 -0.763 . . . . 40.0 110.274 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.39 53.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' GLN . . . . . 0.42 ' OE1' ' OD1' ' A' ' 394' ' ' ASN . 0.0 OUTLIER -67.02 -40.4 87.23 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.593 -0.443 . . . . 40.0 111.175 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.55 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.773 -0.371 . . . . 40.0 111.17 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 484' ' ' ARG . . . . . 0.64 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.44 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.508 ' NZ ' ' OD1' ' A' ' 326' ' ' ASN . 0.4 OUTLIER 61.39 -21.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.186 -0.461 . . . . 40.0 111.113 179.153 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 486' ' ' CYS . . . . . 0.64 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -63.33 124.84 22.28 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.688 -0.405 . . . . 40.0 110.062 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 3.3 t -73.37 -20.39 60.77 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.879 -0.328 . . . . 40.0 111.368 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.14 116.63 43.98 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -107.83 47.85 0.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 40.0 110.677 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.74 0.32 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.472 -0.331 . . . . 40.0 110.74 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.06 47.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' HIS . . . . . 0.457 ' C ' HG22 ' A' ' 350' ' ' THR . 0.1 OUTLIER -90.99 4.49 51.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 40.0 110.207 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -62.25 159.03 15.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 40.0 111.082 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.27 108.73 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.585 . . . . 40.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -91.06 135.02 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 174.58 6.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.511 ' O ' ' O ' ' A' ' 326' ' ' ASN . 17.2 mtt-85 81.86 3.99 1.3 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.49 0.922 . . . . 40.0 113.49 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.577 ' O ' ' O ' ' A' ' 327' ' ' PRO . 0.0 OUTLIER 50.75 174.25 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 119.775 -0.77 . . . . 40.0 109.533 179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' A' ' 326' ' ' ASN . 3.4 Cg_exo -46.15 -164.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.034 1.823 . . . . 40.0 113.264 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.652 ' O ' HG23 ' A' ' 329' ' ' ILE . 1.6 pt20 -25.23 -73.16 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.357 -0.838 . . . . 40.0 110.375 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 328' ' ' GLN . 0.1 OUTLIER -159.05 51.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 CA-C-N 115.998 -0.547 . . . . 40.0 111.491 179.095 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.525 ' O ' ' CD1' ' A' ' 331' ' ' TYR . 6.4 tpt 60.05 16.6 6.02 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 118.122 -1.431 . . . . 40.0 107.884 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 330' ' ' MET . 8.5 p90 37.41 32.65 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.538 -1.21 . . . . 40.0 109.425 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 330' ' ' MET . 10.6 pt20 -115.66 -33.66 5.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.414 -0.812 . . . . 40.0 110.695 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ALA . . . . . 0.712 ' HB1' HD22 ' A' ' 337' ' ' LEU . . . 32.55 87.17 0.11 Allowed Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.568 -0.742 . . . . 40.0 111.6 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 339' ' ' THR . 3.4 Cg_exo -68.01 33.29 0.15 Allowed 'Trans proline' 0 C--N 1.302 -1.92 0 C-N-CA 122.351 2.034 . . . . 40.0 111.429 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 120.79 -66.31 0.44 Allowed Glycine 0 CA--C 1.52 0.357 0 N-CA-C 111.114 -0.795 . . . . 40.0 111.114 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.839 ' O ' HD23 ' A' ' 337' ' ' LEU . 2.2 m -69.1 -51.46 38.39 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 120.776 0.322 . . . . 40.0 110.814 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' LEU . . . . . 0.91 ' H ' HG23 ' A' ' 339' ' ' THR . 0.1 OUTLIER 139.62 -82.21 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 125.437 1.71 . . . . 40.0 106.778 -176.632 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.652 ' O ' ' OG1' ' A' ' 339' ' ' THR . 59.0 t80 -72.45 -36.18 68.46 Favored 'General case' 0 CA--C 1.472 -2.045 0 N-CA-C 104.328 -2.471 . . . . 40.0 104.328 175.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.91 HG23 ' H ' ' A' ' 337' ' ' LEU . 1.4 p 55.43 -96.94 0.06 Allowed 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 110.821 -2.899 . . . . 40.0 111.843 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.78 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 29.1 p90 167.04 70.31 0.0 OUTLIER Pre-proline 0 C--N 1.288 -2.09 0 CA-C-N 109.708 -3.405 . . . . 40.0 105.668 -176.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' PRO . . . . . 0.679 ' O ' ' N ' ' A' ' 345' ' ' ASN . 2.5 Cg_endo -39.04 87.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.562 1.508 . . . . 40.0 112.136 -175.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 340' ' ' PHE . 0.0 OUTLIER -68.56 -19.27 64.47 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.54 -0.464 . . . . 40.0 110.063 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -44.89 -19.6 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.919 0.866 . . . . 40.0 109.648 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 346' ' ' PHE . 6.5 t -167.6 -37.5 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.908 -1.496 . . . . 40.0 108.366 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.679 ' N ' ' O ' ' A' ' 341' ' ' PRO . 2.7 m-20 38.17 -86.36 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 122.735 1.255 . . . . 40.0 110.981 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' PHE . . . . . 0.625 ' N ' ' O ' ' A' ' 344' ' ' THR . 5.4 t80 -66.02 74.46 0.08 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 112.36 -2.2 . . . . 40.0 111.791 -178.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.454 ' CG ' ' O ' ' A' ' 346' ' ' PHE . 33.5 m-20 -176.87 46.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.924 -0.58 . . . . 40.0 109.771 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.26 85.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 40.0 110.609 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.416 ' N ' ' O ' ' A' ' 347' ' ' ASN . 3.8 t -113.97 108.84 17.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.905 -0.589 . . . . 40.0 110.131 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -145.9 85.7 1.7 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.405 . . . . 40.0 110.274 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 25.6 m120 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.27 53.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' GLN . . . . . 0.473 ' OE1' ' ND2' ' A' ' 390' ' ' ASN . 1.1 mt-30 -66.76 -40.34 88.23 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.743 -0.383 . . . . 40.0 111.354 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.11 34.09 5.37 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.967 -0.293 . . . . 40.0 111.17 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 484' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.21 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.405 ' O ' ' CZ ' ' A' ' 325' ' ' ARG . 0.9 OUTLIER 61.28 -20.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.558 . . . . 40.0 111.393 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 486' ' ' CYS . . . . . 0.641 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -63.12 124.84 22.19 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.677 -0.409 . . . . 40.0 110.062 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 487' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 487' ' ' THR . 0.1 OUTLIER -73.2 -19.85 61.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 40.0 111.493 -179.435 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.19 116.63 46.52 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.68 30.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -107.77 47.88 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 40.0 110.643 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.9 0.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.883 -0.327 . . . . 40.0 110.74 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.09 47.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 312' ' ' HIS . 0.0 OUTLIER -90.92 4.98 50.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 40.0 110.254 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.22 159.01 18.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 40.0 111.082 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 314' ' ' VAL . 14.9 p -121.73 108.29 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 40.0 109.91 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.74 135.02 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 40.0 111.142 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 34.2 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' SER . . . . . 0.509 ' OG ' ' CG1' ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 173.79 7.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.574 ' HE ' ' CA ' ' A' ' 325' ' ' ARG . 0.0 OUTLIER 81.12 -160.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.922 -0.581 . . . . 40.0 111.52 177.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.744 ' O ' ' O ' ' A' ' 327' ' ' PRO . 0.0 OUTLIER -152.65 165.47 17.49 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.256 -0.884 . . . . 40.0 109.719 -179.193 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.744 ' O ' ' O ' ' A' ' 326' ' ' ASN . 3.0 Cg_exo -41.63 -148.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 123.167 2.578 . . . . 40.0 112.671 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.485 ' C ' ' O ' ' A' ' 327' ' ' PRO . 4.7 mt-30 -34.87 -67.42 0.14 Allowed 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.575 -0.528 . . . . 40.0 109.575 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.76 ' C ' HD13 ' A' ' 329' ' ' ILE . 0.0 OUTLIER -153.67 22.36 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.495 -1.137 0 CA-C-N 115.478 -0.783 . . . . 40.0 108.924 178.108 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.571 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 2.0 ttt 76.6 16.15 2.02 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.776 -1.102 . . . . 40.0 111.082 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.676 ' H ' HD13 ' A' ' 329' ' ' ILE . 7.7 m-85 38.8 34.29 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.85 -1.167 . . . . 40.0 107.85 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' GLN . . . . . 0.693 ' O ' ' O ' ' A' ' 333' ' ' ALA . 3.6 pt20 -120.15 -50.54 2.25 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.116 -0.947 . . . . 40.0 111.477 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ALA . . . . . 0.693 ' O ' ' O ' ' A' ' 332' ' ' GLN . . . 18.75 118.48 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 123.89 0.744 . . . . 40.0 112.368 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 336' ' ' THR . 3.6 Cg_exo -74.57 36.42 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 N-CA-C 106.425 -2.183 . . . . 40.0 106.425 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.686 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 82.4 -10.54 54.57 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 106.35 -2.7 . . . . 40.0 106.35 -175.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' THR . . . . . 0.751 ' O ' ' N ' ' A' ' 338' ' ' PHE . 0.2 OUTLIER -119.39 69.63 0.83 Allowed 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 113.611 -1.295 . . . . 40.0 109.702 178.137 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 337' ' ' LEU . . . . . 1.025 HD22 ' N ' ' A' ' 337' ' ' LEU . 0.8 OUTLIER 39.35 -76.28 0.0 OUTLIER 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.368 -1.287 . . . . 40.0 112.837 178.422 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.751 ' N ' ' O ' ' A' ' 336' ' ' THR . 0.0 OUTLIER -145.78 -58.76 0.32 Allowed 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 114.378 -1.283 . . . . 40.0 107.735 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.686 ' OG1' ' O ' ' A' ' 338' ' ' PHE . 1.0 OUTLIER 59.25 -99.9 0.1 Allowed 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 111.818 -2.446 . . . . 40.0 112.153 179.207 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.743 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 25.1 p90 173.21 68.67 0.04 OUTLIER Pre-proline 0 C--N 1.293 -1.865 0 CA-C-N 110.42 -3.082 . . . . 40.0 105.296 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' PRO . . . . . 0.626 ' HB2' HD11 ' A' ' 343' ' ' LEU . 3.1 Cg_exo -37.2 118.43 0.23 Allowed 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 121.704 1.603 . . . . 40.0 111.882 -175.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.577 ' O ' ' N ' ' A' ' 344' ' ' THR . 82.9 p -72.13 -24.08 61.41 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.504 -0.478 . . . . 40.0 111.502 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.987 HD12 ' N ' ' A' ' 344' ' ' THR . 0.7 OUTLIER -44.13 -17.43 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.541 0.686 . . . . 40.0 109.408 178.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.987 ' N ' HD12 ' A' ' 343' ' ' LEU . 2.0 t -179.18 28.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.603 -1.18 . . . . 40.0 109.836 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.61 ' O ' ' O ' ' A' ' 344' ' ' THR . 2.2 p30 -41.72 -176.52 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.636 0.731 . . . . 40.0 110.944 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' PHE . . . . . . . . . . . . . 43.5 t80 56.4 94.42 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.454 -1.248 . . . . 40.0 112.578 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.458 ' O ' ' NE2' ' A' ' 312' ' ' HIS . 15.9 t-20 179.45 56.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.494 -0.776 . . . . 40.0 109.611 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.48 139.2 51.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.26 0.553 . . . . 40.0 111.998 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.678 ' SG ' ' O ' ' A' ' 392' ' ' GLU . 1.1 t -175.53 -52.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.362 -0.836 . . . . 40.0 109.429 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' THR . . . . . 0.628 ' OG1' ' O ' ' A' ' 349' ' ' CYS . 29.1 p 57.46 85.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.92 -0.582 . . . . 40.0 110.274 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.678 ' O ' ' SG ' ' A' ' 349' ' ' CYS . 61.0 mm-40 -52.09 -37.05 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -66.42 -40.57 89.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.527 -0.306 . . . . 40.0 111.347 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.67 34.09 5.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' TYR . . . . . 0.561 ' OH ' ' SG ' ' A' ' 349' ' ' CYS . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 484' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.49 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt 61.04 -20.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.988 -0.551 . . . . 40.0 111.41 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' CYS . . . . . 0.637 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -63.89 125.03 23.06 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.062 -0.347 . . . . 40.0 110.062 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 487' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 487' ' ' THR . 3.5 t -73.14 -20.21 60.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 40.0 111.516 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.09 116.63 46.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.77 29.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -108.1 48.07 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 40.0 110.638 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.78 0.32 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.444 -0.344 . . . . 40.0 110.74 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.94 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' HIS . . . . . 0.485 ' C ' HG22 ' A' ' 350' ' ' THR . 7.4 m-70 -92.35 7.55 42.39 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.058 0.456 . . . . 40.0 110.059 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.94 158.84 21.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.02 -0.536 . . . . 40.0 111.082 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.33 107.65 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.018 -0.537 . . . . 40.0 110.141 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.11 135.02 27.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.95 7.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.682 ' CB ' ' O ' ' A' ' 324' ' ' SER . 21.1 ttm180 . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 112.651 0.612 . . . . 40.0 112.651 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.117 0.484 . . . . 40.0 111.012 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -133.81 85.7 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.738 -0.665 . . . . 40.0 110.274 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.25 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -66.62 -40.01 88.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.529 -0.305 . . . . 40.0 111.466 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.86 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.16 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 16.4 tttp 61.76 -22.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.545 . . . . 40.0 111.269 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' CYS . . . . . 0.643 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.24 124.96 22.27 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.556 -0.457 . . . . 40.0 110.062 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 1.5 m -72.71 -20.95 61.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 40.0 111.326 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.68 116.63 45.27 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.67 30.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.58 47.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.578 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.66 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.807 -0.357 . . . . 40.0 110.74 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.01 47.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' HIS . . . . . 0.485 ' C ' HG22 ' A' ' 350' ' ' THR . 0.0 OUTLIER -91.2 5.78 47.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 40.0 110.304 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.81 158.91 20.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 40.0 111.082 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.6 107.9 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.102 -0.499 . . . . 40.0 110.04 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.21 135.02 27.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 173.1 7.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 51.2 ttm-85 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 40.0 111.034 178.64 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 121.202 0.525 . . . . 40.0 111.707 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -154.75 85.7 1.11 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.281 -0.872 . . . . 40.0 110.274 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.37 53.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.09 -39.31 86.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.87 -0.332 . . . . 40.0 111.463 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.88 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . 0.642 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.02 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 22.6 mttp 61.55 -21.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.786 -0.643 . . . . 40.0 111.375 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' CYS . . . . . 0.642 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.24 124.9 22.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.71 -0.396 . . . . 40.0 110.062 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 9.4 t -73.4 -19.8 60.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.407 -0.36 . . . . 40.0 111.458 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.05 116.63 46.18 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.74 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -107.9 47.7 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 40.0 110.658 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.57 0.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.868 -0.333 . . . . 40.0 110.74 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.85 47.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' HIS . . . . . 0.458 ' C ' HG22 ' A' ' 350' ' ' THR . 27.7 m-70 -91.83 5.96 47.91 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.652 -0.419 . . . . 40.0 110.154 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -62.41 158.99 16.31 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.062 -0.517 . . . . 40.0 111.082 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 314' ' ' VAL . 11.9 p -121.66 108.27 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.906 -0.405 . . . . 40.0 109.906 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.71 135.02 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 40.0 111.142 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . 0.515 ' OG ' ' CG1' ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 171.11 8.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 . . . . . 0 N--CA 1.467 0.404 0 CA-C-O 120.866 0.365 . . . . 40.0 110.664 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 C--O 1.232 0.137 0 N-CA-C 108.971 -0.752 . . . . 40.0 108.971 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -150.85 85.7 1.36 Allowed 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 119.418 -0.913 . . . . 40.0 110.274 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.32 53.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' GLN . . . . . 0.598 ' H ' HE21 ' A' ' 393' ' ' GLN . 0.8 OUTLIER -67.45 -39.44 85.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.649 -0.42 . . . . 40.0 111.404 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.27 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.832 -0.347 . . . . 40.0 111.17 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . 0.644 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 63.74 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 34.7 tttp 61.29 -21.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.664 -0.698 . . . . 40.0 111.303 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' CYS . . . . . 0.644 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -61.45 124.94 22.04 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.585 -0.446 . . . . 40.0 110.062 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 16.2 m -73.27 -19.7 61.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 40.0 111.526 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.52 116.63 47.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -107.79 47.79 0.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 40.0 110.636 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.7 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.774 0.321 . . . . 40.0 110.74 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.06 47.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' HIS . . . . . 0.465 ' C ' HG22 ' A' ' 350' ' ' THR . 0.9 OUTLIER -91.51 5.59 48.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.915 0.388 . . . . 40.0 110.23 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -62.77 158.97 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.985 -0.552 . . . . 40.0 111.082 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 70.4 t -120.73 108.24 22.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 40.0 109.976 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.38 135.02 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.76 7.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.679 ' O ' ' O ' ' A' ' 324' ' ' SER . 19.8 mtt180 . . . . . 0 N--CA 1.464 0.242 0 CA-C-N 115.784 -0.644 . . . . 40.0 112.041 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 350' ' ' THR . 21.6 t . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.819 0.342 . . . . 40.0 110.504 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -138.92 85.7 2.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 40.0 110.274 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.24 53.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 393' ' ' GLN . 3.5 mt-30 -66.41 -40.6 89.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.498 -0.319 . . . . 40.0 111.299 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.43 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 -21.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 40.0 111.236 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' CYS . . . . . 0.643 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.23 124.96 22.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.567 -0.453 . . . . 40.0 110.062 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 3.1 t -73.5 -19.11 61.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 40.0 111.565 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -71.02 116.63 48.49 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.69 29.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 5.9 p-10 -107.87 47.81 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.697 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.64 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.457 -0.338 . . . . 40.0 110.74 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.88 47.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 312' ' ' HIS . 3.2 t-80 -92.09 7.82 40.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.99 -0.55 . . . . 40.0 110.253 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -65.64 158.94 25.96 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.915 -0.584 . . . . 40.0 111.082 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.75 108.03 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.757 -0.656 . . . . 40.0 110.117 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.93 135.02 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.31 9.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 324' ' ' SER . 11.3 ttp85 . . . . . 0 C--N 1.328 -0.339 0 N-CA-C 109.399 -0.593 . . . . 40.0 109.399 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 350' ' ' THR . 1.6 p . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.048 0.451 . . . . 40.0 110.677 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p 53.32 85.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.592 -0.731 . . . . 40.0 110.274 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.22 53.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.78 -41.14 88.17 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.547 -0.461 . . . . 40.0 111.263 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.16 34.09 5.33 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.885 -0.326 . . . . 40.0 111.17 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . 0.644 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 63.81 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? 61.68 -22.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.651 -0.704 . . . . 40.0 111.214 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' CYS . . . . . 0.644 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -61.43 124.97 22.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.636 -0.426 . . . . 40.0 110.062 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 487' ' ' THR . 2.5 t -73.11 -20.45 60.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 40.0 111.449 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.7 116.63 45.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -108.03 47.52 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.371 -0.377 . . . . 40.0 110.638 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.08 0.32 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.426 -0.352 . . . . 40.0 110.74 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.07 47.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' HIS . . . . . 0.489 ' C ' HG22 ' A' ' 350' ' ' THR . 0.0 OUTLIER -91.37 6.06 46.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 40.0 110.233 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -64.07 158.91 21.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 40.0 111.082 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.43 108.25 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.04 -0.527 . . . . 40.0 110.014 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.49 135.02 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.5 9.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.637 ' CB ' ' O ' ' A' ' 324' ' ' SER . 2.2 mtp85 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 121.433 0.635 . . . . 40.0 110.642 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . 0.462 ' O ' ' ND2' ' A' ' 482' ' ' ASN . 49.6 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.631 0.253 . . . . 40.0 111.001 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p 47.76 85.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.616 -0.433 . . . . 40.0 110.274 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.23 53.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -67.01 -40.28 87.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.779 -0.368 . . . . 40.0 111.32 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.97 34.09 5.37 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.883 -0.327 . . . . 40.0 111.17 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.1 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 31.6 mttm 61.43 -21.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.949 -0.569 . . . . 40.0 111.357 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' CYS . . . . . 0.643 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.48 125.02 22.49 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.6 -0.44 . . . . 40.0 110.062 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 14.8 p -73.12 -19.73 61.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.127 -0.488 . . . . 40.0 111.563 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.84 116.63 48.09 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.72 29.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.03 47.95 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.397 . . . . 40.0 110.527 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.63 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.431 -0.35 . . . . 40.0 110.74 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.95 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' HIS . . . . . 0.469 ' C ' HG22 ' A' ' 350' ' ' THR . 1.5 t60 -91.9 6.38 46.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.941 0.401 . . . . 40.0 110.183 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.0 158.87 18.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.01 -0.541 . . . . 40.0 111.082 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . 0.439 HG23 ' OG ' ' A' ' 323' ' ' SER . 0.4 OUTLIER -120.76 107.79 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.218 -0.446 . . . . 40.0 109.947 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.94 135.02 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . 0.439 ' OG ' HG23 ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.52 9.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.173 0 CA-C-O 121.197 0.523 . . . . 40.0 111.646 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.837 0.351 . . . . 40.0 110.203 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -145.22 85.7 1.74 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 40.0 110.274 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.35 53.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -67.65 -39.0 84.61 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.628 -0.429 . . . . 40.0 111.473 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.48 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.848 -0.341 . . . . 40.0 111.17 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.12 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 28.6 tttp 61.8 -21.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.019 -0.537 . . . . 40.0 111.434 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' CYS . . . . . 0.641 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.69 124.93 22.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.612 -0.435 . . . . 40.0 110.062 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 10.2 p -73.09 -20.39 60.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 40.0 111.431 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.74 116.63 45.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.62 30.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.41 47.04 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 40.0 110.709 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.37 0.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.841 -0.344 . . . . 40.0 110.74 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.95 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' HIS . . . . . 0.437 ' C ' HG22 ' A' ' 350' ' ' THR . 0.5 OUTLIER -91.06 4.14 52.91 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.141 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -61.21 159.05 12.76 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.068 -0.514 . . . . 40.0 111.082 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.65 108.27 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 40.0 110.068 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.52 135.02 27.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.61 7.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.939 0.4 . . . . 40.0 110.233 178.734 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.23 0.062 0 N-CA-C 109.003 -0.74 . . . . 40.0 109.003 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -145.18 85.7 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.791 -0.763 . . . . 40.0 110.274 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.39 53.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' GLN . . . . . 0.42 ' OE1' ' OD1' ' A' ' 394' ' ' ASN . 0.0 OUTLIER -67.02 -40.4 87.23 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.593 -0.443 . . . . 40.0 111.175 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.55 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.773 -0.371 . . . . 40.0 111.17 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . 0.64 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.44 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.39 -21.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.186 -0.461 . . . . 40.0 111.113 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' CYS . . . . . 0.64 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -63.33 124.84 22.28 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.688 -0.405 . . . . 40.0 110.062 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 3.3 t -73.37 -20.39 60.77 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.879 -0.328 . . . . 40.0 111.368 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.14 116.63 43.98 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -107.83 47.85 0.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 40.0 110.677 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.74 0.32 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.472 -0.331 . . . . 40.0 110.74 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.06 47.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' HIS . . . . . 0.457 ' C ' HG22 ' A' ' 350' ' ' THR . 0.1 OUTLIER -90.99 4.49 51.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 40.0 110.207 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -62.25 159.03 15.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 40.0 111.082 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.27 108.73 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.585 . . . . 40.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -91.06 135.02 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 174.58 6.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 324' ' ' SER . 17.2 mtt-85 . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 113.49 0.922 . . . . 40.0 113.49 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.23 0.064 0 N-CA-C 110.131 -0.322 . . . . 40.0 110.131 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -145.9 85.7 1.7 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.405 . . . . 40.0 110.274 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.27 53.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' GLN . . . . . 0.485 ' NE2' ' OD1' ' A' ' 390' ' ' ASN . 3.7 mt-30 -66.76 -40.34 88.23 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.743 -0.383 . . . . 40.0 111.354 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.11 34.09 5.37 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.967 -0.293 . . . . 40.0 111.17 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.21 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.405 ' O ' ' CZ ' ' A' ' 325' ' ' ARG . 0.9 OUTLIER 61.28 -20.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.558 . . . . 40.0 111.393 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' CYS . . . . . 0.641 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -63.12 124.84 22.19 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.677 -0.409 . . . . 40.0 110.062 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 487' ' ' THR . 0.1 OUTLIER -73.2 -19.85 61.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 40.0 111.493 -179.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.19 116.63 46.52 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.68 30.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.63 HD22 ' N ' ' A' ' 309' ' ' ASN . 0.8 OUTLIER -107.77 47.88 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 40.0 110.643 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.9 0.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.883 -0.327 . . . . 40.0 110.74 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.09 47.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 312' ' ' HIS . 0.0 OUTLIER -90.92 4.98 50.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 40.0 110.254 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.22 159.01 18.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 40.0 111.082 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 314' ' ' VAL . 14.9 p -121.73 108.29 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 40.0 109.91 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.74 135.02 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 40.0 111.142 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . 0.509 ' OG ' ' CG1' ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 173.79 7.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.574 ' HE ' ' CA ' ' A' ' 325' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.922 -0.581 . . . . 40.0 111.52 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . 0.678 ' SG ' ' O ' ' A' ' 392' ' ' GLU . 1.1 t . . . . . 0 CA--C 1.522 -0.131 0 N-CA-C 109.429 -0.582 . . . . 40.0 109.429 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' THR . . . . . 0.628 ' OG1' ' O ' ' A' ' 349' ' ' CYS . 29.1 p 57.46 85.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.92 -0.582 . . . . 40.0 110.274 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.678 ' O ' ' SG ' ' A' ' 349' ' ' CYS . 61.0 mm-40 -52.09 -37.05 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -66.42 -40.57 89.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.527 -0.306 . . . . 40.0 111.347 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.67 34.09 5.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . 0.561 ' OH ' ' SG ' ' A' ' 349' ' ' CYS . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.49 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt 61.04 -20.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.988 -0.551 . . . . 40.0 111.41 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' CYS . . . . . 0.637 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -63.89 125.03 23.06 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.062 -0.347 . . . . 40.0 110.062 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 487' ' ' THR . 3.5 t -73.14 -20.21 60.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 40.0 111.516 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.09 116.63 46.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.77 29.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -108.1 48.07 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 40.0 110.638 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.78 0.32 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.444 -0.344 . . . . 40.0 110.74 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.94 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' HIS . . . . . 0.614 ' O ' ' ND2' ' A' ' 326' ' ' ASN . 7.4 m-70 -92.35 7.55 42.39 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.058 0.456 . . . . 40.0 110.059 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.94 158.84 21.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.02 -0.536 . . . . 40.0 111.082 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.33 107.65 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.018 -0.537 . . . . 40.0 110.141 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.11 135.02 27.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.95 7.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.682 ' CB ' ' O ' ' A' ' 324' ' ' SER . 21.1 ttm180 122.83 -35.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.651 0.612 . . . . 40.0 112.651 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 312' ' ' HIS . 0.1 OUTLIER 64.0 166.46 0.11 Allowed Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 109.017 -0.735 . . . . 40.0 109.017 -179.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.613 ' O ' ' C ' ' A' ' 328' ' ' GLN . 2.9 Cg_endo -41.71 179.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.702 2.268 . . . . 40.0 112.004 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.813 ' O ' HG23 ' A' ' 329' ' ' ILE . 28.0 mt-30 -17.11 -66.72 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.265 -0.425 . . . . 40.0 110.489 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.813 HG23 ' O ' ' A' ' 328' ' ' GLN . 0.4 OUTLIER -166.43 49.04 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.34 0 CA-C-N 115.825 -0.625 . . . . 40.0 110.603 179.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.492 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 7.1 tpp 61.52 15.83 7.07 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 118.289 -1.364 . . . . 40.0 107.486 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.57 ' H ' HD12 ' A' ' 329' ' ' ILE . 1.5 p90 36.51 34.23 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.201 -1.363 . . . . 40.0 109.225 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' A' ' 333' ' ' ALA . 2.4 pt20 -114.62 -36.56 4.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.193 -0.912 . . . . 40.0 111.223 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . 0.629 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 30.98 97.64 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.533 -0.758 . . . . 40.0 111.471 -178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.448 ' HG2' ' OG1' ' A' ' 339' ' ' THR . 4.8 Cg_exo -67.64 12.67 0.19 Allowed 'Trans proline' 0 C--N 1.297 -2.138 0 C-N-CA 121.739 1.626 . . . . 40.0 109.469 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.629 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 135.58 -50.74 0.84 Allowed Glycine 0 C--N 1.333 0.38 0 CA-C-N 114.633 -1.167 . . . . 40.0 110.73 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 336' ' ' THR . 27.4 m -106.9 35.97 2.82 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 120.728 -0.389 . . . . 40.0 111.055 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' LEU . . . . . 0.901 HD22 ' N ' ' A' ' 337' ' ' LEU . 0.5 OUTLIER 63.3 -101.46 0.1 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.371 0.605 . . . . 40.0 111.358 177.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.716 ' C ' ' HG1' ' A' ' 339' ' ' THR . 0.1 OUTLIER -60.58 -42.74 97.29 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 107.163 -1.421 . . . . 40.0 107.163 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.716 ' HG1' ' C ' ' A' ' 338' ' ' PHE . 2.5 p 57.12 -104.59 0.23 Allowed 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 112.003 -2.362 . . . . 40.0 112.056 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.773 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 15.0 p90 174.06 66.93 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 110.753 -2.931 . . . . 40.0 105.625 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . 0.63 ' O ' ' N ' ' A' ' 345' ' ' ASN . 3.4 Cg_exo -39.43 87.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.234 1.29 . . . . 40.0 112.634 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 340' ' ' PHE . 4.6 p -74.52 -14.55 60.83 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.948 -0.76 . . . . 40.0 108.948 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 344' ' ' THR . 0.3 OUTLIER -53.73 -15.42 1.23 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.599 -0.889 . . . . 40.0 108.599 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.828 ' N ' HD12 ' A' ' 343' ' ' LEU . 4.5 t -179.93 27.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.334 -1.303 . . . . 40.0 109.721 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . 0.678 ' O ' ' O ' ' A' ' 344' ' ' THR . 15.6 m-20 -41.78 -172.91 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.494 0.664 . . . . 40.0 110.5 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . . . . . . . . . 55.5 t80 53.9 18.83 1.74 Allowed 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 119.473 -0.891 . . . . 40.0 110.535 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.468 ' ND2' ' SG ' ' A' ' 349' ' ' CYS . 3.6 t30 -173.24 129.0 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.6 -0.727 . . . . 40.0 109.896 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.18 -34.87 6.25 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.686 0.279 . . . . 40.0 110.819 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.468 ' SG ' ' ND2' ' A' ' 347' ' ' ASN . 3.2 m 72.58 76.38 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 40.0 111.012 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -133.81 85.7 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.738 -0.665 . . . . 40.0 110.274 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.25 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -66.62 -40.01 88.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.529 -0.305 . . . . 40.0 111.466 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.86 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.16 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 16.4 tttp 61.76 -22.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.545 . . . . 40.0 111.269 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' CYS . . . . . 0.643 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.24 124.96 22.27 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.556 -0.457 . . . . 40.0 110.062 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 1.5 m -72.71 -20.95 61.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 40.0 111.326 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.68 116.63 45.27 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.67 30.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.58 47.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.578 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.66 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.807 -0.357 . . . . 40.0 110.74 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.01 47.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' HIS . . . . . 0.485 ' C ' HG22 ' A' ' 350' ' ' THR . 0.0 OUTLIER -91.2 5.78 47.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 40.0 110.304 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.81 158.91 20.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 40.0 111.082 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.6 107.9 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.102 -0.499 . . . . 40.0 110.04 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.21 135.02 27.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 173.1 7.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 51.2 ttm-85 69.73 109.96 0.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 40.0 111.034 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 330' ' ' MET . 0.0 OUTLIER -100.17 151.89 37.66 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 40.0 109.739 179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.556 ' O ' ' C ' ' A' ' 328' ' ' GLN . 2.8 Cg_endo -45.77 178.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.449 2.099 . . . . 40.0 111.921 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.72 ' CD ' ' H ' ' A' ' 328' ' ' GLN . 0.5 OUTLIER -23.89 -58.51 0.05 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.254 -0.43 . . . . 40.0 110.314 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 328' ' ' GLN . 0.6 OUTLIER -163.69 44.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 CA-C-N 115.827 -0.624 . . . . 40.0 110.894 178.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.536 ' H ' ' ND2' ' A' ' 326' ' ' ASN . 8.2 tpt 60.9 14.29 5.13 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 118.17 -1.412 . . . . 40.0 108.378 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.68 ' H ' HD12 ' A' ' 329' ' ' ILE . 23.6 m-85 41.12 28.33 0.06 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.993 -1.003 . . . . 40.0 109.068 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . 0.529 ' O ' ' O ' ' A' ' 333' ' ' ALA . 3.4 pt20 -106.12 -39.9 5.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.211 -0.904 . . . . 40.0 112.27 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . 0.704 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 30.4 99.14 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.086 -0.507 . . . . 40.0 110.659 -177.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 337' ' ' LEU . 4.7 Cg_exo -69.74 17.48 0.2 Allowed 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.022 1.815 . . . . 40.0 108.682 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.704 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 130.0 -54.3 0.79 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 113.768 -1.56 . . . . 40.0 110.037 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.776 ' HB ' HG22 ' A' ' 339' ' ' THR . 6.5 m -106.2 45.81 0.96 Allowed 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 120.692 -0.403 . . . . 40.0 110.898 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' LEU . . . . . 0.887 HD22 ' N ' ' A' ' 337' ' ' LEU . 0.7 OUTLIER 60.6 -104.16 0.17 Allowed 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.677 0.751 . . . . 40.0 112.182 176.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.916 ' O ' ' OG1' ' A' ' 339' ' ' THR . 0.0 OUTLIER -73.88 -39.11 64.16 Favored 'General case' 0 CA--C 1.48 -1.719 0 N-CA-C 107.183 -1.414 . . . . 40.0 107.183 178.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.916 ' OG1' ' O ' ' A' ' 338' ' ' PHE . 28.6 p 65.1 -106.41 0.13 Allowed 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 112.539 -2.119 . . . . 40.0 111.95 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.789 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 20.0 p90 171.82 67.33 0.03 OUTLIER Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 110.479 -3.055 . . . . 40.0 105.867 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 345' ' ' ASN . 4.1 Cg_exo -34.81 95.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 121.105 1.203 . . . . 40.0 111.978 -175.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.607 ' C ' ' H ' ' A' ' 344' ' ' THR . 1.2 p -67.49 -15.51 63.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.2 -0.909 . . . . 40.0 111.063 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 344' ' ' THR . 0.4 OUTLIER -50.32 -8.91 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.548 0.69 . . . . 40.0 109.495 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.731 ' N ' HD12 ' A' ' 343' ' ' LEU . 1.4 t -176.69 -33.6 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.484 -1.235 . . . . 40.0 108.546 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . 0.692 ' O ' ' O ' ' A' ' 344' ' ' THR . 0.0 OUTLIER 36.87 -172.58 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.067 0 CA-C-O 122.143 0.973 . . . . 40.0 111.383 178.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.465 ' O ' ' CD2' ' A' ' 346' ' ' PHE . 90.3 t80 43.94 68.69 0.49 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 113.829 -1.532 . . . . 40.0 111.639 173.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -162.85 -175.26 4.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.196 -0.456 . . . . 40.0 110.405 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 349' ' ' CYS . 0.2 OUTLIER -177.17 179.85 0.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.041 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 348' ' ' TYR . 2.3 t 88.8 -173.73 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.202 0.525 . . . . 40.0 111.707 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -154.75 85.7 1.11 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.281 -0.872 . . . . 40.0 110.274 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.37 53.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.09 -39.31 86.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.87 -0.332 . . . . 40.0 111.463 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.88 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . 0.642 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.02 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 22.6 mttp 61.55 -21.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.786 -0.643 . . . . 40.0 111.375 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' CYS . . . . . 0.642 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.24 124.9 22.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.71 -0.396 . . . . 40.0 110.062 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 9.4 t -73.4 -19.8 60.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.407 -0.36 . . . . 40.0 111.458 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.05 116.63 46.18 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.74 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -107.9 47.7 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 40.0 110.658 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.57 0.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.868 -0.333 . . . . 40.0 110.74 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.85 47.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' HIS . . . . . 0.458 ' C ' HG22 ' A' ' 350' ' ' THR . 27.7 m-70 -91.83 5.96 47.91 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.652 -0.419 . . . . 40.0 110.154 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -62.41 158.99 16.31 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.062 -0.517 . . . . 40.0 111.082 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 314' ' ' VAL . 11.9 p -121.66 108.27 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.906 -0.405 . . . . 40.0 109.906 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.71 135.02 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 40.0 111.142 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . 0.515 ' OG ' ' CG1' ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 171.11 8.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -132.7 134.68 45.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.866 0.365 . . . . 40.0 110.664 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.648 ' N ' ' CD ' ' A' ' 327' ' ' PRO . 1.4 m-80 -156.05 41.47 0.14 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.087 -0.506 . . . . 40.0 110.619 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 326' ' ' ASN . 2.6 Cg_endo -46.78 -177.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.996 2.464 . . . . 40.0 112.577 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.535 ' C ' ' O ' ' A' ' 327' ' ' PRO . 2.0 mt-30 -28.12 -73.28 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.498 -0.774 . . . . 40.0 109.675 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.684 HD12 ' H ' ' A' ' 331' ' ' TYR . 0.6 OUTLIER -150.78 45.54 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 CA-C-N 115.836 -0.62 . . . . 40.0 110.664 178.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.49 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 0.8 OUTLIER 60.18 14.53 4.59 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 118.356 -1.338 . . . . 40.0 108.627 178.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.714 ' O ' ' CG ' ' A' ' 331' ' ' TYR . 13.0 t80 42.5 30.41 0.21 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.524 -1.216 . . . . 40.0 109.505 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . 0.547 ' CG ' ' N ' ' A' ' 333' ' ' ALA . 11.9 pt20 -113.73 -43.24 3.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.382 -0.826 . . . . 40.0 111.195 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . 0.547 ' N ' ' CG ' ' A' ' 332' ' ' GLN . . . 35.87 94.21 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.191 -0.913 . . . . 40.0 111.23 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -72.91 45.08 0.85 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.269 1.98 . . . . 40.0 110.693 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 115.29 -72.87 0.25 Allowed Glycine 0 N--CA 1.454 -0.156 0 N-CA-C 110.221 -1.152 . . . . 40.0 110.221 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.648 ' C ' HD22 ' A' ' 337' ' ' LEU . 0.2 OUTLIER -70.16 -72.42 0.2 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.861 -0.792 . . . . 40.0 108.861 178.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' LEU . . . . . 0.912 ' CG ' ' H ' ' A' ' 338' ' ' PHE . 0.0 OUTLIER 165.49 -83.6 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.277 -1.328 . . . . 40.0 111.368 179.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.912 ' H ' ' CG ' ' A' ' 337' ' ' LEU . 28.8 m-85 -64.19 -52.98 56.29 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 106.394 -1.706 . . . . 40.0 106.394 177.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.845 HG23 ' H ' ' A' ' 337' ' ' LEU . 13.3 p 55.78 -106.24 0.31 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 112.046 -2.343 . . . . 40.0 112.94 177.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.763 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 15.1 p90 171.49 71.46 0.03 OUTLIER Pre-proline 0 C--N 1.292 -1.909 0 CA-C-N 110.315 -3.13 . . . . 40.0 104.774 -175.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . 0.51 ' O ' ' CG ' ' A' ' 345' ' ' ASN . 4.5 Cg_exo -36.11 84.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.297 -2.156 0 C-N-CA 121.842 1.694 . . . . 40.0 113.41 -175.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.618 ' N ' ' O ' ' A' ' 340' ' ' PHE . 0.1 OUTLIER -77.61 -10.08 59.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.913 -0.773 . . . . 40.0 108.913 178.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.511 ' N ' HD23 ' A' ' 343' ' ' LEU . 2.2 pt? -52.3 -18.5 1.59 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.288 -1.004 . . . . 40.0 108.288 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.656 ' O ' ' O ' ' A' ' 345' ' ' ASN . 6.2 t -178.29 26.39 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 113.815 -1.539 . . . . 40.0 109.933 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . 0.656 ' O ' ' O ' ' A' ' 344' ' ' THR . 1.3 m120 -43.51 -176.74 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.821 -0.807 . . . . 40.0 108.821 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.609 ' CG ' ' O ' ' A' ' 346' ' ' PHE . 11.3 t80 52.4 35.87 18.51 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.124 -1.03 . . . . 40.0 110.665 175.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.497 ' O ' ' OD1' ' A' ' 347' ' ' ASN . 13.9 t-20 -156.73 12.79 0.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.724 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -83.99 111.02 18.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.159 0.504 . . . . 40.0 110.925 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 28.3 p -167.01 171.07 11.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.439 -0.8 . . . . 40.0 108.971 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -150.85 85.7 1.36 Allowed 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 119.418 -0.913 . . . . 40.0 110.274 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.32 53.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' GLN . . . . . 0.598 ' H ' HE21 ' A' ' 393' ' ' GLN . 0.8 OUTLIER -67.45 -39.44 85.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.649 -0.42 . . . . 40.0 111.404 -179.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.27 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.832 -0.347 . . . . 40.0 111.17 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . 0.644 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 63.74 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 34.7 tttp 61.29 -21.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.664 -0.698 . . . . 40.0 111.303 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' CYS . . . . . 0.644 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -61.45 124.94 22.04 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.585 -0.446 . . . . 40.0 110.062 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 16.2 m -73.27 -19.7 61.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 40.0 111.526 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.52 116.63 47.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -107.79 47.79 0.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 40.0 110.636 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.7 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.774 0.321 . . . . 40.0 110.74 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.06 47.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' HIS . . . . . 0.465 ' C ' HG22 ' A' ' 350' ' ' THR . 0.9 OUTLIER -91.51 5.59 48.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.915 0.388 . . . . 40.0 110.23 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -62.77 158.97 17.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.985 -0.552 . . . . 40.0 111.082 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 70.4 t -120.73 108.24 22.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 40.0 109.976 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.38 135.02 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.76 7.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.679 ' O ' ' O ' ' A' ' 324' ' ' SER . 19.8 mtt180 42.81 126.17 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.784 -0.644 . . . . 40.0 112.041 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.697 ' N ' ' CD ' ' A' ' 327' ' ' PRO . 16.9 t30 -96.88 -37.28 0.27 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.061 -0.518 . . . . 40.0 111.829 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 326' ' ' ASN . 3.7 Cg_exo -72.27 -176.79 2.34 Favored 'Trans proline' 0 C--N 1.301 -1.968 0 C-N-CA 123.193 2.596 . . . . 40.0 113.919 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -104.38 -37.05 7.37 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.91 -1.95 . . . . 40.0 107.204 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.78 HD13 ' N ' ' A' ' 331' ' ' TYR . 0.0 OUTLIER -168.35 1.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 113.735 -1.575 . . . . 40.0 111.565 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.619 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 12.6 tpt 71.35 15.87 6.2 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.594 -0.842 . . . . 40.0 111.465 176.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.78 ' N ' HD13 ' A' ' 329' ' ' ILE . 6.3 t80 38.65 23.27 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.052 0.453 . . . . 40.0 110.729 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 330' ' ' MET . 11.5 pt20 -118.57 -26.97 6.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 40.0 111.069 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . 0.608 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 16.91 94.92 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 115.419 -0.81 . . . . 40.0 113.147 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 1.012 ' HD3' HG22 ' A' ' 339' ' ' THR . 4.6 Cg_exo -72.63 17.68 0.36 Allowed 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 123.233 2.622 . . . . 40.0 108.686 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.608 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 97.53 18.65 27.51 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 114.286 -1.325 . . . . 40.0 109.951 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.748 ' O ' ' N ' ' A' ' 338' ' ' PHE . 66.6 m -138.21 4.02 2.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.851 -0.674 . . . . 40.0 109.754 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' LEU . . . . . 1.111 ' O ' HG23 ' A' ' 339' ' ' THR . 0.0 OUTLIER 47.26 -72.12 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.275 -0.875 . . . . 40.0 110.289 -178.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.847 ' O ' ' OG1' ' A' ' 339' ' ' THR . 10.4 m-85 -50.53 -17.11 0.44 Allowed 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 105.912 -1.884 . . . . 40.0 105.912 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 1.111 HG23 ' O ' ' A' ' 337' ' ' LEU . 73.7 p 63.53 -109.52 0.27 Allowed 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 112.911 -1.95 . . . . 40.0 110.89 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.682 ' O ' ' N ' ' A' ' 342' ' ' SER . 0.0 OUTLIER 171.92 66.01 0.03 OUTLIER Pre-proline 0 C--N 1.286 -2.169 0 CA-C-N 110.193 -3.185 . . . . 40.0 106.29 -177.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 345' ' ' ASN . 5.4 Cg_exo -30.43 84.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.313 1.342 . . . . 40.0 112.513 -174.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 340' ' ' PHE . 1.7 p -73.18 -6.17 44.04 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.834 -1.076 . . . . 40.0 109.135 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 344' ' ' THR . 0.3 OUTLIER -64.24 -4.71 3.94 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.272 -0.876 . . . . 40.0 108.886 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.67 ' O ' ' N ' ' A' ' 346' ' ' PHE . 2.9 t -178.66 -32.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.358 -1.292 . . . . 40.0 108.969 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' A' ' 341' ' ' PRO . 6.8 m-20 27.06 -82.61 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 122.674 1.226 . . . . 40.0 111.443 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 344' ' ' THR . 17.7 t80 -87.97 -52.22 5.39 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 112.338 -2.21 . . . . 40.0 111.319 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.562 ' N ' ' O ' ' A' ' 344' ' ' THR . 17.8 t-20 -58.12 145.46 36.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.955 -0.566 . . . . 40.0 110.947 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' TYR . . . . . 0.503 ' CZ ' ' OD1' ' A' ' 347' ' ' ASN . 2.4 m-85 24.52 99.11 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.818 -0.628 . . . . 40.0 111.783 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 350' ' ' THR . 21.6 t -70.63 -124.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.444 -0.343 . . . . 40.0 110.504 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -138.92 85.7 2.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 40.0 110.274 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.24 53.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 393' ' ' GLN . 3.5 mt-30 -66.41 -40.6 89.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.498 -0.319 . . . . 40.0 111.299 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ASN . . . . . 0.528 ' OD1' ' CZ ' ' A' ' 346' ' ' PHE . 43.5 m-20 -119.43 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 -21.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 40.0 111.236 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' CYS . . . . . 0.643 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.23 124.96 22.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.567 -0.453 . . . . 40.0 110.062 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 3.1 t -73.5 -19.11 61.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 40.0 111.565 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -71.02 116.63 48.49 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.69 29.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 5.9 p-10 -107.87 47.81 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.697 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.64 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.457 -0.338 . . . . 40.0 110.74 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.88 47.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 312' ' ' HIS . 3.2 t-80 -92.09 7.82 40.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.99 -0.55 . . . . 40.0 110.253 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -65.64 158.94 25.96 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.915 -0.584 . . . . 40.0 111.082 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.75 108.03 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.757 -0.656 . . . . 40.0 110.117 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.93 135.02 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.31 9.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 324' ' ' SER . 11.3 ttp85 77.89 93.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.399 -0.593 . . . . 40.0 109.399 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.537 ' OD1' ' NE2' ' A' ' 312' ' ' HIS . 0.5 OUTLIER -63.43 156.32 70.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 40.0 112.044 -178.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 328' ' ' GLN . 2.6 Cg_endo -80.3 -100.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 123.157 2.571 . . . . 40.0 112.087 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.897 ' O ' HG23 ' A' ' 329' ' ' ILE . 1.0 OUTLIER -65.69 -49.6 67.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.639 -0.504 . . . . 40.0 109.639 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.897 HG23 ' O ' ' A' ' 328' ' ' GLN . 1.0 OUTLIER -175.75 38.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 CA-C-N 115.905 -0.589 . . . . 40.0 110.582 178.246 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.537 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 9.9 tpt 63.0 8.06 3.0 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 118.45 -1.3 . . . . 40.0 108.92 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.868 ' H ' HD12 ' A' ' 329' ' ' ILE . 13.8 t80 50.06 20.48 0.61 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.702 -1.136 . . . . 40.0 108.925 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . 0.526 ' O ' ' C ' ' A' ' 333' ' ' ALA . 16.2 pt20 -95.98 -40.36 9.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.012 -0.994 . . . . 40.0 110.849 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 332' ' ' GLN . . . 18.07 94.82 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.19 -0.914 . . . . 40.0 112.151 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.48 38.59 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.158 1.906 . . . . 40.0 110.834 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 119.48 -69.23 0.35 Allowed Glycine 0 CA--C 1.511 -0.196 0 N-CA-C 110.411 -1.075 . . . . 40.0 110.411 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.661 ' O ' ' HB3' ' A' ' 337' ' ' LEU . 0.2 OUTLIER -69.42 -72.7 0.18 Allowed 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 109.073 -0.714 . . . . 40.0 109.073 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' LEU . . . . . 0.93 ' CG ' ' H ' ' A' ' 338' ' ' PHE . 0.0 OUTLIER 165.95 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.376 -1.284 . . . . 40.0 111.846 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.93 ' H ' ' CG ' ' A' ' 337' ' ' LEU . 13.0 m-85 -60.95 -54.07 49.52 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.702 -1.592 . . . . 40.0 106.702 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.833 HG23 ' H ' ' A' ' 337' ' ' LEU . 22.0 p 53.88 -108.31 0.42 Allowed 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 112.025 -2.352 . . . . 40.0 111.864 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.734 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 13.0 p90 176.19 66.07 0.07 OUTLIER Pre-proline 0 C--N 1.287 -2.11 0 CA-C-N 110.456 -3.065 . . . . 40.0 105.424 -176.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . 0.819 ' O ' ' N ' ' A' ' 345' ' ' ASN . 2.7 Cg_endo -36.6 80.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 121.862 1.708 . . . . 40.0 112.157 -175.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.683 ' N ' ' O ' ' A' ' 340' ' ' PHE . 3.0 p -59.28 -21.73 60.09 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.404 -0.518 . . . . 40.0 110.194 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.12 -18.54 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 122.036 0.922 . . . . 40.0 109.132 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.531 ' N ' ' C ' ' A' ' 342' ' ' SER . 6.6 t -167.69 -38.78 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.632 -1.622 . . . . 40.0 107.937 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . 0.819 ' N ' ' O ' ' A' ' 341' ' ' PRO . 0.0 OUTLIER 43.44 -168.55 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 114.644 -1.162 . . . . 40.0 110.575 178.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 347' ' ' ASN . 46.6 t80 49.0 85.63 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.529 -1.214 . . . . 40.0 110.515 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 346' ' ' PHE . 1.0 OUTLIER -47.2 -175.1 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.505 -0.77 . . . . 40.0 111.728 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' TYR . . . . . 0.429 ' CB ' ' O ' ' A' ' 347' ' ' ASN . 4.6 t80 79.26 81.75 0.06 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.537 -0.756 . . . . 40.0 110.599 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 350' ' ' THR . 1.6 p 173.65 -90.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.677 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p 53.32 85.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.592 -0.731 . . . . 40.0 110.274 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.22 53.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.78 -41.14 88.17 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.547 -0.461 . . . . 40.0 111.263 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.16 34.09 5.33 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.885 -0.326 . . . . 40.0 111.17 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . 0.644 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 63.81 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? 61.68 -22.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.651 -0.704 . . . . 40.0 111.214 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' CYS . . . . . 0.644 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -61.43 124.97 22.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.636 -0.426 . . . . 40.0 110.062 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 487' ' ' THR . 2.5 t -73.11 -20.45 60.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 40.0 111.449 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.7 116.63 45.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -108.03 47.52 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.371 -0.377 . . . . 40.0 110.638 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.08 0.32 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.426 -0.352 . . . . 40.0 110.74 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.07 47.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' HIS . . . . . 0.489 ' C ' HG22 ' A' ' 350' ' ' THR . 0.0 OUTLIER -91.37 6.06 46.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 40.0 110.233 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -64.07 158.91 21.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 40.0 111.082 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.43 108.25 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.04 -0.527 . . . . 40.0 110.014 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.49 135.02 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.5 9.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.637 ' CB ' ' O ' ' A' ' 324' ' ' SER . 2.2 mtp85 142.0 -172.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.433 0.635 . . . . 40.0 110.642 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.798 ' O ' ' O ' ' A' ' 327' ' ' PRO . 0.0 OUTLIER -128.76 163.17 46.98 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.051 -0.977 . . . . 40.0 108.943 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.798 ' O ' ' O ' ' A' ' 326' ' ' ASN . 3.2 Cg_exo -39.9 -145.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 123.071 2.514 . . . . 40.0 112.463 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.663 ' C ' HG22 ' A' ' 329' ' ' ILE . 16.6 mm-40 -71.91 -38.63 69.88 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 106.457 -1.682 . . . . 40.0 106.457 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.907 HD13 ' N ' ' A' ' 331' ' ' TYR . 0.0 OUTLIER -175.02 6.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 113.41 -1.723 . . . . 40.0 110.14 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.511 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 1.5 tpt 71.81 8.5 6.08 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 120.033 -0.667 . . . . 40.0 111.326 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.907 ' N ' HD13 ' A' ' 329' ' ' ILE . 0.1 OUTLIER 43.63 27.51 0.16 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.833 -0.802 . . . . 40.0 108.833 -179.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . 0.601 ' O ' ' C ' ' A' ' 333' ' ' ALA . 0.0 OUTLIER -131.87 -22.0 2.39 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.408 -0.815 . . . . 40.0 112.091 -178.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . 0.669 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 9.07 97.74 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 116.418 -0.355 . . . . 40.0 111.54 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.424 ' CD ' HG21 ' A' ' 339' ' ' THR . 4.7 Cg_exo -65.17 20.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 121.809 1.673 . . . . 40.0 110.433 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.669 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 125.65 -55.53 0.73 Allowed Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.256 -0.884 . . . . 40.0 111.362 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 336' ' ' THR . 28.0 m -103.04 29.56 5.4 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 120.779 0.323 . . . . 40.0 111.377 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' LEU . . . . . 0.876 HD22 ' N ' ' A' ' 337' ' ' LEU . 0.5 OUTLIER 60.58 -102.82 0.14 Allowed 'General case' 0 N--CA 1.425 -1.69 0 C-N-CA 120.384 -0.527 . . . . 40.0 111.205 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.547 ' O ' ' OG1' ' A' ' 339' ' ' THR . 0.7 OUTLIER -46.58 -45.33 18.77 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 106.643 -1.614 . . . . 40.0 106.643 178.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.586 HG22 ' H ' ' A' ' 336' ' ' THR . 3.9 p 50.85 -103.27 0.13 Allowed 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 111.372 -2.649 . . . . 40.0 111.852 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.719 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 16.1 p90 171.7 68.96 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.771 0 CA-C-N 110.292 -3.14 . . . . 40.0 105.381 -176.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 345' ' ' ASN . 3.0 Cg_exo -37.47 84.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.65 1.566 . . . . 40.0 112.168 -175.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.647 ' N ' ' O ' ' A' ' 340' ' ' PHE . 2.6 p -70.22 -14.14 62.49 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.679 -0.691 . . . . 40.0 109.419 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.573 HD12 HG22 ' A' ' 344' ' ' THR . 0.6 OUTLIER -47.41 -14.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.846 0.831 . . . . 40.0 108.969 178.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.573 HG22 HD12 ' A' ' 343' ' ' LEU . 4.7 t -174.65 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.083 -1.417 . . . . 40.0 108.739 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . 0.804 ' O ' ' N ' ' A' ' 347' ' ' ASN . 0.9 OUTLIER 35.69 -152.36 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.59 -0.732 . . . . 40.0 109.996 178.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.521 ' O ' ' O ' ' A' ' 347' ' ' ASN . 29.7 t80 18.86 -68.9 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 113.653 -1.612 . . . . 40.0 112.744 174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.804 ' N ' ' O ' ' A' ' 345' ' ' ASN . 22.2 m120 -35.39 163.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.015 -0.539 . . . . 40.0 111.5 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' TYR . . . . . 0.49 ' C ' ' H ' ' A' ' 350' ' ' THR . 46.9 m-85 58.72 74.54 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.886 -0.597 . . . . 40.0 110.15 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.462 ' O ' ' ND2' ' A' ' 482' ' ' ASN . 49.6 t -72.0 19.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.879 -0.6 . . . . 40.0 111.001 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p 47.76 85.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.616 -0.433 . . . . 40.0 110.274 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.23 53.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -67.01 -40.28 87.26 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.779 -0.368 . . . . 40.0 111.32 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.97 34.09 5.37 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.883 -0.327 . . . . 40.0 111.17 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.1 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 31.6 mttm 61.43 -21.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.949 -0.569 . . . . 40.0 111.357 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' CYS . . . . . 0.643 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.48 125.02 22.49 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.6 -0.44 . . . . 40.0 110.062 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 14.8 p -73.12 -19.73 61.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.127 -0.488 . . . . 40.0 111.563 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.84 116.63 48.09 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.72 29.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.03 47.95 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.397 . . . . 40.0 110.527 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.63 0.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.431 -0.35 . . . . 40.0 110.74 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.95 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' HIS . . . . . 0.469 ' C ' HG22 ' A' ' 350' ' ' THR . 1.5 t60 -91.9 6.38 46.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.941 0.401 . . . . 40.0 110.183 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.0 158.87 18.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.01 -0.541 . . . . 40.0 111.082 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.439 HG23 ' OG ' ' A' ' 323' ' ' SER . 0.4 OUTLIER -120.76 107.79 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.218 -0.446 . . . . 40.0 109.947 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.94 135.02 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . 0.439 ' OG ' HG23 ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 170.52 9.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.505 ' C ' HD22 ' A' ' 326' ' ' ASN . 0.1 OUTLIER -153.09 133.2 13.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.197 0.523 . . . . 40.0 111.646 -179.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.571 HD22 ' N ' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -169.75 62.78 0.45 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.385 -0.825 . . . . 40.0 109.842 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 326' ' ' ASN . 3.7 Cg_exo -75.64 -150.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.955 2.437 . . . . 40.0 112.784 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.686 ' C ' HG22 ' A' ' 329' ' ' ILE . 1.9 mm100 -72.47 -32.36 66.17 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.466 -1.309 . . . . 40.0 107.466 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.786 ' C ' HD13 ' A' ' 329' ' ' ILE . 0.0 OUTLIER -177.27 -6.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.165 -1.38 . . . . 40.0 111.927 179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.687 ' CB ' ' O ' ' A' ' 329' ' ' ILE . 22.9 tpp 88.83 12.3 0.08 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.072 -0.651 . . . . 40.0 111.215 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.725 ' N ' HD13 ' A' ' 329' ' ' ILE . 9.3 t80 48.78 10.99 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.201 -0.666 . . . . 40.0 109.201 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . 0.564 ' N ' ' C ' ' A' ' 330' ' ' MET . 4.7 pt20 -100.7 -40.94 7.11 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.55 -0.75 . . . . 40.0 111.443 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 335' ' ' GLY . . . 31.66 92.73 0.05 OUTLIER Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.854 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -67.19 28.72 0.12 Allowed 'Trans proline' 0 C--N 1.3 -2.007 0 C-N-CA 121.618 1.545 . . . . 40.0 111.203 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 123.65 -61.5 0.58 Allowed Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.765 -0.652 . . . . 40.0 111.825 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.816 ' O ' HD23 ' A' ' 337' ' ' LEU . 2.7 m -76.3 -47.24 24.33 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 121.211 -0.196 . . . . 40.0 110.828 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' LEU . . . . . 0.816 HD23 ' O ' ' A' ' 336' ' ' THR . 0.1 OUTLIER 140.09 -82.53 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 125.247 1.592 . . . . 40.0 107.494 -177.316 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.538 ' O ' ' OG1' ' A' ' 339' ' ' THR . 86.7 m-85 -79.31 -29.8 42.55 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 105.071 -2.196 . . . . 40.0 105.071 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.811 HG23 ' H ' ' A' ' 337' ' ' LEU . 11.9 p 50.76 -105.71 0.21 Allowed 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 111.402 -2.635 . . . . 40.0 111.83 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.725 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 20.0 p90 174.51 66.81 0.05 OUTLIER Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 110.303 -3.135 . . . . 40.0 105.664 -177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . 0.769 ' O ' ' N ' ' A' ' 345' ' ' ASN . 2.8 Cg_endo -36.07 85.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.87 1.713 . . . . 40.0 111.796 -175.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.631 ' N ' ' O ' ' A' ' 340' ' ' PHE . 13.0 p -55.25 -21.76 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.857 -0.611 . . . . 40.0 111.121 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 343' ' ' LEU . 0.1 OUTLIER -49.35 -19.11 0.46 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.878 0.847 . . . . 40.0 109.714 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.634 ' C ' ' OD1' ' A' ' 345' ' ' ASN . 13.6 t -163.82 -37.29 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.004 -1.453 . . . . 40.0 108.138 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . 0.769 ' N ' ' O ' ' A' ' 341' ' ' PRO . 0.2 OUTLIER 40.7 -171.67 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 114.536 -1.211 . . . . 40.0 111.34 177.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' A' ' 347' ' ' ASN . 86.4 t80 46.67 -86.9 0.01 OUTLIER 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 113.711 -1.586 . . . . 40.0 112.362 173.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.554 ' N ' ' O ' ' A' ' 345' ' ' ASN . 22.4 t-20 -39.22 150.84 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.708 0.289 . . . . 40.0 110.571 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' TYR . . . . . 0.523 ' N ' ' OD1' ' A' ' 347' ' ' ASN . 0.3 OUTLIER -137.61 -27.4 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.343 -0.389 . . . . 40.0 110.594 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.78 175.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 40.0 110.203 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -145.22 85.7 1.74 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 40.0 110.274 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.35 53.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -67.65 -39.0 84.61 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.628 -0.429 . . . . 40.0 111.473 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.48 34.09 5.36 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.848 -0.341 . . . . 40.0 111.17 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.12 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 28.6 tttp 61.8 -21.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.019 -0.537 . . . . 40.0 111.434 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' CYS . . . . . 0.641 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -62.69 124.93 22.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.612 -0.435 . . . . 40.0 110.062 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 10.2 p -73.09 -20.39 60.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 40.0 111.431 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.74 116.63 45.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.62 30.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.41 47.04 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 40.0 110.709 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.37 0.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.841 -0.344 . . . . 40.0 110.74 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 152.95 47.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' HIS . . . . . 0.437 ' C ' HG22 ' A' ' 350' ' ' THR . 0.5 OUTLIER -91.06 4.14 52.91 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.141 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -61.21 159.05 12.76 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.068 -0.514 . . . . 40.0 111.082 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.65 108.27 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 40.0 110.068 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.52 135.02 27.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 172.61 7.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -150.56 74.75 1.19 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.939 0.4 . . . . 40.0 110.233 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.508 ' OD1' ' NZ ' ' A' ' 485' ' ' LYS . 1.3 t-20 -128.11 86.29 58.4 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.05 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -61.67 -155.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.348 2.032 . . . . 40.0 112.951 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.494 ' C ' HG22 ' A' ' 329' ' ' ILE . 44.0 mt-30 -40.12 -54.92 2.21 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.003 -0.544 . . . . 40.0 109.701 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.828 HG13 ' HB2' ' A' ' 333' ' ' ALA . 0.0 OUTLIER -154.48 14.91 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 CA-C-N 115.476 -0.784 . . . . 40.0 110.585 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.602 ' CB ' ' O ' ' A' ' 329' ' ' ILE . 3.1 tpt 78.53 16.37 1.17 Allowed 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.685 -0.806 . . . . 40.0 111.854 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.727 ' H ' HD13 ' A' ' 329' ' ' ILE . 52.0 t80 43.38 19.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.865 -0.734 . . . . 40.0 109.043 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . 0.578 ' O ' ' C ' ' A' ' 333' ' ' ALA . 4.5 pt20 -108.54 -40.48 5.09 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.464 -0.789 . . . . 40.0 111.518 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . 0.828 ' HB2' HG13 ' A' ' 329' ' ' ILE . . . 2.12 100.53 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.672 0 CA-C-N 115.784 -0.643 . . . . 40.0 112.488 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.36 29.94 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.563 1.509 . . . . 40.0 110.62 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 124.64 -65.94 0.54 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 110.451 -1.06 . . . . 40.0 110.451 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.624 ' C ' HD22 ' A' ' 337' ' ' LEU . 0.2 OUTLIER -71.54 -72.27 0.23 Allowed 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 108.679 -0.859 . . . . 40.0 108.679 178.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' LEU . . . . . 0.898 ' CG ' ' H ' ' A' ' 338' ' ' PHE . 0.0 OUTLIER 166.25 -88.76 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.268 -1.333 . . . . 40.0 111.718 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.898 ' H ' ' CG ' ' A' ' 337' ' ' LEU . 6.0 m-85 -65.51 -48.22 73.3 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.015 -1.476 . . . . 40.0 107.015 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.839 HG23 ' H ' ' A' ' 337' ' ' LEU . 19.1 p 51.28 -104.22 0.16 Allowed 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 112.985 -1.916 . . . . 40.0 112.827 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.746 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 16.9 p90 174.04 67.01 0.04 OUTLIER Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 109.945 -3.298 . . . . 40.0 104.971 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . 0.751 ' O ' ' N ' ' A' ' 345' ' ' ASN . 3.5 Cg_exo -35.59 86.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.602 1.535 . . . . 40.0 112.396 -175.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 340' ' ' PHE . 0.0 OUTLIER -67.54 -21.48 65.46 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.042 -0.725 . . . . 40.0 109.042 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.698 HD12 HG22 ' A' ' 344' ' ' THR . 0.2 OUTLIER -42.9 -23.95 0.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.91 0.862 . . . . 40.0 109.32 178.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.698 HG22 HD12 ' A' ' 343' ' ' LEU . 12.9 t -160.02 -38.4 0.05 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.048 -1.433 . . . . 40.0 108.342 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . 0.751 ' N ' ' O ' ' A' ' 341' ' ' PRO . 1.5 m-20 38.28 -156.43 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 114.979 -1.01 . . . . 40.0 110.525 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.449 ' CE1' ' ND2' ' A' ' 347' ' ' ASN . 29.3 t80 52.65 92.91 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.454 -1.248 . . . . 40.0 111.263 175.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 347' ' ' ASN . 0.6 OUTLIER 63.83 109.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.506 -0.77 . . . . 40.0 110.222 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 349' ' ' CYS . 1.1 t80 -142.43 -6.53 0.91 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.396 -0.366 . . . . 40.0 110.886 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.446 ' O ' ' O ' ' A' ' 348' ' ' TYR . 1.7 t -60.01 -151.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.003 -0.74 . . . . 40.0 109.003 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -145.18 85.7 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.791 -0.763 . . . . 40.0 110.274 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.39 53.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' GLN . . . . . 0.42 ' OE1' ' OD1' ' A' ' 394' ' ' ASN . 0.0 OUTLIER -67.02 -40.4 87.23 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.593 -0.443 . . . . 40.0 111.175 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -118.55 34.09 5.35 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.773 -0.371 . . . . 40.0 111.17 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . 0.64 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.44 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.508 ' NZ ' ' OD1' ' A' ' 326' ' ' ASN . 0.4 OUTLIER 61.39 -21.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.186 -0.461 . . . . 40.0 111.113 179.153 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' CYS . . . . . 0.64 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -63.33 124.84 22.28 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.688 -0.405 . . . . 40.0 110.062 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' THR . . . . . . . . . . . . . 3.3 t -73.37 -20.39 60.77 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.879 -0.328 . . . . 40.0 111.368 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -69.14 116.63 43.98 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.65 30.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -107.83 47.85 0.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 40.0 110.677 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.74 0.32 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.472 -0.331 . . . . 40.0 110.74 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.06 47.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' HIS . . . . . 0.457 ' C ' HG22 ' A' ' 350' ' ' THR . 0.1 OUTLIER -90.99 4.49 51.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 40.0 110.207 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -62.25 159.03 15.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 40.0 111.082 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.27 108.73 23.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.585 . . . . 40.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -91.06 135.02 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 40.0 111.142 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 174.58 6.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.511 ' O ' ' O ' ' A' ' 326' ' ' ASN . 17.2 mtt-85 81.86 3.99 1.3 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.49 0.922 . . . . 40.0 113.49 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.577 ' O ' ' O ' ' A' ' 327' ' ' PRO . 0.0 OUTLIER 50.75 174.25 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 119.775 -0.77 . . . . 40.0 109.533 179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' A' ' 326' ' ' ASN . 3.4 Cg_exo -46.15 -164.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.034 1.823 . . . . 40.0 113.264 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.652 ' O ' HG23 ' A' ' 329' ' ' ILE . 0.0 OUTLIER -25.23 -73.16 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.357 -0.838 . . . . 40.0 110.375 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 328' ' ' GLN . 0.1 OUTLIER -159.05 51.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 CA-C-N 115.998 -0.547 . . . . 40.0 111.491 179.095 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.525 ' O ' ' CD1' ' A' ' 331' ' ' TYR . 6.4 tpt 60.05 16.6 6.02 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 118.122 -1.431 . . . . 40.0 107.884 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 330' ' ' MET . 8.5 p90 37.41 32.65 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.538 -1.21 . . . . 40.0 109.425 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 330' ' ' MET . 10.6 pt20 -115.66 -33.66 5.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.414 -0.812 . . . . 40.0 110.695 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . 0.712 ' HB1' HD22 ' A' ' 337' ' ' LEU . . . 32.55 87.17 0.11 Allowed Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.568 -0.742 . . . . 40.0 111.6 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 339' ' ' THR . 3.4 Cg_exo -68.01 33.29 0.15 Allowed 'Trans proline' 0 C--N 1.302 -1.92 0 C-N-CA 122.351 2.034 . . . . 40.0 111.429 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 120.79 -66.31 0.44 Allowed Glycine 0 CA--C 1.52 0.357 0 N-CA-C 111.114 -0.795 . . . . 40.0 111.114 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.839 ' O ' HD23 ' A' ' 337' ' ' LEU . 2.2 m -69.1 -51.46 38.39 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 120.776 0.322 . . . . 40.0 110.814 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' LEU . . . . . 0.91 ' H ' HG23 ' A' ' 339' ' ' THR . 0.1 OUTLIER 139.62 -82.21 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 125.437 1.71 . . . . 40.0 106.778 -176.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.652 ' O ' ' OG1' ' A' ' 339' ' ' THR . 59.0 t80 -72.45 -36.18 68.46 Favored 'General case' 0 CA--C 1.472 -2.045 0 N-CA-C 104.328 -2.471 . . . . 40.0 104.328 175.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.91 HG23 ' H ' ' A' ' 337' ' ' LEU . 1.4 p 55.43 -96.94 0.06 Allowed 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 110.821 -2.899 . . . . 40.0 111.843 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.78 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 29.1 p90 167.04 70.31 0.0 OUTLIER Pre-proline 0 C--N 1.288 -2.09 0 CA-C-N 109.708 -3.405 . . . . 40.0 105.668 -176.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . 0.679 ' O ' ' N ' ' A' ' 345' ' ' ASN . 2.5 Cg_endo -39.04 87.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.562 1.508 . . . . 40.0 112.136 -175.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 340' ' ' PHE . 0.0 OUTLIER -68.56 -19.27 64.47 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.54 -0.464 . . . . 40.0 110.063 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -44.89 -19.6 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.919 0.866 . . . . 40.0 109.648 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 346' ' ' PHE . 6.5 t -167.6 -37.5 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.908 -1.496 . . . . 40.0 108.366 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . 0.679 ' N ' ' O ' ' A' ' 341' ' ' PRO . 2.7 m-20 38.17 -86.36 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 122.735 1.255 . . . . 40.0 110.981 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . 0.625 ' N ' ' O ' ' A' ' 344' ' ' THR . 5.4 t80 -66.02 74.46 0.08 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 112.36 -2.2 . . . . 40.0 111.791 -178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.454 ' CG ' ' O ' ' A' ' 346' ' ' PHE . 33.5 m-20 -176.87 46.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.924 -0.58 . . . . 40.0 109.771 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.26 85.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 40.0 110.609 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.416 ' N ' ' O ' ' A' ' 347' ' ' ASN . 3.8 t -113.97 108.84 17.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.905 -0.589 . . . . 40.0 110.131 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 313' ' ' ALA . 29.1 p -145.9 85.7 1.7 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.405 . . . . 40.0 110.274 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 392' ' ' GLU . 61.0 mm-40 -52.09 -37.27 53.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' GLN . . . . . 0.485 ' NE2' ' OD1' ' A' ' 390' ' ' ASN . 3.7 mt-30 -66.76 -40.34 88.23 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.743 -0.383 . . . . 40.0 111.354 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.11 34.09 5.37 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.967 -0.293 . . . . 40.0 111.17 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.21 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.405 ' O ' ' CZ ' ' A' ' 325' ' ' ARG . 0.9 OUTLIER 61.28 -20.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.558 . . . . 40.0 111.393 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' CYS . . . . . 0.641 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -63.12 124.84 22.19 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.677 -0.409 . . . . 40.0 110.062 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 487' ' ' THR . 0.1 OUTLIER -73.2 -19.85 61.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 40.0 111.493 -179.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.19 116.63 46.52 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 1.018 HG23 ' H ' ' A' ' 292' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.568 -0.53 . . . . 40.0 109.568 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 1.018 ' H ' HG23 ' A' ' 291' ' ' THR . 71.2 tt0 -59.51 -31.5 69.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 40.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 20.1 tp -82.16 -33.95 29.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 40.0 110.295 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 16.0 m -67.13 -37.71 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 40.0 110.507 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -34.81 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 40.0 110.683 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.32 63.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 40.0 110.62 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -68.95 -11.09 60.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.332 -0.395 . . . . 40.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -68.18 -21.46 64.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 40.0 110.236 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -110.75 38.92 2.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 40.0 110.443 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' TRP . . . . . 0.947 ' CD2' ' CG ' ' A' ' 495' ' ' PRO . 1.8 t90 -67.56 122.96 19.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 40.0 109.82 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 303' ' ' VAL . 32.3 m -119.11 149.19 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 40.0 111.518 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.73 107.33 12.43 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.129 -0.693 . . . . 40.0 109.129 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 301' ' ' VAL . 55.8 t -101.72 132.17 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.041 0.448 . . . . 40.0 111.709 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -126.14 134.87 51.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 40.0 109.945 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 305' ' ' LEU . 80.1 mt -70.17 148.31 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 40.0 111.524 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 355' ' ' SER . . . -110.91 130.53 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.881 -0.6 . . . . 40.0 110.003 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' THR . . . . . . . . . . . . . 40.0 p -70.11 121.43 17.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 40.0 111.502 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.485 ' OD1' ' C ' ' A' ' 308' ' ' ASN . 12.4 p30 -119.68 156.68 30.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 40.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.63 HD22 ' N ' ' A' ' 309' ' ' ASN . 0.8 OUTLIER -107.77 47.88 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 40.0 110.643 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 310' ' ' ILE . 1.5 tt -140.9 0.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.883 -0.327 . . . . 40.0 110.74 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 350' ' ' THR . 51.4 p -128.7 153.09 47.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 40.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 312' ' ' HIS . 0.0 OUTLIER -90.92 4.98 50.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 40.0 110.254 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.568 ' HB2' ' HB ' ' A' ' 350' ' ' THR . . . -63.22 159.01 18.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 40.0 111.082 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 314' ' ' VAL . 14.9 p -121.73 108.29 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 40.0 109.91 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . . . . . . . . . 76.8 mt -89.74 135.02 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 40.0 111.142 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 321' ' ' GLN . . . -60.17 175.98 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.888 -0.596 . . . . 40.0 110.406 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.61 -32.9 62.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.927 0.394 . . . . 40.0 110.758 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -79.7 -5.19 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 40.0 110.751 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm 60.34 34.71 20.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.414 . . . . 40.0 110.058 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 491' ' ' THR . 86.2 mtt-85 -129.07 16.12 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 40.0 110.604 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 316' ' ' ALA . 23.3 tt0 -156.1 141.06 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 40.0 110.441 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.3 p -143.77 142.9 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.809 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . 0.509 ' OG ' ' CG1' ' A' ' 314' ' ' VAL . 67.6 p -143.68 -172.86 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 40.0 110.498 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . 0.78 ' OG ' ' HB2' ' A' ' 483' ' ' PRO . 6.9 m -121.35 173.79 7.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.284 -0.416 . . . . 40.0 110.565 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.574 ' HE ' ' CA ' ' A' ' 325' ' ' ARG . 0.0 OUTLIER 81.12 -160.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.922 -0.581 . . . . 40.0 111.52 177.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.744 ' O ' ' O ' ' A' ' 327' ' ' PRO . 0.0 OUTLIER -152.65 165.47 17.49 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.256 -0.884 . . . . 40.0 109.719 -179.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.744 ' O ' ' O ' ' A' ' 326' ' ' ASN . 3.0 Cg_exo -41.63 -148.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 123.167 2.578 . . . . 40.0 112.671 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.485 ' C ' ' O ' ' A' ' 327' ' ' PRO . 4.7 mt-30 -34.87 -67.42 0.14 Allowed 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.575 -0.528 . . . . 40.0 109.575 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.76 ' C ' HD13 ' A' ' 329' ' ' ILE . 0.0 OUTLIER -153.67 22.36 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.495 -1.137 0 CA-C-N 115.478 -0.783 . . . . 40.0 108.924 178.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.571 ' HB3' ' O ' ' A' ' 329' ' ' ILE . 2.0 ttt 76.6 16.15 2.02 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.776 -1.102 . . . . 40.0 111.082 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.676 ' H ' HD13 ' A' ' 329' ' ' ILE . 7.7 m-85 38.8 34.29 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.85 -1.167 . . . . 40.0 107.85 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' GLN . . . . . 0.693 ' O ' ' O ' ' A' ' 333' ' ' ALA . 5.5 pt20 -120.15 -50.54 2.25 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.116 -0.947 . . . . 40.0 111.477 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . 0.693 ' O ' ' O ' ' A' ' 332' ' ' GLN . . . 18.75 118.48 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 123.89 0.744 . . . . 40.0 112.368 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 336' ' ' THR . 3.6 Cg_exo -74.57 36.42 0.42 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 N-CA-C 106.425 -2.183 . . . . 40.0 106.425 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.686 ' H ' ' C ' ' A' ' 333' ' ' ALA . . . 82.4 -10.54 54.57 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 106.35 -2.7 . . . . 40.0 106.35 -175.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' THR . . . . . 0.751 ' O ' ' N ' ' A' ' 338' ' ' PHE . 0.2 OUTLIER -119.39 69.63 0.83 Allowed 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 113.611 -1.295 . . . . 40.0 109.702 178.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' LEU . . . . . 1.025 HD22 ' N ' ' A' ' 337' ' ' LEU . 0.8 OUTLIER 39.35 -76.28 0.0 OUTLIER 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.368 -1.287 . . . . 40.0 112.837 178.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.751 ' N ' ' O ' ' A' ' 336' ' ' THR . 0.0 OUTLIER -145.78 -58.76 0.32 Allowed 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 114.378 -1.283 . . . . 40.0 107.735 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.686 ' OG1' ' O ' ' A' ' 338' ' ' PHE . 1.0 OUTLIER 59.25 -99.9 0.1 Allowed 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 111.818 -2.446 . . . . 40.0 112.153 179.207 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.743 ' CD2' ' O ' ' A' ' 340' ' ' PHE . 25.1 p90 173.21 68.67 0.04 OUTLIER Pre-proline 0 C--N 1.293 -1.865 0 CA-C-N 110.42 -3.082 . . . . 40.0 105.296 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . 0.626 ' HB2' HD11 ' A' ' 343' ' ' LEU . 3.1 Cg_exo -37.2 118.43 0.23 Allowed 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 121.704 1.603 . . . . 40.0 111.882 -175.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.577 ' O ' ' N ' ' A' ' 344' ' ' THR . 82.9 p -72.13 -24.08 61.41 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.504 -0.478 . . . . 40.0 111.502 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.987 HD12 ' N ' ' A' ' 344' ' ' THR . 0.7 OUTLIER -44.13 -17.43 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.541 0.686 . . . . 40.0 109.408 178.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.987 ' N ' HD12 ' A' ' 343' ' ' LEU . 2.0 t -179.18 28.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.603 -1.18 . . . . 40.0 109.836 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . 0.61 ' O ' ' O ' ' A' ' 344' ' ' THR . 0.1 OUTLIER -41.72 -176.52 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.636 0.731 . . . . 40.0 110.944 -179.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' PHE . . . . . . . . . . . . . 43.5 t80 56.4 94.42 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.454 -1.248 . . . . 40.0 112.578 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.458 ' O ' ' NE2' ' A' ' 312' ' ' HIS . 15.9 t-20 179.45 56.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.494 -0.776 . . . . 40.0 109.611 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.48 139.2 51.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.26 0.553 . . . . 40.0 111.998 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.678 ' SG ' ' O ' ' A' ' 392' ' ' GLU . 1.1 t -175.53 -52.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.362 -0.836 . . . . 40.0 109.429 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' THR . . . . . 0.628 ' OG1' ' O ' ' A' ' 349' ' ' CYS . 29.1 p 57.46 85.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.92 -0.582 . . . . 40.0 110.274 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -117.71 136.65 12.62 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.956 -0.858 . . . . 40.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.0 m -133.56 155.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.902 0.382 . . . . 40.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.6 mt -121.41 -178.46 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 40.0 109.974 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -85.1 168.12 42.49 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.884 -0.886 . . . . 40.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 306' ' ' ALA . 57.1 p -84.96 -16.04 42.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.39 . . . . 40.0 110.522 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.6 135.98 54.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 40.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . 1.005 ' HB3' ' CE2' ' A' ' 478' ' ' PHE . 59.9 p -87.56 160.09 18.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 40.0 110.739 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . . . . . . . . . 80.6 mt -117.69 119.8 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.522 . . . . 40.0 110.17 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 360' ' ' SER . 64.8 p -132.62 17.92 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.856 -0.338 . . . . 40.0 111.607 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.634 ' HB3' ' O ' ' A' ' 359' ' ' THR . 94.2 p 168.48 161.76 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.595 -0.442 . . . . 40.0 110.917 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 71.18 178.05 27.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.729 -0.948 . . . . 40.0 110.729 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 445' ' ' PHE . 77.9 mttt -101.46 149.86 23.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.858 -0.337 . . . . 40.0 110.644 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -139.42 143.31 37.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 40.0 110.322 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 364' ' ' TYR . 29.3 t80 -145.86 133.4 20.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.087 0.47 . . . . 40.0 111.148 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' TRP . . . . . 0.466 ' CE2' ' HB ' ' A' ' 444' ' ' VAL . 40.6 p90 -151.17 150.46 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.675 . . . . 40.0 109.813 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.06 153.37 23.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 40.0 111.174 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.421 HG22 HD23 ' A' ' 492' ' ' LEU . 92.7 t -130.31 125.8 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.734 -0.666 . . . . 40.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -89.31 114.66 26.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.429 . . . . 40.0 111.328 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 369' ' ' VAL . 33.7 m -119.92 51.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.829 -0.623 . . . . 40.0 109.603 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 371' ' ' LYS . 49.8 m -79.87 128.14 33.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 40.0 111.271 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 370' ' ' SER . 65.6 mttt 75.36 1.65 3.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.904 -0.589 . . . . 40.0 111.544 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.662 ' HG2' ' HB ' ' A' ' 488' ' ' VAL . 19.6 mtpp -80.68 134.84 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.668 -0.413 . . . . 40.0 109.923 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 94.8 p -99.5 -0.26 41.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 40.0 111.52 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 408' ' ' LEU . . . -174.35 142.35 0.78 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.832 -0.347 . . . . 40.0 110.687 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' TRP . . . . . 0.676 ' O ' ' CE3' ' A' ' 375' ' ' TRP . 12.2 p-90 -179.55 155.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 40.0 110.767 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 482' ' ' ASN . 2.3 mm -127.9 122.72 59.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.512 . . . . 40.0 109.957 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 377' ' ' LEU . 4.2 pp -141.13 153.42 45.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 40.0 111.083 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.486 ' HA3' HG12 ' A' ' 405' ' ' VAL . . . 160.69 -123.69 1.24 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.5 -1.04 . . . . 40.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 477' ' ' VAL . 71.7 t -136.79 140.27 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 40.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 47.6 t -133.35 153.61 51.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.446 . . . . 40.0 110.656 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ALA . . . . . . . . . . . . . . . -98.14 -0.91 43.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.517 . . . . 40.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 125.3 177.22 14.81 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.143 -0.783 . . . . 40.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -103.17 26.14 8.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 40.0 110.435 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -63.8 -40.36 96.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 40.0 110.817 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . 0.417 ' O ' ' CD1' ' A' ' 391' ' ' ILE . 79.9 p -109.19 51.73 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.313 -0.403 . . . . 40.0 110.546 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -104.03 -22.6 13.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 40.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -84.86 -47.87 9.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 40.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.1 ttp -52.29 -41.44 62.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.887 -0.597 . . . . 40.0 111.426 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.664 ' O ' ' C ' ' A' ' 390' ' ' ASN . 28.8 m-85 -117.96 34.41 5.17 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 40.0 111.488 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.664 ' C ' ' O ' ' A' ' 389' ' ' TYR . 80.7 m-20 19.54 61.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.314 -0.554 . . . . 40.0 109.83 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.684 ' HA ' ' HB3' ' A' ' 396' ' ' ASN . 69.5 mt -66.34 -72.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.956 -0.566 . . . . 40.0 111.471 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.678 ' O ' ' SG ' ' A' ' 349' ' ' CYS . 61.0 mm-40 -52.09 -37.05 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 40.0 111.773 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -66.42 -40.57 89.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.527 -0.306 . . . . 40.0 111.347 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 395' ' ' GLU . 43.5 m-20 -119.67 34.09 5.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.66 0.267 . . . . 40.0 111.17 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 394' ' ' ASN . 57.6 mt-10 35.43 46.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.352 -0.386 . . . . 40.0 110.701 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.685 ' HA ' ' HG3' ' A' ' 428' ' ' PRO . 49.8 t30 -87.91 61.92 6.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.319 -0.401 . . . . 40.0 110.387 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . 0.561 ' OH ' ' SG ' ' A' ' 349' ' ' CYS . 28.2 m-85 -79.62 125.31 29.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.603 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . 0.546 ' HB2' ' CD2' ' A' ' 401' ' ' TYR . 61.7 mt-30 -149.36 139.59 13.47 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.118 0.485 . . . . 40.0 110.681 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.544 ' HD2' ' OD1' ' A' ' 419' ' ' ASP . 2.2 Cg_endo -58.88 -27.47 84.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.457 2.105 . . . . 40.0 111.631 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 401' ' ' TYR . 18.5 ptpt -74.88 -15.44 60.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.146 0.498 . . . . 40.0 109.768 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . 0.546 ' CD2' ' HB2' ' A' ' 398' ' ' GLN . 20.7 m-85 -102.48 -4.76 24.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 40.0 110.122 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . 95.5 43.36 3.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.914 -1.275 . . . . 40.0 109.914 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -137.76 112.5 8.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.239 0.543 . . . . 40.0 111.856 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' TRP . . . . . . . . . . . . . 15.4 m-90 -121.94 77.87 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.558 -0.905 . . . . 40.0 108.558 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.486 HG12 ' HA3' ' A' ' 378' ' ' GLY . 14.6 m -136.47 168.73 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.839 0.828 . . . . 40.0 113.044 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' ILE . . . . . . . . . . . . . 28.0 pt -124.6 157.24 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.097 -1.41 . . . . 40.0 107.782 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' HA3' HD13 ' A' ' 376' ' ' ILE . . . -140.34 162.83 26.48 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 119.368 -1.396 . . . . 40.0 113.539 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 374' ' ' ALA . 8.3 tp -131.9 133.12 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.304 -0.948 . . . . 40.0 108.67 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLN . . . . . 0.842 ' O ' ' HB2' ' A' ' 413' ' ' LYS . 9.2 pt20 -142.78 147.75 36.04 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.194 -0.602 . . . . 40.0 111.951 -178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 58.3 mt-10 75.43 -6.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.524 -0.762 . . . . 40.0 110.84 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 107.35 -35.9 4.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.788 -0.72 . . . . 40.0 112.767 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.39 25.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 117.281 0.541 . . . . 40.0 111.911 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . 0.842 ' HB2' ' O ' ' A' ' 409' ' ' GLN . 80.2 mttt -116.14 90.42 3.33 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.134 -0.626 . . . . 40.0 111.29 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' TYR . . . . . 0.597 ' CZ ' HD13 ' A' ' 408' ' ' LEU . 96.0 m-85 -89.56 149.71 22.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.687 . . . . 40.0 109.921 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 430' ' ' ILE . 18.6 m -162.59 158.27 23.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.023 0.44 . . . . 40.0 111.21 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 416' ' ' VAL . 7.5 p -116.84 127.66 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.764 -0.653 . . . . 40.0 110.079 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -79.18 122.66 26.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 40.0 110.977 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -122.52 174.62 6.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 40.0 110.146 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 399' ' ' PRO . 81.3 m-20 -65.9 138.95 58.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 40.0 110.54 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -108.65 166.38 12.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.112 -0.795 . . . . 40.0 111.112 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 28.0 t -58.95 138.31 57.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.734 0.302 . . . . 40.0 110.612 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' SER . . . . . 0.853 ' O ' ' HD3' ' A' ' 425' ' ' PRO . 59.4 p -63.6 -24.19 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 40.0 110.505 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -63.79 -20.23 65.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.094 0.473 . . . . 40.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 425' ' ' PRO . 35.2 p -136.83 64.67 50.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 40.0 109.268 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . 0.853 ' HD3' ' O ' ' A' ' 422' ' ' SER . 4.1 Cg_exo -59.86 -25.13 78.48 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 123.229 2.619 . . . . 40.0 113.808 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.38 18.95 2.04 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.315 -0.554 . . . . 40.0 111.486 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . . . -150.5 121.88 3.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 40.0 111.029 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 396' ' ' ASN . 3.4 Cg_exo -78.09 173.61 13.69 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.949 2.433 . . . . 40.0 112.289 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -105.77 74.5 1.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 40.0 110.084 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 430' ' ' ILE . 19.4 mt -60.39 129.11 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 40.0 111.747 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 69.6 t -119.02 128.58 25.87 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 108.932 -0.766 . . . . 40.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 431' ' ' VAL . 3.2 Cg_exo -72.52 134.14 21.88 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.605 2.204 . . . . 40.0 112.815 -178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 73.6 mt -98.56 141.53 31.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.651 -0.704 . . . . 40.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 22.6 t -87.07 88.74 7.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.872 0.368 . . . . 40.0 110.63 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' VAL . . . . . . . . . . . . . 65.6 t -103.37 120.46 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.085 -0.507 . . . . 40.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.3 -43.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 40.0 110.137 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 45.9 mm -105.01 97.64 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.809 -0.632 . . . . 40.0 111.0 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 99.7 m -44.65 119.66 3.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.593 -0.443 . . . . 40.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.9 127.36 11.41 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.915 2.41 . . . . 40.0 112.617 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.27 -8.68 38.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 40.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.941 ' NH1' ' SG ' ' A' ' 493' ' ' CYS . 26.1 ttm180 -159.62 124.84 4.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.254 -0.884 . . . . 40.0 109.309 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.41 135.3 46.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 40.0 111.553 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -104.29 127.59 9.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.657 -0.977 . . . . 40.0 110.657 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 365' ' ' TRP . 17.1 t -108.88 126.85 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.889 0.376 . . . . 40.0 110.911 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 362' ' ' LYS . 23.7 t80 -122.04 128.72 51.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 40.0 109.925 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 74.7 t -122.69 125.49 72.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.002 0.429 . . . . 40.0 111.44 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 451' ' ' CYS . 42.7 t0 -113.01 72.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.861 -0.609 . . . . 40.0 110.487 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 447' ' ' ASP . 3.8 t80 -35.16 -59.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 40.0 111.153 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.658 ' HA ' ' OE1' ' A' ' 449' ' ' GLU . 7.7 mm-40 -48.53 -51.3 28.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.488 . . . . 40.0 111.178 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -80.2 -14.63 58.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.382 -0.372 . . . . 40.0 111.135 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 447' ' ' ASP . 81.3 m 61.34 61.54 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.675 -0.41 . . . . 40.0 110.086 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 468' ' ' PHE . 68.9 p -144.24 144.89 31.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.017 0.437 . . . . 40.0 111.429 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 468' ' ' PHE . 48.2 t -127.59 110.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 40.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.6 m -106.45 150.31 26.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.267 0.556 . . . . 40.0 112.141 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -123.23 121.88 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.201 -0.909 . . . . 40.0 109.125 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.91 145.19 34.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.06 0.457 . . . . 40.0 111.676 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -97.93 79.55 2.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.704 -0.68 . . . . 40.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 441' ' ' ARG . 17.6 mm -42.36 -40.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 40.0 111.69 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' THR . . . . . . . . . . . . . 21.3 m -70.15 -21.38 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.971 -0.291 . . . . 40.0 111.53 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -109.44 63.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 40.0 110.726 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 53.66 14.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 40.0 110.506 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 71.06 33.3 65.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.333 -0.707 . . . . 40.0 111.333 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -71.23 145.46 49.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.041 -0.355 . . . . 40.0 110.041 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.53 133.3 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 40.0 111.135 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.76 -51.09 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.838 -0.619 . . . . 40.0 109.683 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -157.41 158.48 35.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.265 -0.879 . . . . 40.0 109.213 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -147.57 120.04 8.48 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.351 -0.54 . . . . 40.0 111.465 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 452' ' ' THR . 56.3 m-85 -84.11 121.95 28.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 40.0 110.0 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . . . . . . . . . 24.8 m -111.18 154.42 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 40.0 111.401 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 53.48 50.54 17.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 40.0 110.698 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 71.0 m -78.07 139.55 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 40.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.4 m -76.46 78.98 3.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 40.0 110.223 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 451' ' ' CYS . 9.5 m-30 -88.04 64.85 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 40.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 51.5 p -96.37 -9.31 30.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 40.0 110.002 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 476' ' ' PRO . 9.5 mtpp -131.31 166.29 28.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 40.0 110.152 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 475' ' ' LYS . 2.4 Cg_endo -72.66 125.73 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.664 2.243 . . . . 40.0 111.639 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 379' ' ' VAL . 29.1 m -104.01 157.63 5.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 40.0 111.434 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' PHE . . . . . 1.005 ' CE2' ' HB3' ' A' ' 357' ' ' SER . 3.1 m-85 -135.48 158.6 74.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 40.0 109.851 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.16 122.88 10.22 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.252 1.968 . . . . 40.0 110.567 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . 0.492 ' C ' HD12 ' A' ' 481' ' ' LEU . 76.5 t80 -97.72 134.95 40.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 40.0 112.405 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 480' ' ' TYR . 3.7 mp -135.93 144.24 45.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.295 -0.866 . . . . 40.0 109.306 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 376' ' ' ILE . 39.5 t-20 -158.93 108.05 1.58 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.195 -0.602 . . . . 40.0 111.704 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.78 ' HB2' ' OG ' ' A' ' 324' ' ' SER . 3.1 Cg_exo -52.15 -38.78 71.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.556 2.171 . . . . 40.0 111.327 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 486' ' ' CYS . 25.8 ttt180 69.97 64.49 0.23 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 40.0 110.281 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt 61.04 -20.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.988 -0.551 . . . . 40.0 111.41 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' CYS . . . . . 0.637 ' H ' ' C ' ' A' ' 484' ' ' ARG . 38.2 t -63.89 125.03 23.06 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.062 -0.347 . . . . 40.0 110.062 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 487' ' ' THR . 3.5 t -73.14 -20.21 60.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 40.0 111.516 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.662 ' HB ' ' HG2' ' A' ' 372' ' ' LYS . 65.8 t -70.09 116.63 46.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.088 0.471 . . . . 40.0 109.894 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.39 141.0 72.62 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.985 2.457 . . . . 40.0 114.866 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' MET . . . . . 0.471 ' H ' ' HG2' ' A' ' 490' ' ' MET . 8.4 ptm -107.77 114.42 28.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.784 -1.098 . . . . 40.0 110.164 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' THR . . . . . 0.88 HG22 ' H ' ' A' ' 492' ' ' LEU . 7.0 m -97.23 176.0 6.07 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.149 0.796 . . . . 40.0 113.149 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' LEU . . . . . 0.88 ' H ' HG22 ' A' ' 491' ' ' THR . 5.3 mt -127.0 76.61 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.568 -1.197 . . . . 40.0 112.13 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' CYS . . . . . 0.941 ' SG ' ' NH1' ' A' ' 441' ' ' ARG . 60.4 m -7.48 -114.94 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.134 -1.026 . . . . 40.0 109.843 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' SER . . . . . 0.907 ' HB2' ' O ' ' A' ' 493' ' ' CYS . 31.6 m 114.83 102.28 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 108.049 -1.093 . . . . 40.0 108.049 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.947 ' CG ' ' CD2' ' A' ' 300' ' ' TRP . 3.5 Cg_exo . . . . . 0 C--N 1.293 -2.389 0 C-N-CA 124.879 3.719 . . . . 40.0 112.318 -177.463 . . . . . . . . 1 1 . 1 stop_ save_